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Type VI Secretion Systems (T6SSs) are critical virulence determinants in several Gram-negative 
pathogens. In Burkholderia pseudomallei, the etiological agent of melioidosis, the T6SS-1 cluster 
is essential for bacterial virulence in mammalian hosts. It plays a role in the intracellular life cycle 
of this pathogen, such as intracellular replication and induction of multi-nucleated giant cell 
formation that facilitates intercellular spread. T6SS-1 expression is only upregulated upon host 
cell infection, indicating that T6SS-1 expression requires sensing of signals from the host 
cell. Inside the host, the BsaN regulator from the T3SS-3 cluster controls the gene expression of 
both VirAG and BprC, which are the regulators of T6SS-1 genes. While most of the T6SS-1 
genes are under VirAG control, only the tssAB operon requires both VirAG and BprC. VirAG is a 
two-component sensor regulatory system, with VirA being the sensor kinase and VirG being the 
cognate response regulator. Using immunofluorescence staining and the promoter of hcp1 linked 
to EGFP reporter in wildtype bacteria and an escape-deficient mutant, we identified that the 
expression of Hcp1, a major component of T6SS-1 under VirAG control, occurs when the 
bacteria had escaped from the phagosomal compartment into the cytosol. We also discovered that 
low molecular weight thiols such as cysteine and glutathione, present mainly in the cytosolic 
compartment, significantly upregulate hcp1 expression through VirA.  Mammalian cells depleted 
of glutathione showed significant reduction of T6SS1 expression when infected with bacteria. We 
hypothesize that thiol compounds reduce the disulphide bonds formed between the cysteine 
residues in VirA. Through site directed mutagenesis, we identified a cysteine residue on VirA that 
is likely located in the bacterial periplasm that when mutated leads to constitutive hcp1 
expression.  Work is in progress to elucidate the chemical modifications of VirA by thiol 
compounds. These results will help us understand how B. pseudomallei adapts to the mammalian 
host environment to aid in survival and persistence through the sensing of host cytosolic signals. 
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1.1 Overview of Bacterial Secretion Systems 
Bacteria have to constantly influence their external environment in ways that benefit them in 
order to thrive in them. Protein secretion systems, which are macromolecular complexes that 
span the bacterial envelopes for translocating substrates from the cytoplasm out to the 
extracellular environment or a target cell, are systems that bacteria use to modify their 
environment. The proteins they secrete include adhesins, toxins, proteases and effector 
proteins, which are involved in nutrient acquisition, organelle biogenesis, motility and 
virulence for pathogenic bacteria (Mota and Cornelis, 2005; Gerlach and Hensel, 2007; 
Sandkvist et al., 1997).  Although the secretion of most of these proteins into the media or to 
their cell surfaces is an essential process for all bacteria, secretion of virulence factors is a 
virulence determinant for pathogenic bacteria.  
 
As Gram-negative bacteria have two lipid bilayers, proteins have to be transported across 
both inner and outer membranes in order to be targeted into the medium or target cells. As 
such, they have evolved more complicated, specialized and dedicated secretion systems that 
are exclusively restricted to them.  These systems are widespread in pathogenic bacteria, 
allowing them to target eukaryotic cells, to modify host physiology and to replicate within the 
host. Thus far, six secretion systems have been identified in Gram-negative bacteria, namely 
Type I through Type VI (Tseng et al., 2009). Each of these systems possesses distinct 
characteristics, which involve specific components for the transport of effector proteins across 
the inner membrane, the periplasm and the outer membrane of the bacterial cell envelope. 
Secretion systems are classified into two main groups: the Sec dependent or the Sec-
independent systems (Saier, 2007). A summary of all known bacterial secretion systems is 






Figure 1. Schematic diagrams of protein secretion systems in Gram-negative bacteria. 
OM: outer membrane; IM: inner membrane; HM: host membrane; OMP: Outer membrane 
protein; MFP: membrane fusion protein adapted from (Tseng et al., 2009).  
 
The Sec dependent system or the general secretory pathway (GSP or Sec) is common to both 
Gram-positive and negative bacteria for the transport of proteins across the cytoplasmic 
membrane. These include the Type II secretion and the Type V autotransporters. The 
hallmark of this system is that the Sec translocase machinery recognizes a 15-25 amino acid 
signal sequence at the N terminal of the proteins being targeted for secretion, and translocates 
them across the inner membrane into the periplasmic region in an unfolded state (Papanikou 
et al., 2007). They may remain there or be transported through a channel made by special 
pore forming proteins (T2SS) or autotransportered (T5SS) across the outer membrane 
(Stathopoulos et al., 2000).   
 
Sec independent pathways tend to allow a more direct way of protein transport across both the 
inner and outer membrane simultaneously, bypassing the general Sec machinery (Tseng et al., 
2009). These include the Type I secretion, or ATP-binding cassette transporter; the Type III 
secretion; the Type IV secretion, or conjugation and virulence related systems; and the Type 
VI secretion system.  
 
Type III Secretion System (T3SS) 
A well characterized and studied secretion system is the Type III secretion system which is 
largely restricted to but widespread in Gram-negative pathogenic bacteria such as Yersinia, 
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Samonella, Shigella, Escherichia and Pseudomonas etc (Mota and Cornelis, 2005). 
Structurally, T3SS appears to have evolved from the bacterial flagella system, as many of the 
components are homologous to proteins involved in flagellar assembly apparatus (Cornelis, 
2006; Saier, 2004). Instead of releasing toxins into the extracellular milieu, T3SS is an 
injectisome nanomachine that allows bacteria to inject toxins, which are called effectors, 
directly into host cytosol upon close contact with host cells (Mota and Cornelis, 2005). This 
system is often associated with the secretion of virulence factors across the bacterial envelope 
into host cytoplasm. In this way, extracellular antibodies from the host against the effectors 
will not be triggered (Coombes and Finlay, 2005).  
  
Inside the host, T3SS effectors thwart host cellular processes, including immune and defense 
responses to the benefit of the bacteria (Mota and Cornelis, 2005). Even though T3SS 
effectors from different bacteria display a large repertoire of cellular functions, certain groups 
of them have somewhat conserved biological functions. For instance, SopE form Salmonella 
and BopE from Burkholderia are Guanine Exchange Factors (GEFs) that modulate 
the function of guanosine triphosphate (GTP)-binding proteins such as Cdc42 and Rac1, 
which promote cytoskeleton rearrangements for the invasion of non-phagocytic cells (Stevens 
et al., 2003; Hardt et al., 1998). Other functions include inhibiting mitogen-activated protein 
kinases (MAPKs) (Orth et al., 1999; Trosky et al., 2004),  inducing caspase 1 dependent cell 
death in the host (Sun et al., 2005; Hilbi et al., 1998; Hersh et al., 1999), and modulating 
transcription factors such as nuclear factor NF-kappaB (Schesser et al., 1998; Haraga and 
Miller, 2003; Collier-Hyams et al., 2002). These alterations of crucial host regulatory 
molecules and cellular signalling pathways allow the bacteria to inhibit phagocytosis, to 
invade both non-phagocytic and phagocytic cells, to replicate and colonize within the host, to 
modulate host inflammatory responses, to induce apoptosis, or to disrupt host vesicular 
trafficking (Mota and Cornelis, 2005; Scherer et al., 2000; Sun et al., 2005). Ultimately, these 
allow the bacteria to evade the host defence systems to favour its survival and persistence 




Clearly, regulation of T3SS requires several mechanisms to ensure synchronized T3SS gene 
expression with its cellular functions that were mentioned previously. As T3SS of various 
pathogens functions as a primary defense mechanism against phagocytosis or for invasion, 
host cell contact is a primary activating signal for T3SS gene expression and secretion in 
these pathogens (Hayes et al., 2010). The central regulators involved are usually members of 
the AraC family. For instance, the T3SS Salmonella pathogenic island 1 (SPI-1) is expressed 
through the AraC regulator HilA upon intimate contact between the pathogen and the host to 
initiate invasion of non-phagocytic epithelial cells (Lee et al., 1992). Similarly, the T3SS of 
Pseudomonas aeruginosa and T3SS-3 of Burkholderia pseudomallei were shown to be 
induced upon host cell contact through the regulators ExsA and BsaN respectively (Diaz et al., 
2011; Chen et al., 2011). In addition, environmental signals such as Ca2+
(Ellermeier and Slauch, 
2008)
 limitation and iron 
availability also activate T3SS SPI-1 transcription in Salmonella 
. Upon invasion, expression of SPI-1 genes is downregulated while T3SS SPI-2 genes is 
upregulated within the Salmonella-containing vacuole (SCV) in response to phagosomal 
signals such as acidic pH, antimicrobial peptides, limitation of Ca2+and Mg2+ (Prost and 
Miller, 2008)
 
. The upregulation of SPI-2 permits intracellular proliferation and persistence of 
Salmonella inside its host. Such examples illustrate the precise temporal and spatial regulation 
of T3SS for efficient pathogenesis of the bacteria.  
 
1.2 Type VI Secretion Systems 
 
1.2.1 Discovery of T6SS 
When it comes to Type VI Secretion System (T6SS), much less is known compared to T3SS. 
Despite being named T6SS only in 2006, hints of its existence were present a decade ago with 
a finding by Williams et al showing that a haemolysin co-regulated protein (Hcp) from Vibrio 
cholerae was secreted by a novel mechanism (Williams et al., 1996). Initially, the T6SS were 
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identified as T4SS-related machineries as one of the genes is of high homology to the IcmF 
protein of the T4SS in Legionella pneumophila (Das and Chaudhuri, 2003). As such the 
conserved loci found in multiple bacteria were previously designated as IAHP, which stands 
for IcmF-associated homologous proteins (Das and Chaudhuri, 2003). However, other T4 
components are not encoded within the T6SS loci. At about the same time, Spaink and 
colleagues showed that a large gene cluster (imp cluster) from Rhizobium participates in 
protein export and thus mark the discovery of a novel secretion system (Bladergroen et al., 
2003). T6SS has only moved centre-stage after its discovery as a new player in bacterial 
pathogenesis in V. cholerae and P. aeruginosa by John Mekalanos's group in 2006 (Pukatzki 
et al., 2006; Mougous et al., 2006). Subsequently, there have been extensive studies on T6SS 
structure (Leiman et al., 2009), characterization of effectors (Pukatzki et al., 2009), secretion 
mechanisms (Basler et al., 2012), T6SS roles in host pathogenesis  and most recently, on 
genetic regulation of T6SS.   
1.2.2 T6SS gene clusters 
Sequence analysis indicates that the T6SS clusters are found in more than 100 sequenced 
genomes of a wide range of Gram-negative bacteria such as Salmonella typhimurium, 
Escherichia coli, Yersinia pestics, Edwardsiella tarda, Francisella tularensis, P. aeruginosa, 
V. cholera and Burkholderia species (Boyer et al., 2009). As it is widely distributed, it might 
be one of the most common secretion systems utilized by pathogens for pathogenesis.  
Comparative genomic analyses revealed that the T6SS gene clusters, which generally consist 
of 15-20 genes, are in a specifically conserved genetic organization (Cascales, 2008; 
Shrivastava and Mande, 2008). However, there are some variations in terms of composition 
and gene arrangement between species (Boyer et al., 2009). Most of these conserved genes 
encode for proteins that constitute the core components that are essential for secretory 




In certain cases, there are multiple T6SS copies in a single organism. For instance, there are 
five T6SS gene clusters in the genomes of Y. pestis and up to six clusters in Burkholderia 
species (Bingle et al., 2008; Schell et al., 2007). This suggests redundancy for virulence or 
that each T6SS may be important in a context-specific manner, such as having a role 
specifically for a particular ecological setting or host (Schwarz et al., 2010).  
1.2.3 Structure of the Type VI Secretion System 
T6SS is composed of at least 13 subunits, which are believed to be the essential structural 
components of the secretion apparatus. Aside from these, there are accessory proteins which 
are proposed to facilitate T6SS assembly or may confer regulatory roles both transcriptionally 
and post translationally in activating the system. Even though a high resolution structure of 
the whole system is not avaliable yet, a comprehensive model of the dynamic of T6SS 
assembly, secretion and disassembly has recently been proposed (Basler et al., 2012; Brunet 
et al., 2013; Leiman et al., 2009). Biochemical, bioinformatics and structural studies suggest 
that T6SS core components assemble into an apparatus resembling an inverted bacteriophage 
tail that is embedded in the bacterial cell envelope (Leiman et al., 2009). In general, models 
suggest that T6SS injects proteins into host cells in a way that is somehow similar to how T4 
phage injects DNA into bacterial cells (Leiman et al., 2009). Figure 2 depicts a schematic 




Figure 2. Schematic drawings of the T4 bacteriophage in comparison with the putative 
T6SS. A) T4 bacteriophage are attached to the membrane of host cells via the tail fibers. 
Upon contraction of its tail sheath, it delivers the tail spike carrying its DNA into bacterial 
host cells. B) Putative T6SS structure based on homology to phage proteins and localization 
of core components depicts an inverted T4 Phage. Similarly, upon contraction of its sheath, 
T6SS translocate its spike-like protein together with its effectors into target host membrane. 
T6SS components and the homologous proteins counterparts in phage are represented in the 
same color (adapted from (Ho et al., 2014)  
 
Hcp and VgrG  
Among all the conserved proteins, Hcp and valine-glycine repeat G (VgrG) are the hallmarks 
of T6SS. Hcp is assembled into hexameric rings which then polymerize in a head to head or 
head-to-tail fashion to form a filamentous tubular structure of stacked hexamers (Mougous et 
al., 2006; Cascales and Cambillau, 2012). The tertiary structure is similar to that of the gpV, a 
major tail filament protein of phage λ (Mougous et al., 2006).  Plausibly, the Hcp tube forms 
the channel for effector proteins or substrates to be transported out of the bacterial cell. VgrG, 
which is assembled into a trimer, docks at the tip of the Hcp tube, and assumes a folded and 
quaternary arrangement similar to the spike of T4 bacteriophage gp27/gp5 complex. This is 
somewhat akin to the T4 bacteriophage cell-puncturing device, which is the needle or spike, 




membrane, allowing the substrate or effectors carried by the Hcp tube to be delivered into the 
host cell cytosol (Silverman et al., 2012) .  
According to the phage model of T6SSs, Hcp and VgrG are expected to be physically 
attached.  In fact, several groups have reported that Hcp and VgrG display codependency for 
assembly and secretion (Pukatzki et al., 2007; Hood et al., 2010; Pukatzki et al., 2006). In a 
proposed model, it suggests that Hcp polymerization requires the recruitment of VgrG to the 
apparatus (Pukatzki et al., 2009). It is conceivable that when the VgrG trimer is assembled in 
the periplasm, Hcp rings may dock beneath it and polymerize to form the internal tube. Both 
are then secreted together with Hcp tube pushing the VgrG tip to penetrate the outer 
membrane, allowing the tube to extend outwards into the extracellular space (Pukatzki et al., 
2009).  
Studies have shown that Hcp and VgrG were present in culture supernatant of bacterial cells 
expressing T6SS, thus indicating that both proteins were secreted, probably for the assembly 
of the apparatus (Zheng and Leung, 2007; Pukatzki et al., 2006). Hcp was reported to be in 
the sputum of cystic fibrosis patients colonized with P. aeruginosa, suggesting the secretion is 
also relevant in vivo (Mougous et al., 2006). In addition, mice infected with wild-type 
Aeromonas hydrophila and patients infected with B. pseudomallei developed antibodies 
towards Hcp, indicating the relevance of T6SS during these infections  (Suarez et al., 2008; 
Burtnick et al., 2011).  
Interestingly, VgrGs of a minority of bacteria carry a C-terminal extension that do not have 
any structural role and may be functioning as an effector domain. These VgrGs have been 
named "evolved VgrGs”.  The best example of evolved VgrG is the VgrG1 from V. cholerae 
which is delivered into the host cell cytosol to cross link host actin (Pukatzki et al., 2007). In 
A. hydrophila, C- terminal extension of VgrG1 was shown to cause ADP-ribosylation of host 
proteins (Suarez et al., 2010). Other pathogens such as P. aeroginosa and B. pseudomallei 
also encode evolved VgrGs but with unknown functions (Pukatzki et al., 2009). On the other 
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hand, VgrGs from bacteria such as E. coli, S. typhimurium, and F. tularensis are not equipped 
with an effector domain, but still exhibit a T6SS-dependent virulence phenotype (Pukatzki et 
al., 2009). Hence, the optional evolved VgrGs may play additional roles required by certain 
groups of pathogens.  
 
VipA/B and the mode of T6SS action.  
In the bacteriophage, a contractile sheath surrounds the tail filament in a helical fashion. 
Similarly in T6SS, two of the subunits, VipA and VipB in V. cholera (Bönemann et al., 2009), 
and BcsLB and BcsLC (Aubert et al., 2010)in Burkholderia cenocepacia  form the outer 
tubular structure enclosing an inner Hcp tube, just like contractile phage sheath. In a proposed 
model, the internal diameter of VipA/VipB complex would be sufficient to accommodate a 
thinner inner Hcp tube (Cascales and Cambillau, 2012).  Recent time-lapse imaging 
demonstrated that the dynamics of VipA/VipB tubules involves cycling between assembly, 
contraction, disassembly and re-assembly of the apparatus. Whole-cell electron 
cryotomography revealed that the VipA/VipB sheath exists in either extended or contracted 
conformations (Basler et al., 2012). Another highly conserved T6SS protein (VCA0109) in 
Vibrio, which is a homolog of the T4 baseplate protein gp25, likely forms the baseplate 
complex that may represent an assembly platform for both Hcp tube and the VipA/VipB 
sheath (Leiman et al., 2009). These data support a model of T6SS action that is similar to the 
contraction mechanism of the phage tail (Basler et al., 2012). The first step involves the 
formation of the base-plate complex, followed by the polymerization of the outer sheath 
around the inner Hcp tube in an extended conformation. Contraction of VipA/VipB provides 
the force to propel the Hcp tube and the substrates it carries towards the cell exterior prior to 
secretion (Silverman et al., 2012). During the disassembly stage, ClpV ATPase is recruited to 
depolymerize VipA/VipB dimers and the released dimers are then recycled to re-assemble to 
form new T6SS apparatus at either the original position or at alternative site (Bönemann et al., 
2009; Kapitein et al., 2013).   
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Other core genes of T6SS cluster are membrane associated components, which form a ring-
like structure complex that spans the cell envelope. These include membrane proteins such as 
the IcmF homolog, TssL, TagL and TssJ of the T6SS in enteroaggregative E. coli
(Aschtgen et al., 2010)
 (EAEC) 
. Possibly, they are essential for anchoring and stabilizing the whole 
T6 apparatus to the cell envelope (Silverman et al., 2012).  
1.2.4 Role of T6SS in pathogenicity, non-pathogencity and interbacterial competition  
Earlier studies have yielded important insights into the ability of T6SS to induce 
pathogenicity in eukaryotic hosts by various means. However, T6SSs are also found in 
symbionts that may have a mutualistic relationship with the host, and also in many 
nonpathogenic species from the marine and soil environments (Boyer et al., 2009). This 
suggests that bacteria may utilize T6SS in non-pathogenicity related circumstances. Recently, 
new reports have demonstrated the role of T6SSs in interbacterial interactions which enable 
organisms to outcompete commensal bacteria during colonization. Table 1 is a summary of 
the diverse functions of T6SS in various bacteria.  
Table 1. Summary of known T6SS functions in various bacteria 
Bacterium Related functions of T6SS Source 
V. cholera The T6SS factor VasX is required for virulence 
towards amoeba Dictyostelium.  
VgrG1 cross-link host actin in macrophages and 
Dictyosteium.  
VgrG3 targets the peptidoglycan of other bacteria 
such as E. coli.  
(Miyata et al., 2011) 
 
(Pukatzki et al., 
2007) 
(Dong et al., 2013) 
P. aeruginosa T6SS is required for virulence in cystic fibrosis-like 
rat.  
Tse2 bacteriolytic effector arrests B. thailandensis and 
E. coli growth.  
Tse1 and 3 are peptidoglycan-lytic enzymes that 
target bacterial cell wall.  
(Potvin et al., 2003) 
 
(Hood et al., 2010) 
 
(Russell et al., 2011) 
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S. enterica T6SS is required for invasion of (HepG2) epithelial 
cells.  





F. tularensis T6SS is implicated in intracellular replication and 
phagosomal escape in macrophages.   
(Chong et al., 2008) 
B.thailandensis T6SS-6 is involved in inter-bacterial interactions and 
provides a competitive advantage in survival against 
P. putida. 
T6SS-1 is required for virulence in mice. 
(Schwarz et al., 
2010) 
 




T6SS-1 is required for optimal intracellular 
replication and induce multinucleated giant cell 
formation in macrophages 
T6SS-1 is required for virulence in hamsters and 
mice.  
(Burtnick et al., 
2011) 
 
(Burtnick et al., 
2010) 
E. tarda Intracellular replication in gourami phagocytes (Rao et al., 2004) 
A. hydrophila Inhibition of macrophage phagocytic activity by 
binding to the host actin 
(Suarez et al., 2008; 
Suarez et al., 2010) 
 
T6SS as a virulence factor 
Generally, T6SS has been well-studied in the context of pathogenic bacteria-host interactions. 
In many pathogens, T6SS is implicated in inducing diseases or disorders in hosts. 
Significantly, attenuation in virulence was demonstrated in mutants with either the T6SS 
components or the regulatory network controlling their expression being affected. In V. 
cholera, mutation of either VasA, VasH or VasK was shown to attenuate virulence in the 
Dictostelium amoebae host model system (Pukatzki et al., 2006). In E. tarda, mutations of 
fourteen individual Evp (T6SS) genes, such as EvpC (the Hcp homolog) led to reduced 
virulence in blue gourami hosts (Parsons and Heffron, 2005; Zheng and Leung, 2007). In 
Salmonella, SPI-6 T6SS was shown to contribute to pathogenesis in a mouse model of 
typhoid (Hood et al., 2010). Despite their importance in mammalian virulence, the underlying 
mechanism of T6SS and its role in pathogenesis remains unclear.  In fact, most effector 
proteins have yet to be identified.  However, our understanding of T6SS functions has grown 
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considerably in recent years. There are a few examples in which molecular understanding of 
T6SS involvement in cellular processes is known. As mentioned previously, the ability of 
VgrG1 in V. cholera to cross link host actin which causes macrophage morphological changes, 
allows it to defend itself from amoebae killing and promotes intestinal inflammation in mice 
(Schwarz et al., 2010). Similarly in A. hydrophila, its evolved VgrG has ADP-
ribosyltransferase activity that targets host actin (Suarez et al., 2010). Other processes 
facilitated by T6SSs include inhibition of macrophages phagocytic activity, cytotoxicity, host-
cell invasion, phagosomal escape, intracellular replication within macrophages, survival and 
persistence within the host. (Hood et al., 2010; Parsons and Heffron, 2005; Chong et al., 2008; 
Wang et al., 2011). Studies indicated that the IcmF homolog SciS of S. enterica limits 
intracellular growth in macrophages at a later stage of infection (24 h post infection), resulting 
in lower mortality rates in mouse model of infection, thus favoring persistence within the host 
(Parsons and Heffron, 2005). Furthermore, the T6SS-1 cluster in Burkholderia species was 
shown to be absolutely necessary for virulence in mammalian hosts and survival in 
macrophages as fatality in mice and hamster were completely abolished in the T6SS-1 
mutants (Schwarz et al., 2010; Schell et al., 2007; Burtnick et al., 2011). 
T6SS in antipathogenic interaction 
While many studies demonstrated the role of T6SS in pathogenesis, there are few examples 
that support T6SS to have mutualistic effects such as limiting bacterial replication inside the 
host and having antivirulence activity towards them. This was recently shown in a symbiont 
of rodent gastrointestinal tracts, Helicobacter hepaticus. In this case, T6SS functions to limit 
adherence to and internalization by mouse intestinal epithelial cell line (Chow and 
Mazmanian, 2010). Furthermore, it was also shown that a T6SS mutant in H. hepaticus, 
ΔicmF, had increased colonization of the murine intestine and induced a higher inflammatory 
responses compared with the wild-type (Chow and Mazmanian, 2010). This data suggest that 
T6SS is involved in limiting pathogenesis to maintain a long-term, symbiotic relationship 
with its murine host.      
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T6SS in interbacterial interaction 
Even though the importance of T6SS in pathogenesis has emerged over the years, the 
majority of organisms carrying T6SSs are non-pathogenic, and instead found in marine 
environments. This suggests that some of the T6SSs are not involved in host cell interactions, 
but in nonpathogenic bacteria-host interactions such as commensal or mutualistic 
relationships to mediate cooperative or competitive interactions between bacteria. Recent 
studies have highlighted the involvement of T6SS in interbacterial interaction. A study 
conducted by Mougous group demonstrated that the Hcp Secretion Island 1 (HSI-1) T6SS in 
P. aeruginosa encodes three substrates, Tse1 to Tse3 (Hood et al., 2010). Tse2 is an effector 
protein or toxin that is released into the bacterial cytoplasm to arrest the growth of prokaryotic 
cells. Tse1 and Tse3 are two peptidoglycan degrading effectors targeted to the periplasm of 
prey cells. Herein, the effectors hydrolyze and remodel the peptidoglycan protective barrier of 
the host, thereby providing an advantage in survival fitness for itself in competition with other 
bacteria. Upon close contact with recipient cells, bacterial strains lacking the specific 
immunity proteins Tsi1/Tsi3 and Tsi2 are efficiently outcompeted (Hood et al., 2010; Russell 
et al., 2011). Recently, time-lapse fluorescence microscopy demonstrated that T6SS 
dependent killing of V. cholera or Acinetobacter baylyi by P. aeruginosa is greatly stimulated 
by T6SS activities initiated by the prey species, in what the authors termed as “tit for tat” 
retaliation (Basler et al., 2013). The data suggest that T6SS effectors mediate competitive 
interactions among bacteria.  
Several bacteria that possess multiple copies of T6SS gene clusters in their genome have 
multiple hosts or are able to thrive in diverse environments. Given the mounting evidence for 
divergent functions of T6SSs, it is likely that each cluster encodes a specialized system for 
interactions with particular hosts, competing microbes or cooperators found in diverse 
environments.  This is well illustrated by the specialized T6SSs of Burkholderia thailandensis, 
which is a saprophyte that dwells in soil and also a very close relative to a facultative human 
pathogen that causes melioidosis, B. pseudomallei. Of the five T6SS clusters that it possesses, 
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only one of the clusters (T6SS-1) is essential for virulence in a murine acute melioidosis 
model (Schwarz et al., 2010). Another cluster (T6SS-6) was implicated in interspecies 
interactions with other proteobacteria such as Pseudomonas putida (Schwarz et al., 2010). 
This suggests that cellular specificity might be hardwired into the secretion apparatus, and 
T6SS is indeed a versatile tool which enables bacteria to communicate with other organisms 
in many contexts for virulence, mutualism or competitive purposes.  
1.2.5 Regulation of T6SS 
Generally, expressions of T6SSs are strictly regulated with respect to their host functions 
and/or by specific environmental cues at transcriptional, translational and post-translational 
levels. Common regulators such as two-component systems (TCS), AraC regulators, sigma 
activators and even quorum sensing systems were shown to regulate T6SS in various bacteria. 
In fact, the regulation can be complex involving regulatory network control by other global or 
virulence regulators. In several bacteria, T6SS expression is linked to regulation by multiple 
TCSs such as PhoP/Q, PhoB/R and EsrA/B in E. tarda and PhoP/Q, SsrA/B and EnvZ/OmpR 
in Salmonella (Xu and Hensel, 2010; Zheng et al., 2005; Chakraborty et al., 2011; Feng et al., 
2003). For E. tarda, the AraC transcription regulator EsrC from the T3SS cluster serves as a 
crosstalk protein which activates both the evp (T6SS homolog) operon and specific T3SS 
genes (Zheng et al., 2005). In contrast, SsrB upregulates T3SS SPI-2 inside macrophage 
vacuole while down regulating T6SS expression (Xu and Hensel, 2010)
Besides the knowledge gained on the regulatory cascade of T6SS, many studies have also 
reported the environmental signals that influences its expression. These are usually 
physiochemical parameters such as changes in temperature, pH, oxygen tension and ions 
which includes Mg
. Such integration of 
regulatory systems in pathogens interlinks the expression of various virulence factors for 
optimal pathogenicity in the hosts. 
2+ (Chakraborty et al., 2011; , iron, phosphate Chakraborty et al., 2010; 
Brunet et al., 2011). For instance, the evp cluster in E. tarda is induced at low temperature of 
23-25 °C, under acidic pH, and in low iron and phosphate concentrations (Chakraborty et al., 
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2010; Chakraborty et al., 2011). Likewise, expression of T6SS is induced at low temperature 
while repressed at high tememperature (37 °C) in Y. pestis (Pieper et al., 2009). In a plant 
pathogen Agrobacterium tumefaciens, T6SS is also induced at low pH (Wu et al., 2012). For 
many pathogens, cellular signals are required to induce T6SS expression as the upregulation 
was only observed upon host cell infection (de Bruin et al., 2007; Shalom et al., 2007; 
Parsons and Heffron, 2005). However, the direct host signals that trigger T6SS activation and 
transcription inside host cells have not been identified in any bacteria thus far. The regulation 
and signals for T6SS expression will be reviewed and discussed in further detail in the 
subsequent chapters. 
 
1.3  Two-component systems  
Two-component systems are signal transduction devices widely present in prokaryotes to 
sense and respond to a diversity of environmental stimuli. Generally, environmental sensing 
is coupled to changes in gene regulation for adaptation to changing growth conditions. A 
typical TCS is comprised of two conserved proteins: a membrane-bound histidine kinase (HK) 
sensor and a response regulator (RR) protein that binds to DNA to activate or repress target 
gene expression (Chang and Stewart, 1998). In terms of the signal transduction process, 
signals detected by the HK are translated to a cellular signal by autophosphorylation at a 
conserved histidine site. The signal is then relayed to the cognate response regulator through 
phosphorylation at an aspartic residue, and generation of the output response through 
regulating the expression of target genes (Krell et al., 2010). 
Among the common signals that were identified by some of the well-studied TCSs are 
chemical and physical parameters such as ion concentration, pH, temperature, osmolarity and 
oxygen tensions (Krell et al., 2010). Most of these TCSs are implicated in regulating essential 
functions for growth, survival and adaptation. In addition, many TCSs play a crucial role in 
the pathogenicity of bacteria in which attenuation of the virulence properties were described 
in many TCS mutants (Beier and Gross, 2006). There are a significant number of TCSs that 
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contribute to bacterial virulence regulation. Of note, some TCSs are integrated into complex 
networks of transcriptional regulators for T6SSs expression in various bacteria.    
One of the best-characterized TCS is the EnvZ/OmpR system in E. coli and Salmonella, 
which senses changes in osmolarity. In response, this system regulates the expression of 
OmpF and OmpC porin genes to control the diffusion of ions or molecules across bacterial 
membranes (Slauch et al., 1988). Besides being an osmosensor, OmpR-EnvZ plays a part in 
virulence by controlling the transcription of ssrA/ssrB virulence TCS in Salmonella, which is 
the main regulator of T3SS SPI-2 and a repressor of T6SS SPI-6 (Feng et al., 2003).  Another 
well-studied virulence TCS that is conserved across a variety of Gram-negative pathogens is 
the PhoPQ system, with PhoQ being the sensor kinase while PhoP is the cognate transcription 
regulator. PhoPQ is found as a dimer in the inner membrane of bacterial envelop which 
senses phagosomal signals such as antimicrobial peptides, acidic pH, decrease in divalent ions 
Mg2+ , Ca2+ (Bader et al., 2005; Prost and Miller, 2008).  In Salmonella, activation of PhoP 
causes regulation in Mg2+
(Prost and Miller, 2008)
 uptake, LPS modification, resistance to antimicrobial peptides and 
other virulence genes . Inside phagosomes, PhoPQ also upregulates 
expression of ssrAB and subsequently regulates SPI-2 genes for intracellular survival while 
down regulating SPI-1 invasion related genes through the repression of hilA regulator (Bajaj 
et al., 1996), and suppressing T6SS genes (Xu and Hensel, 2010; Parsons and Heffron, 2005). 
Mutation of PhoPQ resulted in strong virulence attenuation in mice, inability to survive and 
persist within macrophages and increased susceptibility to host immune defenses such as 
antimicrobial peptide (Groisman, 2001). Currently, extensive studies on mechanisms of 
virulence regulation by TCS are becoming increasingly available. In the subsequent chapters, 
the role of TCS in the context of T6SS virulence will be discussed in detail.  
1.4. Burkholderia and Melioidosis  
B. pseudomallei is a Gram-negative saprophyte that thrives in diverse ecological niches. 
Besides the primary reservoirs such as soil, muddy and stagnant water, it seems equally adept 
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at surviving in plants (Holden et al., 2004; Lee et al., 2010), amoebae (Inglis et al., 2000), 
nematodes (Gan et al., 2002) and many mammalian species including humans (Sprague and 
Neubauer, 2004).  
Furthermore, B. pseudomallei is the causative agent of melioidosis, a potentially fatal disease 
endemic in Southeast Asia, Northern Australia and other tropical regions (Cheng and Currie, 
2005). Since this bacterium grows best in soil and water, most cases of this disease occur 
during the rainy seasons. It is a constant threat to individuals such as farmers who are 
constantly exposed to soil and pooled water in rice paddies where the bacteria dwell.  The 
main route of infection with B. pseudomallei typically occurs via cutaneous inoculation, 
where wounds on the skin or the mucosal surface come into direct contact with contaminated 
water or soil. However, it can also occur through inhalation or aspiration, and rarely, 
ingestion (Currie et al., 2001).  
The disease has a wide range of disease manifestations ranging from asymptomatic infection 
to acute or chronic pneumonia, localized infections, and even dissemination of infection to 
distant sites and multiple organ failure (Wiersinga et al., 2006). The most severe 
manifestation is septic shock in which a sudden drop in blood pressure is experienced, and it 
is often associated with pneumonia (Wiersinga et al., 2006). Recurrent infection is common 
despite sufficient antibiotic treatment, which can occur many years after the onset of primary 
infection (Wiersinga et al., 2006). Predominantly, the fatality of this disease is associated with 
immunocompromised individuals (>80%) who have one or more pre-existing conditions such 
as diabetes mellitus (50% of the cases) and renal failure (Wiersinga et al., 2006). Other risk 
factors such as chronic alcohol consumption and old age were also shown to predispose 
individuals to the disease (Currie et al., 2010; Lo et al., 2009), much  research interest in the 
pathogenesis of this pathogen has increased following its classification as a potential 
bioterrorism agent by the US Centre for Disease Control and Prevention because of their 
aerosol infectivity (CDC, 2000).  
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Treatment of  this disease is particularly problematic as B. pseudomallei is intrinsically 
resistant to many antibiotics including penicillin, third-generation cephalosporins, macrolides, 
rifamycins, colistin and aminoglycosides due to the presence of efflux pumps which are able 
to expel these chemicals out from the bacterium  (White, 2003; Moore et al., 1999). Currently, 
patients are treated intravenously with ceftazidine, and followed by oral uptake of 
trimethoprim-sulphamethoxazole with or without doxycycline (Chetchotisakd et al., 2013; 
Cheng and Currie, 2005).  So far, there is still no effective vaccine available for melioidosis.  
The genome of B. pseudomallei consists of a large 4.07 Mb chromosome 1 which encodes for 
essential genes for growth and metabolism, and a smaller 3.17 Mb chromosome 2 which 
encodes for accessory functions such as pathogenicity in various hosts (Holden et al., 2004). 
Its genome is highly similar to that of a closely related but avirulent species, B. thailandensis, 
in terms of gene synteny and overall sequence homology. (Kim et al., 2005; Schwarz et al., 
2010). In fact, the geographical niche of B. pseudomallei overlaps with that of B. 
thailandensis. It is estimated that the two species were from a common ancestor 
approximately 47 million years ago (Yu et al., 2006). B. mallei, the etiological agent of 
glanders, is generally accepted as a clonal descendent of B. pseudomallei through genome 
loss or deletions during its evolution into an obligate zoonotic pathogen (Godoy et al., 2003). 
Despite B. thailandensis being relatively non-pathogenic and B. mallei being a zoonotic 
pathogen, there were incidences of human infections caused by these two species (Glass et al., 
2006; Burtnick et al., 2010).  As these three species share high similarity in their genomes, it 
is through no coincidence that they possess similar virulence determinants and share a very 
similar intracellular life-cycle in their mammalian hosts.   
1.5 Intracellular life cycle of B. pseudomallei  
B. pseudomallei is capable of invading various cell types, including phagocytic and non-
phagocytic cells. Being an intracellular pathogen, it uses multiple mechanisms to evade host 
immunity for its own survival and replication inside phagocytic cells. Some of these evasive 
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mechanisms include resistance to human defensins (Jones et al., 1996), preventing 
bactericidal killing by the host through repression of  inducible nitric-oxide synthase (iNOS) 
induction (Utaisincharoen et al., 2001) and NF-κB activation (Tan et al., 2010), and 
exhibiting early endosomal escape into the cytosol (Burtnick et al., 2008; Stevens et al., 
2002). Likely, the bacterium utilizes the T3SS-3 translocon components of the needle 
complex to lyse the endosomal membrane for it to escape into the cytosol (Stevens et al., 
2002). Furthermore, BopA effector of the T3SS-3 may be vital for the evasion of autophagy 
(Cullinane et al., 2008). In the cytosol, the intracellular bacteria can propel themselves by 
promoting host actin polymerization by BimA, which is located at one pole of the bacterial 
cell (Stevens et al., 2005). This results in actin-based membrane protrusions from one end of 
the bacterial pole, facilitating its spread to neighboring cells without being exposed to 
antibodies or humoral immune responses that are present extracellularly.  B. pseudomallei 
also induces the formation of multinucleated giant cells (MNGC) by cell fusion to facilitate 
cell to cell spread (French et al., 2011; Burtnick et al., 2008). Such a strategy allows the 
bacterium to persist inside the host without being exposed to antibiotics in the extracellular 
milieu.  
1.6 Virulence factors of B. pseudomallei 
Similar to many Gram-negative pathogens, B. pseudomallei posesses an arsenal of virulence 
determinants for its survival and adaption to many host niches. These include the capsular 
polysaccharide that acts as a barrier towards complement deposition, a less immune-
stimulatory lipopolysaccharide (LPS), flagella for motility, pili for adherence to the host cells 
and protein secretion systems for exporting effector proteins that subvert host-cell processes 
(Wiersinga et al., 2006).  
T3SS in B. pseudomallei 
As mentioned previously, T3SS is one of the most important and well characterized 
mechanisms responsible for virulence in many Gram-negative pathogens (Coburn et al., 
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2007). B. pseudomallei possesses three T3SS clusters (Winstanley et al., 1999), but only the 
T3SS-3 cluster has been shown to be critical for bacterial pathogenesis in mammalian hosts 
(Stevens et al., 2004; Warawa and Woods, 2005). T3SS-1 and T3SS-2 are similar to the T3SS 
of the plant pathogen Ralstonia solanacearum which were shown to be essential during 
infection of tomato plant (Winstanley et al., 1999; Lee et al., 2010). These data suggest that B. 
pseudomallei is also a potential plant pathogen. On the other hand, T3SS-3 cluster shares 
homology with the Inv/Mxi-Spa-like T3SS system of Salmonella and Shigella (Stevens et al., 
2002).  At the cellular level, T3SS-3 has been implicated in bacterial invasion of non-
phagocytic cells such as epithelial cells, early endosomal escape into the host cytosol 
(Burtnick et al., 2008), intracellular survival and replication, and inducing cytotoxicity 
towards macrophages in a caspase-1 dependent manner (Sun et al., 2005), and MNGC 
formation (Suparak et al., 2005). Just like other secretion systems, the T3SS-3 locus, 
designated Bsa, encodes for components of the secretion apparatus and effector proteins 
(Stevens et al., 2002). Briefly, it consists of five integral membrane proteins (BsaZ, BsaY, 
BsaX, BsaW and BsaQ) which are part of the secretion apparatus. Mutation in BsaZ resulted 
in attenuation of virulence in Syrian hamsters and T3SS-3 related functions (Warawa and 
Woods, 2005; Burtnick et al., 2008). The needle tip complex consisting of the translocons 
(BipB and BipC) and a needle cap (Bip D) protects the bacterium from unnecessary secretion 
of effectors in the absence of host contact (Veenendaal et al., 2007). Among the effectors, 
BopE is the homolog of SopE from Salmonella SPI-1 which functions as a guanine nucleotide 
exchange factors for Rho GTPases such as Cdc42. Another effector translocated by T3SS-3 is 
BopA which is reported to suppress or evade host autophagy for intracellular survival 
(Cullinane et al., 2008). However, deletion of BopE and BopA did not show any attenuation 
in virulence in Syrian hamsters or BALB/c mice, thus leaving their functions in T3SS-3 
pathogenicity doubtful (Stevens et al., 2004; Warawa and Woods, 2005). This is in contrast to 
the avirulent phenotype seen in mice and hamsters with the BsaQ or BsaZ structural mutants, 
or the T3SS-3 cluster deletion mutant (Sun et al., 2005). It is possible that the severely 
reduced virulence observed when the secretion function of T3SS-3 is disabled and the lack of 
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virulence attenuation when the T3SS-3 effectors are deleted is due to downstream effects 
caused by other virulence factors upon endosomal escape, which is controlled by T3SS-3.   
Expression of T3SS-3 has been demonstrated in B. pseudomallei grown in culture media 
without the presence of host cells (Sun et al., 2010). It was shown that regulation of T3SS-3 
cluster is through a regulatory cascade that initiates from BspR, a TetR-family transcriptional 
regulator (Sun et al., 2010). Through an undefined mechanism, BspR activates and exerts its 
effect through BprP, a novel transmembrane regulator located outside but in proximity to the 
currently delineated T3SS-3 region. In turn, BprP activates an AraC family transcription 
regulator BsaN, as well as other genes in the T3SS-3 cluster encoding for components of the 
secretion complex. Together with a co-activator BicA chaperone, BsaN controls the 
expression of BopE and BopA effectors, and several putative regulators in the T3SS-3 cluster, 
one of which is another AraC regulator, BprC. Despite its gene locus being in the T3SS-3 
cluster, BprC controls the expression of a subset of genes in theT6SS-1 cluster. Furthermore, 
BsaN also activates the expression of VirA and VirG, which comprise the master TCS 
regulator of T6SS genes as shown in B. mallei (Sun et al., 2010; Schell et al., 2007). BsaN 
also regulates the expression of TssM, an T3SS-3-independent effector which is a 
deubiquitinase that suppresses host immune response during B. pseudomallei infection (Tan 
et al., 2010). The model of this regulatory cascade is depicted in the subsequent chapter.  
1.7 T6SS in Burkholderia species  
Currently, the knowledge on T6SS in Burkhoderia species is relatively limited. In contrast to 
most bacterial species which harbor one or two copies of T6SS clusters, six evolutionarily 
distinct T6SS gene clusters are variably present in the Burkholderia. While B. pseudomallei 
possesses all six T6SS clusters, B. mallei and B. thailandensis genomes encode unique sets of 
five of the six clusters (Schell et al., 2007). To date, there are conflicting nomenclatures for 
Burkholderia T6SS clusters with publications referring to the same cluster both as T6SS-1 
(Schell et al., 2007) and T6SS-5 (Shalom et al., 2007). For clarity purposes, we have adopted 
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the one proposed by Schell and colleague for our study. The T6SS-1 cluster in B. 
pseudomallei was first discovered through an in vivo expression technology (IVET) which 
was induced only upon macrophages infection (Shalom et al., 2007). Of the four conserved 
systems among the three species, only the T6SS-1 cluster is required for virulence in 
mammalian hosts.  An alignment of the T6SS-1 cluster shows that it is highly similar in both 
gene sequence and organization between the three species (Figure 3). In B mallei, mutations 
in the T6SS-1 cluster resulted in strains that were avirulent in hamsters (Schell et al., 2007). 
Similarly, the homologous T6SS-1 cluster in B. pseudomallei and B. thailandensis is critical 
for virulence in a mouse infection model (Chen et al., 2011; Schwarz et al., 2010). 
Importantly, serum from mice, horse and human patients reacted with the T6SS-1 Hcp1 
protein (BPSS1498/BMAA0742) in immunoblot assay, suggesting that Hcp1 is immunogenic 
and expressed during infection (Burtnick et al., 2011). At the cellular level, T6SS-1 plays a 
role in the intracellular life cycle of these pathogens. T6SS-1 has been shown to be critical for 
intracellular growth, actin polymerization and causing cell fusion resulting in the formation of 
multi-nucleated giant cells (MNGCs) in vitro (Schell et al., 2007). A T6SS-1 hcp1 mutant in 
B. pseudomallei exhibited attenuated virulence in hamster, deficiencies in actin-based motility, 
MNGC formation, intracellular replication and cytotoxicity (Burtnick et al., 2011). It is 
currently unknown if other T6SS clusters are dispensable for virulence or are specific for 
other particular niches or hosts (Schwarz et al., 2010).  
Based on the T6SS models described previously in other bacteria such as Vibrio, a predictive 
homologous model for T6SS-1 structure in the three Burkholderia species is illustrated in 
Figure 4 (Silverman et al., 2012; Basler et al., 2012). As mentioned in detail in the earlier 
section, T6SS structure resembles that of the contractile T4 phage. Similarly, Hcp forms the 
tubule for the transportation of effectors and VgrG punctures the target cell membrane to 
deliver effectors into the host cell cytosol (Silverman et al., 2012). TssA and TssB are the 
homologs of VipA and VipB dimers in Vibrio that form the outer layer sheath to enclose the 
inner Hcp tube (Silverman et al., 2012). The gp25 homolog (T4 phage) in these three species 
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is TssC, which is likely part of the baseplate complex that is necessary for the assembly of the 
Hcp tube and the TssA/TssB outer sheath. Other components such as TssL, IcmF and TssJ are 
putative membrane-associated proteins that span the cell membrane for anchoring the 
secretion system to the cell envelope. Currently, most of the components which include TssD 
to TssI remain uncharacterized.  
Figure 3. Genetic organization of the T6SS-1 loci in i) B. pseudomallei K96243 (BPSS1490 
to BPSS1514) in comparison to the homologs in ii) B. thailandensis E264 (BTH_II0852 - 
BTH_II0877) and iii) B. mallei ATCC 23344 (BMAA0727 - BMAA0751). Genes and their 
direction of transcription are represented by arrows. Annotation of the tss genes were 
reassigned in this review, mostly following the designation from De Shazer (Schell et.al, 
2007).  Shown in blue are the bim clusters required for actin tail motility. Shown in black are 
the T6SS genes that code for the T6SS-1 apparatus, membrane complex and the accessory 
proteins. Shown in green are the adjacent genes that include dubA (a deubiquitinase), 
BPSS1513 and folE which are of unknown functions. Shown in red are the virA/G 
homologues, the TCS that regulates the T6SS cluster, dubA (tssM), BPSS1513 homologs and 




Figure 4. Schematic diagram showing the putative model of a bacteriophage-like T6SS 
apparatus in Burkholderia genus.  This model integrates the current data on the localization 
and topologies of the homologous T6SS core components from other bacteria. The hallmark 
of T6SS is the Hcp proteins (blue), which were shown to form hexameric rings and assemble 
into a tube like structure for the transportation of effectors. TssC (orange), a gp-25 homologue, 
forms the base-plate complex to initiate Hcp tube polymerization. TssA/B subunits (light and 
dark green) polymerize to form a tubular sheath which wrapped around the inner Hcp tube. 
The ClpV ATPase (pink) was shown to disassemble the sheath and TssA/B dimmers released 
are recycled and reassembled into new sheaths. VgrG trimer (light blue) is a puncturing 
device that perforates both the bacterial and the host envelopes to release effectors into the 
host cytoplasm. IcmF (red), TssJ (brown) and TssL (yellow) are inner membrane proteins that 
anchor the T6SS-1 apparatus to the bacterial cell wall.  
 
1.8 Objectives of the study 
As the T6SS-1 of B. pseudomallei is required for virulence in animal models of infection, 
most studies focus on identifying T6SS-1 cellular functions and effectors that lead to its 
pathogenesis. However, the nature of signals and the signal transduction cascade for T6SS-1 
expression is unknown. We believe that understanding the regulation of T6SS gene 
expression would reveal crucial aspects of B. pseudomallei virulence and pathogenesis. It also 
builds the foundation for the development of therapeutic drugs to inhibit its expression for 
effective control of the disease in the long term.  
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Currently, the knowledge on how T6SS-1 is regulated is incomplete. Shalom et al. found that 
T6SS-1 in B. pseudomallei was poorly expressed in cell culture media alone but was induced 
to about 12 fold upon macrophages infection through IVET (Shalom et al., 2007). In B. mallei 
and B. pseudomallei, T6SS-1 gene expression was only induced in extracellular bacteria when 
a two-component regulatory system VirAG, and an AraC regulator BprC, were overexpressed 
in trans (Schell et al., 2007). VirA is a membrane-associated histidine kinase sensor that 
senses environmental cues while VirG is its cognate response regulator (Krell et al., 2010). 
Likely, VirA senses specific conditions within macrophages, or within host cells to activate 
T6SS-1. At present, how T6SS-1 expression is precisely regulated by the bacteria inside host 
cell and the host signal that it senses is still unknown. In this project, we elucidate the 
regulation of T6SS-1 gene expression of B. pseudomallei inside host cells and identify the 
host signal which its regulator senses. This will provide a critical insight into how B. 
pseudomallei senses its presence inside mammalian hosts and adapts its virulence to the host 
environment to further its own survival and spread. Equally important is the discovery of a 
novel mode of communication between the host and pathogen.  
Furthermore, the model of T6SS-1 and its components are assumed and merely predicted 
based on the homology of T6SSs from other pathogens. In fact, there is ambiguity on whether 
some of the genes currently assigned to T6SS-1 are really part of T6SS-1. Interestingly, a 
conserved T6SS component, ClpV is not required for T6SS phenotypic functions in B. 
pseudomallei and B. thailandendsis (French et al., 2011). Hence, we also aim to decipher the 
roles of some of these T6SS-1 components in the current known assays for measuring T6SS-1 
functions such as MNGC formation, actin motility and intracellular growth.   
In summary, the specific aims for this study are to: 
1. Investigate the regulation of T6SS-1 gene expression during host cell infection.  
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2. Identify the intracellular signal(s) sensed by the bacterium and elucidate the 
mechanism of how the signals are relayed by the bacterium to activate T6SS-1 gene 
expression inside host cells. 
3. Examine and compare the functional phenotypes of various T6SS-1 deletion mutants 







































The contents in this chapter has been published in:   
The Regulation of Type VI Secretion System during Burkholderia pseudomallei infection 
Infection and Immunity, Aug. 2011, p. 3064–3073 Vol. 79, No. 8 
2.1 Introduction 
Bacteria are constantly subjected to modifications in their environment. To adapt and respond 
to such changes appropriately, one effective means is by activation of secretion systems such 
as T6SS.  It is well-established that T6SSs are found in Gram-negative bacteria from diverse 
environments, from saprophytes to pathogens, and appear to be adapted to the specific needs 
of each bacterial species in the unique environment each occupies (Jani and Cotter, 2010; 
Schwarz et al., 2010). In view of that, T6SS expression can be precisely regulated with 
respect to their host functions and/or by specific environmental cues (Bernard et al., 2010; 
Miyata et al., 2013). Hence, defining the nature of these signals and elucidating the T6SS 
regulatory cascades are crucial for revealing their functions and understanding how T6SSs 
contribute to bacterial adaptation or pathogenesis.   
Although the signals required for T6SS expression in different bacteria are mainly unknown, 
most studies have identified the regulatory components and revealed regulation at the 
transcriptional level. Most regulations involve a network of transcriptional factors and global 
regulators such as TCS, quorum sensing (QS) systems and sigma factor 54 (σ54
(Leung et al., 2011)
) which are 
also interlinked with the regulatory machineries of other virulence factors . 
These regulators can function as either activators or repressors. In certain T6SS clusters, TCS 
plays a crucial role in relaying the environmental signals by the sensor to the cognate 
regulator that drives T6SS transcription. For instance, PhoP/Q TCS in E. tarda activates 
another TCS, EsrA/B (Chakraborty et al., 2010). EsrB in turn drives the expression of the evp 
T6SS gene cluster through an AraC-like transcription factor (TF), EsrC (Zheng et al., 2005). 
Likewise, VirA/G TCS together with an AraC regulator, BprC, induce T6SS-1 cluster in B. 
pseudomallei and B. mallei (Schell et al., 2007; Sun et al., 2010). In S. enterica, the two-
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component regulatory system SsrAB, represses a T6SS gene sciS during the early phase of 
infection when the bacterium does not require its activity yet (Parsons and Heffron, 2005).   
In some cases, global regulators such as QS and σ54 
(Ishikawa et al., 2009)
add an additional layer of T6SS control. 
Being a cell density-dependent regulatory system, QS serves as a form of crosstalk between 
expression of virulence systems and population density. A good example is illustrated in V. 
cholera LuxQ/LuxO QS system, with LuxQ being the sensor kinase while LuxO being the 
downstream response regulator. This system upregulates the expression of sRNA molecules 
which in turn inhibit the expression of a TetR- family global transcriptional regulator, HapR. 
It was reported that a decrease in LuxO and an increase in HapR QS regulators induced hcp 
expression but repressed biofilm formation . Furthermore, VasH which 
is encoded in the V. cholera T6SS cluster interacts with σ54
(Ishikawa et al., 2009; 
 (RpoN) and provides additional 
control on T6SS by increasing hcp transcription Leung et al., 2011). In 
P. aeruginosa, QS was shown to regulate its three T6SS clusters differentially, which were 
termed Hcp Secretion Island (HSI). Both HSI-2 and HSI-3 T6SS gene clusters were 
positively regulated by the LasR/LasI and RhlR/RhlI QS systems whereas HSI-1 was 
negatively regulated by LasR (Lesic et al., 2009). Besides QS, HSI-1 was also regulated post-
transcriptionally by the Gac/Rsm pathway (a global regulator that controls many cellular 
processes including virulence factor), which senses extracellular bacterial-derived signals. 
The repressor RetS and the activator LadS of the Gac/Rsm pathway reciprocally influence 
HSI-1 expression, with retS knockout showing an increase in T6SS assembly, activation and 
effector secretion (Mougous et al., 2006).  Apparently, the detailed characterization of T6SS 
regulation varies from one system to another and there is no common regulatory pathway. In 
fact, bacteria may utilize dedicated regulatory mechanism specific for their environment or 
host.  
Currently, the knowledge on how T6SS-1 virulence factor is regulated in Burkholderia group 
is incomplete. In terms of transcriptional regulation in B. mallei and B. pseudomallei, T6SS-1 
was highly upregulated in extracellular bacteria when the AraC regulator BprC, and the two-
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component regulatory system VirAG, were expressed in trans (Schell et al., 2007; Burtnick et 
al., 2011). VirA is the membrane-associated histidine kinase sensor that monitors 
environmental signals while VirG is its cognate response transcription factor that drives 
T6SS-1 transcription (Krell et al., 2010).  Furthermore, our group has previously 
demonstrated that T3SS-3 and T6SS-1 in B. pseudomallei are coordinately expressed through 
the BspR dependent regulatory cascade when it is grown in culture medium (Sun et al., 2010). 
As shown in Figure 5, the cascade initiates from BspR, and this in turn activates BprP and 
BsaN regulators. BsaN, being the central regulator encoded within the T3SS-3 cluster, 
controls both the expression of T3SS-3 effectors (BopA and BopE) and T6SS-1 regulators 
(BprC and VirAG). In contrast to Burknick and Schell data which were obtained through 
overexpression of both regulators in trans, this study reveals that the regulation of T6SS-1 is 
dependent on BprC endogenously, but not VirAG (Sun et al., 2010). However, these 
regulation profiles of T6SS-1 gene cluster were determined without host cell infection and 
with bacteria in medium.  
Previously, it was reported that expression of T6SS-1 in B. pseudomallei was poor in cell 
culture media alone and was only upregulated inside macrophages (Shalom et al., 2007).  At 
present, how T6SS-1 expression is regulated by the bacteria inside host cell remains unclear. 
Given its importance inside cells as a virulence determinant, it will be more relevant to 
examine the T6SS-1 regulation upon interaction with the host. Hence, in this chapter, we 
elucidate the detailed regulatory cascade of T6SS-1 gene expression of B. pseudomallei in 
relation to T3SS-3 inside host cells. Since macrophages are known to be an important target 
for intracellular bacterial infection in vivo, and the pathogenesis of B. pseudomallei depends 
on its ability to survive and replicate within these phagocytic cells, we use mouse 




Figure 5: Model of BspR dependent regulation of T3SS-3 and T6SS-1 through 



















2.2 Materials and Methods 
 
2.2.1 Cell culture  
RAW264.7 mouse macrophage-like cell line and human embryonic kidney epithelial cells 
(HEK293T) were obtained from American Type Culture Collection (Rockville, MD) and 
maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco, CA) supplemented with 
10% heat-inactivated fetal bovine serum (FBS) (Hyclone Laboratories, UT), 2 mM L-
glutamine (Gibco, CA), 100 units/ml penicillin (Gibco, CA), and 0.1 mg/ ml streptomycin 
(Gibco, CA) (DMEM complete) in a humidified 37°C, 5% CO2 tissue-culture incubator. 
Human myelomonocytic lymphoma cell line U937 was maintained in RPMI 1640 (Gibco, CA) 
supplemented with 10 % heat-inactivated FBS, 2mM L-glutamine (Life Technologies, CA) 
and 1 % penicillin/streptomycin (Gibco, CA) (RPMI complete) at 37 °C in a humidified 5 % 
CO2
2.2.2 Bacterial strains and growth conditions 
 atmosphere. Human macrophages differentiated from primary monocytes were obtained 
from Lim Yan Ting (Paul A. MacAry lab, National University of Singapore). 
Bacterial strains and plasmids used in this chapter are listed in Table 2. Mutants created were 
derived from a B. pseudomallei clinical strain KHW, isolated in Singapore (Liu et al., 2002). 
All bacterial strains were maintained on Trypticase Soy Agar (TSA) (Difco Laboratories, 
Detroit, MI) by culturing at 37 °C for 48 hours and kept in 4 °C for maximum of one month 
before re-streaking. Overnight cultures were prepared by inoculating few colonies into 2 ml 
of LB broth and incubating at 37 °C with shaking at 100 rpm while log-phase cultures were 
prepared by sub-culturing an overnight culture at a 20 X dilution for 2 h. To quantity the 
bacterial numbers,  optical density (OD) of a culture was measured using a  
spectrophotometer and calculated by using 1 OD600 = 2 X 106 cfu/µl. Antibiotics added to LB 
medium were as follows ( in µg/ml): For E. coli, ampicillin (Amp), 100; trimethroprim (Tm), 
25; and for B. pseudomallei, gentamicin (Gm),50; Tm, 50; Kanamycin (Km), 250. All 
antibiotics are from Sigma-Aldrich, MO. 
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Table 2. List of bacterial strains and plasmids used in this chapter 
Strain or 
plasmid 
Relevant characteristic(s) Source or reference a 
B. pseudomallei   
KHW B. pseudomallei wild-type strain Gm (Liu et al. 2002) r 
ΔvirAG KHW ΔvirAG::FRT, codon 1-233 of BPSS1494 
and 56-614 codon of BPSS1495 were deleted 
(Sun et al., 2010) 
ΔbprC KHW ΔbprC::zeo, codon 209-353 of BPSS1520 
was replaced by zeo cassette, Zeo
(Sun et al., 2010)
r 
 
ΔbspR KHW ΔbpsR::zeo, codon 13-205 of BPSS1105 
was replaced by zeo cassette, Zeo
(Sun et al., 2010)
r 
 
ΔbprP KHW ΔbprP::FRT, codon 11-311 of BPSS1553 
was deleted  
(Sun et al., 2010) 
ΔbsaN KHW ΔbsaN::FRT, codon 14-236 of BPSS1546 
was deleted 
(Sun et al., 2010) 
E. coli   
DH5α Cloning host (Sambrook et al., 
1989) 
SM10 λpir Donor strain for conjugation (Simon et al., 1983) 
Plasmids   
pGEM-T TA-cloning vector, Apr Promega, MI   
pMLBAD Broad host range vector containing pBBR1 ori, 






pMLBAD-virA pMLBAD containing virA orf from KHW, Tm This study r. 
pMLBAD-virG pMLBAD containing virG orf from KHW, Tm This study r 
pMLBAD-
virAG 




pMLBAD-bprC pMLBAD containing bprC orf from KHW, Tm This study r 




2.2.3 Cloning of genes into expression vector for complementation 
Bacterial genomic DNA was extracted using the Zygmo Quick-gDNA MiniPrep kit (Zymore 
Research, CA). The pMLBAD broad host range vector was used for cloning of full-length 
35 
 
virA, virG and bprC for overexpression in B. pseudomallei (Lefebre and Valvano, 2002). The 
primers used to amplify the full-length gene through PCR are listed in Table 3.  
 
Table 3. List of primers for cloning 
 
a 



















AAGCTTCGGAATCGACATTCATCGT3'               
a 
 
Restriction sites in the linker regions are underlined.  
 
PCR amplification was carried out with the My CyclerTM thermo cycler machine (Biorad, CA) 
using the following conditions: 95°C for 5 min, 30 cycles each of 10 s at 95 °C, 30 s at 59 °C, 
extension time of 1 min per kb at 72 °C, and a final extension of 5 min at 72 °C. PCR 
products purified using Wizard SV PCR Clean-Up system (Promega, MI), were first cloned 
into pGEM-T Easy vector system (Promega, MI) and transformed into E.coli DH5α 
competent cells. The resulting plasmids were isolated using Wizard Plus SV Minpreps DNA 
Purification System (Promega, MI) according to the manufacturer's protocol, digested with 
respective restriction enzymes (Promega, MI) and ligated to the linearized pMLBAD vector 
using T4 ligase (Promega, MI). Successful clones were screened by PCR and DNA 
sequencing was performed (1st Base, Singapore) to make sure that the constructs were correct 
before transforming into SM10 λpir conjugating strains. Resulting plasmids were then 
conjugated from E. coli SM10 into B. pseudomallei on membrane filters on nonselective LB 
agar at a ratio of 1:1, with E. coli as donors and B. pseudomallei as recipients. Conjugation 
was carried out at 37°C for 3 h before the filters were transferred onto selective Gmr and Tmr
 
 




2.2.4 Cell infections 
RAW264.7 cells and HEK293T cells (0.5 X 106/well) were seeded and grown overnight in 
complete DMEM in 12 well plates. The next day, cells were changed to RPMI media 
supplemented with 10% FBS prior to infection. To block phagocytic uptake, cells were 
pretreated with cytochalasin D (2 µg/ml) (Sigma, MO) for 2 h prior to infection. For U937 
cells,  0.5 X 106
 
/well of cells were seeded in RPMI complete in 12 well plate and activated 
with 200 ng/mL of phorbol 12-myristate 13-acetate (PMA) (Sigma, MO) for 24 h. Media was 
changed to RPMI supplemented with 10% FBS without antibiotics and incubated for a further 
24 h. All cell types were infected with log phase culture bacteria with a multiplicity of 
infection (MOI) of 100:1 and cells were centrifuged at 200 g for 5 min at room temperature to 
allow maximum cell to bacteria contact. At 2 h post infection, kanamycin (250 µg/ml) was 
added to the cultured cells to kill off extracellular bacteria.  
2.2.5 RNA isolation and measurement of gene expression by real-time PCR 
Infected cells were washed once with 1 X phosphate-buffered saline (PBS) before total 
bacterial and host cell RNA were isolated with TRIzol reagent (Life technologies, CA) and 
purified with PureLink RNA Mini Kit (Life technologies, CA) according to the 
manufacturer's instruction. DNA contamination was removed from the RNA samples by 
treating with Ambion Turbo Dnase (2 Unit for 10 μg of RNA) for 30 min at 37 ⁰C (Life 
techonologies, CA). To inactivate DNase, 2 μl of DNase Inactivation Reagent was added to 
the mixture (Life techonologies, CA). cDNA was synthesized using 1 mg of RNA and the 
High Capacity Reverse Transcription Reagent Kit (Life Technologies, CA). Transcripts were 
quantified using iQTM SYBR Green Supermix for iQ5 (Biorad, CA) in a BioRad iQ5 Thermo 
Cycler machine (Biorad, CA). Real time PCR primers were designed using Primer3 software 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) based on genomic DNA sequence 
of B. pseudomallei K96243 strain which sequence is highly homologous to KHW and are 
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listed in Table 4.  Relative RNA level of a particular gene in mutant strains was normalized to 
that of the wild-type using the 2-ΔΔ (Livak and 
Schmittgen, 2001)
Ct method with 16S rRNA as reference gene 
. The 16S rRNA was used as it is highly abundant and the expression 
remains constant throughout various different conditions (Sun et al., 2010). The house-
keeping gene dnaK which encodes for a protein involved in DNA replication was used as an 
internal control.  
 
Table 4. List of real-time PCR primers used in this chapter 
 
Gene Sequence 
16S 5' GGCTAGTCTAACCGCAAGGA 3' 
5' TCCGATACGGCTACCTTGTT 3' 
dnaK 5' CGCAGATCGAAGTGACCTT 3' 
5' ATCTTCTCGATCTCGGCTTC 3' 
bspR 5' GCTCGGCTACTACATGGTGTC 3' 
5' AGCAGCAACTCGGTGTTCATC 3' 
bprP 5' CGGCGACATCGTCACCAC 3' 
5' GGTGATAACTGCCTTCCGTGAC 3' 
bsaN 5' AATAAATCGGCGCTGGTTATCGGC 3' 
5' AGCAATTTCGCCGCCTCGAATAAC 3' 
bicA 5' ATAGATGCCGTCCATCAGGT 3' 
5' CGACGTGAACATAGACGACA 3' 
bopE 5' TCCTTCGCTTCGCTGAAGATCG 3' 
5' ATTCGGCCGGCAAGTCTACG 3' 
bprC 5' GCGGAACAGCCGATAGAG 3' 
5' CATCGAGCAGCATCTTCATC 3' 
virG 5' CCCCATAGCGTCTCCACCTC 3' 
5' GATCCGAAGCATCCCGAACTG 3' 
tssA 5' GTCGACAAGGACGACTTCAA 3'  
5' GAGCGTGAGCTGGAGGTT 3' 
hcp1 5' CACATCCTCGCCTTCAA 3' 
5' ATCTCGAACTCTTCCATCATCT 3' 
vgrG 5' CTCACGTCCGGCAACAAGTTC 3' 
5' TTGCCGCCCATCGACACC 3' 
 
2.2.6 Bacterial uptake in RAW264.7 macrophages upon cytochalasin D treatment 
To determine if uptake of B. pseudomallei into RAW264.7 cells was inhibited by cytochalasin 
D, cells (0.5 X 106 cells/well) seeded in triplicate and grown overnight in complete DMEM in 
12 well plates. The next day, RAW264.7 cells were changed to RPMI media without 
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antibiotic and pretreated with cytochalasin D (2 µg/ml) (Sigma, MO) for 2 h prior to infection 
with log phase B. pseudomallei wild-type strain (KHW) at an MOI of 100:1. After 1 h of 
incubation at 37 °C, infected cells were washed once with 1X PBS before changing to fresh 
medium with cytochalasin D (2 µg/ml) added back in and  addition of kanamycin (250 µg/ml) 
to kill off extracellular bacteria. After an additional 2 h of incubation, cells were washed three 
times with 1X PBS and lysed with 1 ml of 0.1% Triton X-100 in PBS (Sigma, MO), and 
serial dilutions of 10-fold were performed on the lysates and plated onto TSA agar. Plating 
for each dilution was done in duplicate. Colonies were enumerated after incubation at 37 °C 
for 24 h to calculate bacterial uptake and data were expressed as colony forming unit (cfu) per 
million infected cells/well.    
 
2.2.7 Statistical analysis 
Student's t-test for unpaired samples was used for statistical analysis. A p-value of <0.05 is 
















2.3 Results  
 
2.3.1 T6SS-1 gene expression is highly upregulated during host cell infection.   
As Shalom et al. has found that T6SS-1 is only induced upon interaction with macrophages 
(Shalom et al., 2007), we further validated and investigated the physiological activation level 
inside host cells. Since our group has previously shown that the T6SS-1 regulators, VirAG 
and BprC, were regulated directly by T3SS-3 BsaN and indirectly by BspR and BprP 
upstream regulators (Sun et al., 2010), we examined whether the expression of these 
regulators were also induced inside cells. To do so, we used RAW264.7 macrophage-like cell 
line as an in vitro infection model. Cells were infected with B. pseudomallei wild-type strain 
KHW at an MOI of 100:1. At 5 h post infection, bacterial RNA was isolated from the infected 
monolayer and mRNA transcript levels were quantitated by real-time PCR. Inside RAW264.7, 
transcript levels of T6SS-1 structural genes tssA (BPSS1496), hcp1 (BPSS1498), and vgrG 
(BPSS1503) in bacteria were all significantly higher as compared to bacteria grown in culture 
medium (RPMI) alone, with hcp1 having the highest degree of upregulation of  >100 fold 
(Figure 6A). This suggests that the presence of host signals inside cells is required for T6SS-1 
expression. The expression of T3SS-3 regulators bspR, bprP, bsaN and bprC were also 
elevated but at a lower extent (<10 fold increase) as compared to T6SS-1 genes (Figure 6A). 
In contrast, the expression of T6SS-1 response regulator virG and the house-keeping gene 
dnaK were similar in medium or in cells. As VirG is part of the regulatory system, it likely 
plays a role in activating T6SS-1 gene expression without its own expression being 
significantly affected during host cell infection. It may be possible that upregulation of T6SS-
1 is due to the sensing of certain host signals by the VirAG two-component sensor since their 
own expression levels are not upregulated. 
To test the relevance of T6SS-1 upregulation in human macrophages, we infected PMA 
activated U937 human monocytic cell line and primary macrophages with the wild-type strain 
KHW. Consistent with RAW264.7 cells, hcp1 expression increased to about 30 and 23 fold in 
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U937 cells and primary macrophages respectively as compared to in medium alone (Figure 
6B and 6C). Furthermore, we determined whether the upregulation of T6SS-1 genes is only 
specific to macrophages or also applicable to other cell types. As epithelial cells are at the 
front line of defense encountering B. pseudomallei in most modes of acquisition such as 
inhalation and inoculation through cuts in skin, we examined whether T6SS-1 was also 
expressed in HEK293T  human embryonic kidney epithelial cells. Similar to phagocytic cells, 
expression of the T6SS-1 genes were significantly upregulated, with hcp1 having the highest 
upregulation of >100 fold in HEK293T cells (Figure 6D). We conclude from these results that 
activation of T6SS-1 transcription occurs during infection of host cells, regardless of the cell-
types that are infected. As only the expression of T6SS-1 genes increase while the level of 







































































































Figure 6. Expression of T3SS-3 and T6SS-1 genes in culture broth and inside host cells. 
Relative mRNA levels of T3SS-3 and T6SS-1 genes of B. pseudomallei at 5 h post infection 
in A) RAW264.7 cells, B) primary macrophages, C) U937 cells and D) HEK293T cells were 
measured by real-time PCR with respect to bacterial 16S gene expression. Expression levels 
in the cells were normalized to bacteria grown in RPMI medium alone. The dnaK gene is 
used as a housekeeping gene control. All assays were performed in duplicate and values 
represent the means ± standard deviation (SD). Data are representative of three individual 
experiments.  
 
2.3.2 T6SS-1 expression inside macrophages is dependent on bacterial internalization  
Since T6SS-1 expression was highly upregulated upon host cell infection, we determined 
whether internalization of bacteria by phagocytosis is necessary for the activation of T6SS-1.  
Cytochalasin D is widely used as an inhibitor for actin dynamics in eukaryotic cells (Schliwa, 
1982).  Here, we verified that cytochalasin D can effectively block the phagocytic uptake of B. 
pseudomallei by RAW264.7 cells. Incubating cells with cytochalasin D for 2 h prior to 
infection reduced the bacterial uptake by 27 fold at 3 h post infection as compared to the 
untreated control (Figure 7).  In terms of gene expression, expression of T3SS-3 genes bsaN, 
bopE and bprC were similar ( < 2 fold difference) between infected macrophages treated or 
untreated with cytochalasin D, but expression of T6SS-1 genes tssA, hcp1 and vgrG were 
decreased by more than 10 fold in infected macrophages treated with cytochalasin D than 
those that were untreated (Figure 8). This suggests that activation of T3SS-3 requires only 

























Figure 7. Effect of cytochalasin D on internalization of B. pseudomallei in RAW264.7 
macrophages. Cells were pretreated with cyto D (2 µg/ml) for 2 h prior to infection. B. 
pseudomallei was then added to the monolayers at an MOI of 100:1. At 1 h post infection, 
kanamycin (250 µg/ml) was added to kill off extracellular bacteria and incubated for an 
additional 2 h. Cell monolayers were then lysed and viable intracellular bacteria were 
quantitated by plating serial dilutions of the lysate. Cytochalasin D was kept in the incubation 
medium throughout the experiment. Data are expressed as mean number of cfu/million 
infected cells ± standard deviation of the mean for triplicate.  ** P <0.01  
 
 
Figure 8. Effect of cytochalasin D on T3SS-3 and T6SS-1 expression during infection. 
Cells were untreated (black bar) or pretreated (white bar) with cytochalasin D (2 µg/ml) for 2 
h prior to infection. Cell monolayers were then infected with B. pseudomallei at MOI of 100:1 
for 5 h. mRNA transcript were isolated and measured by real-time PCR. Expression levels 
were normalized to bacteria from infection of untreated RAW264.7 cells. Data are 
representative of three individual experiments.   
 
2.3.3 Coordinate expression of T3SS3 and T6SS1 during host cell infection 
To understand the kinetics of both T3SS-3 and T6SS-1 expression inside RAW264.7 cells, we 
performed time course analysis of various genes from 1 h to 6 h post infection. The result 
shows that expression of T3SS-3 cluster genes and virG peaked at 4 h post infection, whereas 
expression of tssA and hcp1 peaked at 5 h post infection (Figure 9A and 9B).  Conceivably, a 
slight delay in the peak of T6SS-1 gene expression in relative to T3SS-3 genes corresponds to 
the fact that contact with macrophages is sufficient to trigger T3SS-3 expression while 






















Figure 9. Time course expression of T3SS-3 and T6SS-1 genes inside RAW264.7 cells.  
Cells were infected with wild-type B. pseudomallei at MOI of 100:1 and mRNA transcripts of 
the bacterial genes at 1 h to 6 h post infection were measured by real-time PCR. Relative 
mRNA level of A) T3SS-3 genes and B) T6SS-1 genes at various time points were 
normalized to those at 1 h time point. Assays were performed in duplicate and error bars were 
represented in ± SD. Data are representative of three individual experiments.  
 
2.3.4 T6SS-1 expression inside macrophages is absolutely dependent on VirAG and less 
on BprC 
To determine the regulation of T6SS-1 expression, various regulatory deletion mutants 
(ΔbspR, ΔbprP, ΔbsaN, ∆bprC and ∆virAG) that were constructed from previous study (Sun 
et al. 2010) were examined. We compared the expression of T3SS-3 and T6SS-1 genes in the 
wild-type and these regulatory mutants during RAW264.7 cells infection. The results showed 
that the upstream regulation is similar to that observed in the bacterial culture alone as 



















































on BspR and BprP. Both T3SS-3 genes bopE (effector) and bicA (chaperone) expression 
were > 10 fold down in ∆bspR, ∆bprP and ∆bsaN mutants as compared to that in the wild-
type strain (Figure 10A).  Likewise at the downstream level, expression of the regulators 
bprC and virAG and all T6SS-1 genes were dependent on BsaN in culture medium (Figure 
10B). The expression level of virG decreased by >10 fold, whereas the expression of bprC 
and T6SS-1 genes (tssA, hcp1 and vgrG) decreased by >100 fold in the ΔbsaN compared to 
the wild-type strain during infection (Figure 10B).   
In contrast, the expression profiles of T6SS-1 genes in ∆bprC and ∆virAG mutants were 
considerably different inside RAW264.7 cells as compared to in culture medium. In the 
medium, the expression of T6SS-1 genes tssA, hcp1 and vgrG in the ∆bprC strain, but not in 
the ∆virAG mutant, were more than 10 times lower than in wild-type strain. (Figure 10C).  
Inside RAW264.7 cells, only tssA was significantly decreased to > 100 fold in the ∆bprC as 
compared to the wild-type strain but not the other two T6SS-1 genes (hcp1 and vgrG) (Figure 
10C). Since, the expression of tssA in ∆bprC mutant could be complemented by 
overexpressing bprC in trans on pMLBAD plasmid (pML-bprC), (Figure 10D), it indicates 
that BprC is responsible for upregulating the tssA and tssB operon. In the ∆virAG mutant, the 
expressions of tssA, hcp1 and vgrG were significantly lower than the wild-type (>100 fold 
decrease) inside RAW264.7 cells (Figure 10C), indicating that their transcriptions are 
dependent on VirAG. Importantly, their expression in the ∆virAG mutant could also be 
restored by virAG complementation on a pMLBAD plasmid (pML-virAG), but not by 
individual gene (pML-virA or pML-virG) (Figure 10E). Taken together, these results 
demonstrate that while the two-component system VirAG is absolutely required for the 
intracellular activation of T6SS-1 , BprC is only required  for activation of a subset of T6SS-1 
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Figure 10. Expression of T3SS-3 and T6SS-1 genes in B. pseudomallei wild-type strain 
(KHW) and regulator mutants. Bacteria were grown in culture medium RPMI or were 
infected in RAW264.7 cells. For infection, cells were infected with B. pseudomallei at MOI 
of 100:1 for 5 h. Transcript level of various T3SS-3 and T6SS-1 genes in A) ΔbspR and 
ΔbprP  B) ΔbsaN  C) ΔbprC and ΔvirAG D) ΔbprC + pMLbprC  and E) ΔvirAG + pMLvirA 
and pMLvirG were normalized to that of wild-type parental strain. For A, D and E, 
expression of genes were measured upon cell infection. For B and C, expression during 
infection is relative to that in the culture medium. Assays were performed in duplicate and 
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T6SS has been shown to be a critical virulence determinant in several Gram-negative 
pathogens (Rao et al., 2004; Potvin et al., 2003; Suarez et al., 2008).  B. pseudomallei harbors 
six T6SSs, but only the T6SS-1 cluster is required for bacterial virulence in mammalian hosts 
and it plays an important role in the intracellular lifecycle of this pathogen (Pilatz et al., 2006; 
Burtnick et al., 2011; Schwarz et al., 2010). As most studies have been focusing on 
investigating the roles of T6SS, little is known about the regulation of this virulence factor. In 
this study, we characterized the expression of T6SS-1 inside host cells and provided evidence 
that T6SS-1 is differentially regulated once inside the host.  
Previously, our group has discovered a regulatory cascade that co-ordinately controls the 
expression of T3SS-3 and T6SS-1 in B. pseudomallei grown in culture medium (Sun et al., 
2010). Hence, we study the regulation of T6SS-1 in relation to T3SS-3. Both virulence factors 
were activated in the presence of host signals as expression of both secretion systems were 
significantly elevated upon RAW264.7 macrophages infection.  
To show its relevance to human infection, we have also demonstrated T6SS activation in 
primary human macrophages and U937 monocytic cell line. Besides phagocytic cells, T6SS-1 
genes were also significantly upregulated in HEK293T epithelial cells, thus demonstrating 
that the induction is not cell-type specific and certain host specific signal(s) is/are required for 
the activation. 
(Chong et al., 2008; 
In fact, up-regulation of T6SS gene clusters has been shown to occur in a 
variety of intracellular pathogens following interactions with their hosts. Indeed, these 
cellular-induced T6SS clusters are critical in intracellular processes such as intracellular 
survival, delaying phagocytosis and replication. For instance, the Francisella pathogenicity 
island (FPI) T6SS homolog of F. tularensis was induced during the early phagosomal stage in 
a murine bone marrow-derived macrophages model to facilitate phagosomal escape and 
intracellular survival Lindgren et al., 2004). In S. enterica, many of the 
SPI-6 T6SS genes were only upregulated during macrophages infection which is required for 
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delaying phagocytosis and limiting intracellular replication to persist inside macrophages 
(Mulder et al., 2012; Parsons and Heffron, 2005). Similarly in B. pseudomallei, expression of 
both T3SS-3 and T6SS-1 genes increase rapidly inside macrophages suggesting that these 
secretion systems are necessary for intracellular activities once they were inside cells.  
In addition, we demonstrated that T3SS-3 and T6SS-1 expression are coordinately regulated 
both spatially and temporally. Cytochalasin D, an inhibitor that is commonly utilized for 
blocking phagocytosis, blocked the expression of T6SS-1, but not T3SS-3. This indicates that 
whereas T3SS gene expression initiates upon contact with host cells, T6SS-1 expression only 
increases significantly inside host cells upon bacterial internalization. There is a slight delay 
in the peak of T6SS-1 gene expression as compared to its regulators and T3SS-3 genes, 
suggesting expression of T3SS-3 precedes T6SS-1. Moreover, regulation of both secretion 
systems is interlinked through BsaN. Apparently, BsaN provides the crosstalk among T3SS-3 
and T6SS-1 to ensure precise and appropriate expression of both virulence factors inside hosts. 
Such crosstalk communication among T3SS and T6SS are also seen in other pathogens such 
as E. tarda, S. enterica and A. hydrophila (Leung et al., 2011). As mentioned previously, 
EsrC in E. tarda serves as a crosstalk protein (somewhat analogous to BsaN) which activates 
the whole evp (T6SS homolog) operon and specific T3SS genes (Zheng et al., 2005). T6SS is 
therefore connected to T3SS through EsrC and an upstream regulator EsrB, which relay 
signals from PhoP/Q (Zheng et al., 2005). Crosstalk in A. hydrophila is more complex as it 
involves communication among two flagella systems, T3SS, T6SS and QS. The σ54
(Vilches et al., 2009)
 factor, 
RpoN, is one of the crosstalk proteins that control both flagella systems (lateral/polar) and the 
T3SS . In addition, the N-acylhomoserine lactone QS regulator AhyIR 
was shown to upregulate T3SS expression (Vilches et al., 2009). Complex network of 
transcription regulators (TRs) in S. enterica also provides crosstalk among two T3SSs such as 
SPI-1 and SPI-2, and the T6SS SPI-6. These TRs include the PhoP/Q and SsrA/B TCSs, with 
PhoP being the master regulator that controls the downstream SsrA/B TCS, which 
subsequently regulates SPI-2 and SPI-6 T6SS genes (Xu and Hensel, 2010; Bijlsma and 
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Groisman, 2005). Such intelligent integration of communication networks allow pathogens to 
co-coordinately regulate virulence factor activities during infection which contribute to 
bacterial survival inside the host.  In some intracellular pathogens, T3SS and T6SS are 
inversely controlled by antagonistic regulators. This is illustrated by the RetS and LadS 
signalling pathways in P. aeruginosa, with RetS positively regulates T3SS and represses 
T6SS while LadS does the opposite (Moscoso et al., 2011). Unlike cooperative functions of 
T3SS and T6SS in B. pseudomallei infection, such reciprocal regulatory network in P. 
aeruginosa enables the bacteria to switch between biofilm lifestyle contributed by T6SS that 
establish a chronic infection and planktonic lifestyle with motility associated with T3SS that 
establish an acute infection (Moscoso et al., 2011).  
 
Furthermore, we elucidated the first comprehensive regulatory cascade of T6SS-1 in B. 
pseudomallei. Even though VirAG is known to be the main regulator of T6SS-1 and it being 
encoded immediately upstream of the T6SS-1 cluster, it does not control T6SS-1 expression 
when the bacteria were grown in culture medium. This 
(Schell et al., 
2007)
explains why Burtnick et al has to 
overexpress virAG to see T6SS-1 upregulation in extracellular bacteria since endogenous 
VirAG could not drive T6SS1 expression when bacteria were extracellular 
. In this study, we have demonstrated the control of T6SS-1 expression by VirAG in the 
physiological context. Inside mammalian cells, VirAG becomes the major regulator and is 
absolutely required for expressing core T6SS components such as hcp1and downstream genes, 
while BprC is only required for regulating the tssAB operon. 
(Prost and Miller, 2008)
It is likely that VirAG senses 
certain host intracellular signals and relay it to its cognate regulator VirG, which in turn binds 
to the relevant promoters to initiate T6SS-1 gene transcription. This is similar to Salmonella’s 
PhoPQ system, which senses signals inside host phagosome such as acidic pH and 
antimicrobial peptides for T3SS SPI-2 expression . Such a strategy of 
adopting a different regulatory mechanism inside the host depicts how bacteria adapt to its 
host environment upon invasion. Notably, the expression of virG does increase over time as 
demonstrated in the kinetic profile upon host cell infection (Figure9B). Perhaps, virG 
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expression increases with growth in both medium and in cells as there is no significant 
difference observed at 5 hr post infection as compared to in medium alone ( Figure 
6A).  
 
Based on our findings, we have proposed a model of regulation of T6SS-1 inside cells 





Model of T6SS-1 regulation inside host cells (adapted from Chen et al., 2011). 
Another important point is that our group has also demonstrated that both ΔvirAG and ΔbprC 
mutants were avirulent in a mouse infection model, thus showing the importance and 
relevance of T6SS-1 regulation in vivo (Chen et al., 2011). According to Burtnick et al, 
VirAG is only specific for upregulation of the T6SS-1 cluster, but not other T6SS clusters 

















2010). This indicates that VirAG is a crucial player for expressing a major virulence factor in 
contribution to B. pseudomallei pathogenesis.  
In conclusion, our study in this chapter demonstrates that the expression of T6SS1 gene 
cluster is tightly regulated at the transcriptional level. The complexity in T6SS-1 gene 
regulation likely ensures that this virulence factor is expressed only at appropriate times 
during the infection process. The present challenge is to identify the direct signals and 
environmental cues that trigger T6SS-1 expression pertaining to B. pseudomallei.  This 










































Cellular functions of 




Some of the contents in this chapter have been published in                                                  
The Regulation of Type VI Secretion System during Burkholderia pseudomallei infection 
Infection and Immunity, Aug. 2011, p. 3064–3073 Vol. 79, No. 8 
3.1 Introduction 
The discovery of T6SS in various Gram-negative bacteria has triggered immense interest in 
this new secretion system. Initially, researchers studying T6SS in a wide range of pathogens 
have focused on investigating its role in interaction with the hosts. Through mutations of 
T6SS core components and various infection models, these studies have provided explicit 
evidence that T6SS is a virulence factor and plays a role in bacterial pathogenesis. Currently, 
the knowledge on how T6SS functions in targeting eukaryotic cells is still fragmented and 
points to a certain degree of variability among different pathogens. In fact, we do not yet have 
a holistic understanding of the mechanistic basis of how T6SS confers virulence to bacteria in 
eukaryotic hosts. Recently, a new perspective is revealed as T6SS was also reported to have 
antibacterial activity (Hood et al., 2010). It has become clear that T6SS can be classified 
under two broad categories: those contributing to virulence in eukaryotic cells and those 
required for inter-bacterial interaction.  In this chapter, we will thoroughly review and discuss 
specifically the role of T6SS in virulence in eukaryotic hosts.  
The pioneering study by Pukatzki et al. demonstrated that T6SS in V. cholerae was required 
for cytotoxicity towards Dictyostelium discoideum amoeba and mammalian macrophages 
(Pukatzki et al., 2006).  This leads to the question of whether T6SS is also required for 
virulence in other important pathogens. Many instances where pathogen virulence was 
attenuated in whole-organism infection models or eukaryotic cells are associated with 
mutations affecting T6SS structure or T6SS regulatory networks. Implications of T6SS 
involvement in virulence is seen in diverse bacterial species ranging from plant pathogens 
(e.g. Pectobacterium, Rhizodium) (Roest et al., 1997), animal pathogens (e.g. E. tarda) (Rao 
et al., 2004), to important human pathogens (e.g  P. aeruginosa, B. pseudomallei, V. cholera, 
S. enterica) (Hood et al., 2010; Mulder et al., 2012; Miyata et al., 2011; Potvin et al., 2003; 
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Chen et al., 2011).  In P. aeruginosa, mutation of various genes in the HSI-1 (T6SS) cluster 
showed an attenuated virulence phenotype in a chronic infection model in the rat lung (Potvin 
et al., 2003). Likewise, E. tarda evp mutants showed a lower rate of replication than the wild-
type strain in gourami phagocytes (Rao et al., 2004). In A. hydrophila, T6SS mutants were 
less virulent in a mouse model of septicemia, less cytotoxic towards epithelial HeLa cells and 
macrophages as compared to the wild-type (Suarez et al., 2008).  
Rapid progress in understanding the molecular mechanism of T6SS involvement in virulence 
has since been made. It is clear that secretion of Hcp and VgrG is the hallmark of T6SS. 
However, both substrates are codependent for export and are essential structural constituents 
of the T6SS which assemble into a needle-like injectisome on the bacterial surface (Pukatzki 
et al., 2009). In fact, little is known about the “true” substrates that are secreted by the T6SS 
apparatus into the host directly to modify the eukaryotic host. Thus far, the well-studied ones 
are the T6SS effectors from V. cholera. For instance, VgrG1 is a specialized protein which 
contains a C-terminal actin crosslinking domain that binds and cross link G-actin in the host 
and hence confers cytotoxicity towards D. discoideum and J774 macrophages (Pukatzki et al., 
2007; Ma et al., 2009). In addition, two other effectors TseL and VasX also play a role in 
virulence towards D. discoideum (Dong et al., 2013). VasX was shown to be secreted and 
target membrane phospholipids that contain a phosphorylated group, including each of those 
phosphatidylinositol phosphates (PIPs) found in eukaryotic membranes (Miyata et al., 2011). 
Since these inositol phosphates are uncommon in bacteria, it is likely that VasX targets host 
membrane lipids specifically to interfere with their PIP metabolism (Miyata et al., 2011).  
Similarly, the secreted VgrG1 of A. hydrophila contains a C-terminal VIP-2 domain that 
exhibits ADP ribosylation of actin and thus induces cytotoxicity towards HeLa cells (Suarez 
et al., 2010).  
Besides hijacking host actin and membrane lipids, other processes facilitated by T6SS or 
functional phenotypes assigned to T6SS include adherence and invasion of the host cells, 
intracellular growth or survival and persistence within the eukaryotic host. In F. tularensis, 
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T6SS is important for optimal phagosomal escape into the cytosol and intracellular replication 
in primary murine macrophages as shown through IgIC and IglD mutations (Chong et al., 
2008). Furthermore, both SciZ and SciN components of sci-1 T6SS in EAEC, 
a diarrhoeagenic
(Aschtgen et al., 2010; 
 E. coli strain,  are required for adhesion and biofilm formation, hence 
leading to colonization of the intestinal mucosal which causes diarrhea 
Aschtgen et al., 2008). The SciS (the icmF homolog) in S. enterica limits intracellular growth 
in macrophages at late stages of infection (Parsons and Heffron, 2005). This is a mode to 
promote survival and persistence within the host by reducing virulence as shown in a mouse 
model of infection (Parsons and Heffron, 2005).  However, the deleted genes may form part 
of the T6SS secretion apparatus and may not be the secreted substrates that manipulate host 
defense mechanisms.  
 
In the context of Burkholderia species, the first clue on T6SS participation in virulence in 
mammalian host is shown through a transposon mutant with an insertional mutation of the 
tssK gene in B. pseudomallei. This mutant exhibited significant attenuation of virulence in 
BALB/c mouse infection and a reduction in plaque formation (Pilatz et al., 2006). Similarly 
in B. thailandensis, mice infected with a tssK deletion mutant survived through 14 days after 
infection whereas wild-type infected mice died within three days (Schwarz et al., 2010). 
Bacterial loads in both cases were significantly reduced in spleen, liver and lung of mice 
infected with the mutant. In B. mallei, tssB, hcp, tssD and tssE deletion mutants were 
avirulent in Syrian hamster model of infection (Schell et al., 2007). Furthermore, deletion in 
hcp1 or vgrG also resulted in abrogation of virulence (Burtnick et al., 2011). Even though 
multiple copies ( four to six copies ) of T6SS clusters are present in the Burkholderia group, 
only the T6SS-1 in these three Burkholderia species is absolutely critical for bacterial 
virulence in its mammalian host as seen by the abrogation of virulence when any of these 
T6SS-1 genes were deleted (Burtnick et al., 2011; Schwarz et al., 2010).  
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Since we have shown previously that T6SS-1 is only expressed inside cells, one would expect 
that T6SS-1 plays a part in the intracellular lifecycle of B. pseudomallei. In B. mallei, ΔtssE 
T6SS-1 mutant exhibits defects in intracellular growth, cytotoxicity, MNGC formation and 
actin-based motility in murine macrophages (Burtnick et al., 2010). However, there are 
conflicting reports on the role of T6SS-1 in actin based motility, since a B. thailendensis 
ΔclpV T6SS-1 mutant could still engage robustly in actin polymerization (French et al., 2011). 
Thus far, the only unambiguous role that has been attributed to T6SS-1 in vitro is the 
induction of MNGC formation, which is evidenced through the Δhcp1 mutant in B. 
pseudomallei that demonstrated attenuation in MNGC formation in macrophages (Burtnick et 
al., 2011). MNGC is a unique characteristic of certain Burkholderia species, which may 
represent a strategy for persistence within a host by spreading intercellularly without being 
exposed to antimicrobial substances in the extracellular milieu (Kespichayawattana et al., 
2000). However, the specific bacterial effectors and host factors that are involved or the 
mechanism of how T6SS induces MNGC is yet to be identified.  
In this chapter, we interrogate in detail the functions of T6SS-1 in B. pseudomallei infection. 
Besides addressing the discrepancy in the role of T6SS-1 in actin based motility as mentioned 
above, we also assess whether T6SS-1 is required for cytotoxicity and intracellular replication. 
As most of these phenotypic functions were already shown in B. mallei and B. thailandensis, 
we want to determine whether this is also true for the T6SS-1 in B. pseudomallei. In addition, 
we aim to identify the role of various T6SS-1 components by examining the interactions of 
these mutants in RAW264.7 murine macrophages using the current known assays such as 
actin tail formation, MNGC formation and intracellular growth to have a preliminary idea 
whether these components could be structural proteins that form the apparatus or secreted 
effectors. The genes deleted in these mutants include those encoding the T6SS outer sheath 
(TssA and TssB), the T6SS regulators (VirAG and BprC), other T6SS conserved machinery 
such as ATPase ClpV that is required to recycle TssA/B dimers, as well as BimE, which may 
or may not be part of the T6SS cluster.  
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3.2.1 Bacterial strains and growth conditions 
3.2 Materials and Methods 
The bacterial strains and plasmids used in this study are listed in Table 5. All bacterial strains 
were maintained and cultured as mentioned in Chapter 2. Similarly, quantification of the 
bacterial numbers by measuring OD using a spectrophotometer was described in detailed in 
Chapter 2. Antibiotics added to LB medium were as follows (in µg/ml): For E. coli, 
kanamycin (Km), 25; tetracyclin (Tc), 20; trimethoprim (Tm), 25 and for B. pseudomallei, 
gentamicin (Gm),50; Km, 250; Tc, 50; Tm, 50. All antibiotics are from Sigma-Aldrich, MO. 
3.2.2 Construction of B. pseudomallei ΔbimE, ΔclpV, ΔbsaM mutants 
All mutants created were derived from a clinical strain of B. pseudomallei isolated in 
Singapore, strain KHW (Liu et al., 2002). In frame deletion mutations were constructed by 
allelic exchange. Gene loci that were targeted for deletion are as follow, with reference to the 
genome sequence of K96243 strain: bimE (BPSS1493), clpV (BPSS1502) and bsaM 
(BPSS1547). Approximately 1 kb fragments upstream and downstream of the target gene 
were amplified from genomic DNA and cloned into pK18mobsacB vector (Schäfer et al., 
1994) simultaneously using In-Fusion PCR cloning kit (Clontech, CA). PCR primers for 
plasmid constructions are listed in Table 6. For the construction of clpV mutant, a FRT-
flanked tet cassette from pFRTT1 was inserted between the upstream and downstream gene 
fragments of clpV to generate pKO-clpV. The resulting plasmids (pKO-bimE, pKO-bsaM, 
pKO-clpV) were then introduced into E. coli S17-1 (λpir) and subsequently conjugated into B. 
pseudomallei KHW strain.  Clones with successful single cross-overs by homologous 
recombination were first selected on TSA plate with 250 µg/ml kanamycin and 50 µg/ml 
gentamycin and the positive clones were grown in LB + 15% sucrose for four passages to 
counter-select against the sacB gene in the pK18mobsacB plasmid backbone. Successful 
double cross-over clones were screened via colony PCR for the deletion of target genes from 
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kanamycin sensitive colonies. (The resulting plasmids for conjugation were constructed by 
Chen Yahua.) 
3.2.3 Construction of B. pseudomallei ΔtssAB mutant 
The Δ tssAB deletion mutant was generated using allelic exchange with the pheS negative 
selection marker adapted from Barrett et al (Barrett et al., 2008). The gene loci BPSS1496 
(tssA) and BPSS1497 (tssB) were targeted for deletion. Briefly, approximately 1 kb fragments 
upstream and downstream of tssAB were amplified from genomic DNA and cloned into 
pBAKA vector (using EcoRI and HinDIII as RE sites) in E.coli E1345 strain (Barrett et al., 
2008). PCR primers for plasmid constructions are listed in Table 6.  The FRT-flanked tet 
cassette from pFRTT1 was inserted between the gene fragments at BamH1 site to generate 
pKO-tssAB. The resulting plasmid was transformed into E. coli E1354 and conjugated into 
KHW strain. Clones with successful single cross-over by homologous recombination were 
first selected on LB plates containing tetracycline (50 μg/ml) for retention of tet marker. 
Positive clones were then grown in the counter-selection medium (M9 media + 1% 
chlorophenylalanine) for 3 days to counter select against the pheS gene in the pBAKA 
plasmid backbone. Successful double cross-over clones were screened for the retention of tet 
marker and the loss of the tssAB sequence by colony PCR. To flip out the chromosomally 
integrated tet marker at the FRT sites, Flp recombinase on a curable plasmid pFLP-AB5 was 
introduced similarly by conjugation (Barrett et al., 2008). Successful clones were then 
screened for Tet sensitivity.  
Table 5. List of bacterial strains and plasmids used in this chapter 
Strain or plasmid Relevant characteristic(s) Source or reference a 
    
B. pseudomallei   
KHW B. pseudomallei wild-type strain Gm (Liu et al., 2002)r  
ΔvirAG KHW ΔvirAG::FRT, codon 1-233 of 
BPSS1494 and 56-614 codon of BPSS1495 
were deleted 
(Sun et al., 2010) 
ΔbprC KHW ΔbprC::zeo, codon 209-353 of 
BPSS1520 was replaced by zeo cassette, Zeo
(Sun et al., 2010)
r 
 
ΔtssAB KHW ΔtssAB::FRT, codon 7-164 of This study 
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BPSS1496 and codon 1-432 of BPSS1497 
were deleted 
ΔclpV KHW ΔclpV::FRT, codon 8-1012 of 
BPSS1502 was deleted 
This study 
ΔbimE KHW ΔbimE, codon of 89-628 of BPSS1493 
was deleted 
This study 
ΔbsaN KHW ΔbsaN::FRT, codon 14-236 of 
BPSS1546 was deleted 
(Sun et al., 2010) 
ΔbsaM KHW ΔbsaM, codon 39-411 of BPSS1547 
was deleted 
This study 
ΔT3SS-3 KHW ΔT3SS-3::zeo, BPSS1520-1552 region 
was replaced with zeo cassette, ZeoR
(Tan et al., 2010)
  
 
ΔT6SS-1 KHW Δ(bimE+ virAG +T6SS-1)::FRT, 
BPSS1493-1511 region was deleted.  
reg (Tan et al., 2010) 
E. coli   
DH5α Cloning host Sambrook et al., 1989) 
S17 S17-1 Donor strain for conjugation  (Simon et al., 1983) 
E1345 EPMax10B-pir116-Δasd::Gm (Barrett et al., 2008) 
E1354 EPMax10B-pir116-Δasd-mob-Km-trp::Gm (Barrett et al., 2008) 
   
Plasmid   
pBAKA  Conjugative suicide vector based on asdPa, 
containing pheS 
(Barrett et al., 2008) 
pK18mobsacB Conjugative, suicide vector, Kmr
 
  (Schäfer et al., 1994) 
pUCP28T Broad-range plasmid, Tm (West et al., 1994)r  
pFRTT1 pGEM contains FRT sites and tetRA 
sequence, Apr, Tc
(Sun et al., 2010)
r 
 
pFLP-AB5 Contains a FPL recombinase gene, pheS+
1% chlorophenylalanine, Tm
 as 
counter selection in 
(Barrett et al., 2008)
r 
 
pKO-tssAB pBAKA containing tetR cassette flanked by 




pKO-clpV pk18 with upstream and downstream 
sequences of clpV , Km
This study 
r 
pKO-bimE pk18 with upstream and downstream 
sequences of bimE , Km
This study 
r 
pKO-bsaM pk18 with upstream and downstream 
sequences of bsaM, Km
This study 
r 
pUCP-clpV pUCP containing clpV orf  inserted 
downstream of the lac promoter, Tm
This study 
r 
aAbbreviations: Kmr, kanamycin resistant; Tcr, tetracycline resistant; trimethoprim resistant, 
Tmr ; gentamycin, Gmr
 
 ; 




Primer name Sequence 
pKO-tssAB tssA up         F 5’ GAATTCGATGCACATCGACAGGATC 3’      
 tssA up         R 5’ GCGATAGACGATGTTGACC 3’ 
 tssB down    F 5’ ATCCAGAACAAGATCCCGA 3’ 
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 tssB down    R 5’ AAGCTT
pKO-bsaM 
TTCCAACGAGTATCCCGAA 3’ 
bsaM up       F 5’ AAGCTT
 
CACGCGACGCGATTTTGAATTG 3’ 
bsaM up       R 5’ AAGCTT
 
GCTCGCCGACGCAGAAAAATA 3’ 
bsaM down F 5’ GAATTC
 
AAGCTTGATCACGCGTCCTGGTATTT 3’ 
bsaM down R 5’ TTGGATCC
pKO-clpV 
AAGCGAGACGTAGATGCTG 3’ 
clpV up         F 5’ CCATGATTACGAATTC
 
AATGGCTGCCGATTCCG 3’ 
clpV up         R 5’ TACCCGGGGATCC
 
TCCTTTCGCGGTGAAGTCCTC  3’ 
clpV down   F 5’ GAGGATCC
 
CCGGGTAAGGAGTTCCCGATGCCTTC 3’ 
clpV down   R 5’CCAAGCTT
pKO-bimE 
GCATGCCTGCAGGTCCTTCGTGTGGAAGTGCT3’ 
bimE up       F 5’ CCATGATTACGAATTC
 
GGCGCAGTACAGGAGAGGAC 3’ 
bimE up       R 5’ TACCCGGGGATCC
 
TCCCGACGAGCAAATCCTTG 3’ 
bimE down  F 5’ GAGGATCC
 
CCGGGTAAGGACGGTGCTTGACGAG 3’ 
bimE down  R 5’ CCAAGCTTGCATGCCTGCAGCATGGACGAGTTCAACGAGA 3’ 
a 
 
Restriction sites in the linker regions are underlined.  
 
3.2.4 Cloning of clpV into expression vector for complementation 
The full-length open reading frame of clpV (BPSS1502) was amplified from KHW genomic 
DNA and cloned into the pUCP28T broad host range vector for overexpression in B. 
pseudomallei (West et al.1994). The primers used for amplification through PCR are listed 
below, and amplification was carried out using the following conditions: 95°C for 5 min, 30 
cycles each of 10 s at 95 °C, 30 s at gradient annealing temperature from 56 to 61 °C, 
extension time of 1 min at 72 °C, and a final extension of 5 min at 72 °C. The PCR product 
was purified using the Wizard SV PCR Clean-Up system (Promega, MI), and cloned directly 
downstream of the lac promoter in the pUCP28T vector using the In-Fusion PCR cloning kit 
(Clontech, CA). The resulting plasmid, pUCP-clpV, was transferred by conjugation from E. 
coli SM10 to B. pseudomallei ΔclpV on nitrocellulose membrane filters with E. coli as donors 
(≈108) and B. pseudomallei as recipients (≈108). Conjugations were performed on non-
selective LB agar for 3 h at 37°C before transferring filters onto selective Gmr and Tmr
 
 TSA 
agar. Successful clones that are resistant to both antibiotics are B. pseudomallei conjugated 
with pUCP-clpV. 
Primers for clpV complementation: 
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ClpV F: ACATGATTACGAATTCCAATGGCTGCCGATTCCG 
ClpV R: CCAAGCTTGCATGCCTGCAGGAAGGCATCGGGAACTCC 
 
3.2.5 Intracellular survival and replication of B. pseudomallei in cells 
RAW264.7 and HEK293T cells were seeded (2.5 X 105
3.2.6 Cytotoxicity assay 
 cells/well) and grown overnight in a 
24 well plate. Cells were infected with overnight bacteria at MOI of 0.1:1. At 1 h post 
infection, infected cells were washed once with 1X PBS before addition of fresh culture 
medium with 250 µg/ml kanamycin to kill off extracellular bacteria. At respective time points, 
infected cells were washed thrice with 1X PBS before lysing with 0.1 % (v/v) Triton X-100 
(Sigma, MO), and serial dilutions of 10-fold were performed on the lysates and plated onto 
TSA agar. Plating for each dilution was done in duplicate. Colonies were enumerated after 
incubation at 37 °C for 24 h to calculate bacterial loads in the cells and data are expressed as 
cfu/well.  
RAW264.7 cells were seeded (2.5 X 105
% Cytotoxicity =  (Test LDH release - spontaneous release X 100) 
 cells/well) and infected with various B. pseudomallei 
strains grown overnight at MOI of 10:1. At 2 h post infection, 250 μg/ml of kanamycin was 
added to kill off extracellular bacteria. Supernatants (10 μl) from each well were collected at 8 
h and 24 h post infection and diluted 10 X with 1X PBS (a total volume of 100 μl) to measure 
the Lactate Dehydrogenase activity (LDH)  using the Cytotoxicity Detection Kit (Clontech, 
CA) according to the manufacturer's instructions. Maximum release of LDH was achieved by 
lysis of untreated cells with 1 % Triton-X100 in infection medium while spontaneous LDH 
release was measured using supernatant from uninfected cells. Percentage cytotoxicity was 
calculated as follow:  




3.2.7 Immunofluorescence staining and confocal microscopy 
RAW264.7 cells (2.5 X 105 cells/well) were seeded on 13mm cover slips in 24 well plates and 
grown overnight at 37 °C under 5% CO2. 
3.2.8 RNA isolation and real time quantification of bimA expression  
. Cells were infected with overnight culture of 
various B. pseudomallei strains at an MOI of 10:1. After 2 h of infection, kanamycin (250 
µg/ml) was added to kill off extracellular bacteria. At specific time points, cells were washed 
once with 1X PBS, and fixed overnight in 1 % para-formaldehyde (PFA) at 4 °C. Prior to 
immunostaining, fixed cells were washed three times with the wash buffer: 1X PBS 
containing 10 mM glycine (Sigma, MO). Staining was performed at room temperature and all 
antibodies were diluted at 1:100 in PBS containing 0.05 % saponin (Sigma, MO), 10 % fetal 
bovine serum (Gibco), 10 mM HEPES (Sigma, MO) and 10 mM glycine. Infected cells were 
stained with B. pseudomallei LPS-specific rabbit polyclonal antibodies (Provided by Ganjana 
Lertmemongkolchai, Khon Kaen University, Thailand) for 45 min. Subsequently, cells were 
washed three times and incubated with Alexa Fluor 488 phalloidin (Life Technologies, CA) 
to stain for host actin and Alexa Fluor 405 goat anti-rabbit IgG (Life Technologies, CA) for 
45 min. After three washes with wash buffer and rinsed once with water, coverslips were 
mounted on glass slides using Prolong Gold antifade reagent (Life Technologies, CA). 
Confocal microscopy was performed with the LSM 710 Zeiss imaging system using a 63X oil 
objective lens (Carl Seiss MicroImaging Inc.). Images were acquired using the LSM 710 Zen 
2010 software (Carl Zeiss MicroImaging Inc.). To quantify the percentage of actin-tail 
formation, three representative fields were taken for each mutant. In each field, a total of 200 
intracellular bacteria were counted and the percentage of bacteria forming actin tails was 
calculated by the number of bacteria forming tails divided by 200 x100. 
RAW264.7 cells were seeded (0.5 X 106 cells/well) overnight in 12 well-plates and infected 
with various mid-log phase bacterial strains at MOI of 100:1 for 5 h. Infected cells were then 
washed once with 1X PBS and lysed with Trizol reagent (Life Technologies, CA) for RNA 
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isolation. RNA was purified using illustra RNAspin Mini Kit together with On-column 
DNase treatment according to manufacturer’s protocol (GE Healthcare Life Science, NJ). 
cDNA was synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo 
Scientific, MA) according to manufacturer’s protocol. Transcripts of bimA were quantified 
using iQTM
bimA F: 5’ AGCAGAGCATCACCGACAC 3’ 
 SYBR Green Supermix for iQ5 (Biorad, CA) in a BioRad iQ5 Thermo Cycler 
machine (Biorad, CA).  Real time primers were designed and relative gene expression were 
calculated as mentioned in chapter 2. The following bimA primers were used for real-time 
PCR detection: 
bimA R: 5’ ACATCGGGAATCATCGTCAG 3’ 
3.2.9 Multinucleated Giant Cell Formation (MNGC) 
RAW264.7 cells were seeded overnight at density of 2 X 105 
3.2.10 Statistical analysis 
cells/well in 24 well plates and 
infected with overnight bacterial culture at MOI of 10:1. At 2 h post infection, 250 µg/ml of 
kanamycin was added to kill off extracellular bacteria. After 10 h and 18 h of infection, 
infected RAW264.7 cells in 24 well plates were washed once with 1X PBS and fixed with 
100% methanol for 1 min. Methanol was aspirated and subsequently cells were rinsed once 
with water before staining in the wells using 500 µl of Giemsa stain (at 1:20 dilution of the 
stock with distilled water) (Sigma-Aldrich, MO) for 20 minutes. After staining, cells were 
washed once with water and air-dried before viewing under light microscope (IX51 Olympus) 
at 100X magnification.  
Student's t-test for unpaired samples was used for statistical analysis. A p-value of <0.05 is 






3.3.1 T6SS-1 is essential for the optimal growth of B. pseudomallei in macrophages. 
It is well-established that the T3SS-3 in B. pseudomallei is required for intracellular survival 
and replication within RAW264.7 cells (Burtnick et al., 2008) and J774A.1 cells 
(Muangsombut et al., 2008). Recently, T6SS-1 in B. mallei has also been demonstrated to 
play a part in the growth in phagocytic cells (Burtnick et al., 2010). Hence, we want to 
determine if this is also true for the T6SS-1 in B. pseudomallei. Furthermore, in order to get a 
better understanding of the role of both secretion systems in the intracellular life cycle of B. 
pseudomallei, we assessed the relative importance of T6SS-1 in respect to T3SS-3 for its 
survival and replication inside RAW264.7 cells. In this instance, both ΔT3SS-3 and ΔT6SS-
1reg strains, each with the whole gene cluster deleted were used. In ∆T3SS-3, the whole T3SS-
3 locus (BPSS1520-BPSS1552) was deleted, whereas in ∆T6SS-1reg
To investigate the bacterial uptake and replication associated with both mutants, a time course 
assay was performed with bacterial quantification at 2, 6 and 24 h post infection. Following 
bacterial uptake (2 h), there was no significant difference between the number of wild-type 
KHW and both ΔT3SS-3 and ΔT6SS-1
 , the operon containing 
the T6SS-1 regulatory genes virAG (BPSS1494-5), an unknown gene bimE (BPSS1493), and 
the entire T6SS-1 locus (BPSS1496-1511) were deleted.  
reg mutants located intracellularly, suggesting that 
neither secretion systems were implicated in invading RAW264.7 macrophages (Figure 12A 
and 12B). While the ΔT3SS-3 mutant demonstrated a significant growth defect with about 10 
fold decrease at 6 h and >1000 fold decrease at 24 h post infection (Figure 12A), ΔT6SS-1reg 
mutant only showed an impairment at 24 h post infection with a 100 fold decrease in 
replication as compared to the wild-type (Figure 12B). Similarly in the T6SS regulatory 
mutants, ΔbprC and ΔvirAG, bacterial loads were about 10 fold and 50 fold lower than those 
of the wild-type respectively at 24 h post infection, indicating an apparent growth defect in 







Figure 12. Time course of intracellular replication of B. pseudomallei wild-type and 
mutant strains in RAW264.7 murine cells. Monolayers of cells were infected with 
overnight culture of wild-type KHW and A) ΔT3SS-3, B) ΔT6SS-1reg and C) ΔbprC and 
ΔvirAG at an MOI of 0.1. At 1 h post infection, kanamycin (250 μg/ml) was added to kill off 




























































infection by plate counting. The values are expressed as bacteria cfu/well, and are the means 
± standard deviations of triplicate. Data are representative of three individual experiments. 
*P<0.05 is statistically significant as compared to the wild-type. 
 
To investigate in detail the role of individual T3SS-3 and T6SS-1 regulators and components 
in replication, various mutants were examined. TssA and TssB, which are mainly under BprC 
control as shown in Chapter 2, are the homologs of VipA/VipB in V. cholera. VipA and VipB 
are dimers that form the external sheath of the T6SS apparatus in the cytoplasmic region. To 
examine the importance of this sheath in T6SS-1 function, a ΔtssAB mutant was created. In 
addition, the upstream regulatory mutant ΔbsaN and other mutant strains were included for 
comparison at 24 h post infection. The result shows that bacterial numbers of all mutants and 
the wild-type strain were at comparable levels during the initial internalization stage, at 2 h 
post infection (Figure 13). Similar to ∆bprC, ∆tssAB infected cells showed a 10 fold decrease 
in bacterial load as compared to wild-type infected cells at 24 h post infection (Figure 13). 
The same degree of defect seen is expected as tssA and tssB are under BprC control.  A more 
severe defect observed in the ∆virAG mutant (50 fold decrease) as compared to ΔbprC and 
∆tssAB indicates the importance of other T6SS-1 components for the optimal growth of B. 
pseudomallei inside host cells since VirAG controls the main T6SS-1 cluster encompassing 
core T6SS-1 components such as Hcp and downstream genes. Both ∆T6SS-1reg and  ∆bsaN  
mutants exhibited a more severe defect than the ∆virAG as the T6SS-1 locus is completely 
deleted in the former and the entire T6SS-1 gene transcription is not "turned on" in the latter. 
∆T3SS-3 mutant exhibited the most severe defects in replication with about more than 1000 
fold decrease as compared to the wild-type. It is important to note that the defect in 
replication/survival observed in ∆T3SS-3 is likely due to a combination effect of disruption of 
both T3SS-3 and T6SS-1 as bsaN is also deleted in this mutant. Taken together, our results 
show that besides T3SS-3 being the main contributor in intracellular survival and replication 
of B. pseudomallei, T6SS-1 is essential for optimal growth only at a later stage of infection. 
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Possibly, both secretion systems are needed to confer optimal growth and survival of B. 
pseudomallei inside macrophages.  
 
Figure 13. Intracellular replication of B. pseudomallei wild-type and mutant strains in 
RAW264.7 murine cells at 24 h post infection. Monolayers of RAW264.7 cells were 
infected with overnight culture of various B. pseudomallei strains at an MOI of 0.1. At 1 h 
post infection, kanamycin (250 μg/ml) was added to kill off extraceullular bacteria. 
Intracellular bacterial loads were quantified at 2 h and 24 h post infection by plate counting 
and the data is expressed as bacterial cfu/well. The values of the mutants are compared to that 
of the WT strain and are expressed as means ± standard deviations of triplicate. * P <0.05 is 
statistically significant as compared to the wild-type.  
 
3.3.2 T6SS-1 plays a minor role in killing of macrophages  
Since T6SS-1 modulates intracellular behavior of B. pseudomallei, we investigated whether it 
has a role in causing cell death. To quantitate the integrity of B. pseudomallei -infected cells, 
we examined the relative cytotoxicity of the wild-type and various mutants by measuring the 
release of LDH from the infected cells. At 8 h post infection, ΔbsaN, ΔvirAG and ΔtssAB have 
a significant decrease of about 10-20% in the ability to kill macrophages as compared to the 
wild-type (Figure 14A). A lower cytotoxicity observed in these mutants is unlikely to be 
dependent of the amount of intracellular bacteria as there was no significant difference in the 
















































































comparison with T3SS-3 function in inducing cell death, we included the T3SS-3 mutant 
ΔbsaM, which has a conserved structural component of the T3SS-3 apparatus being deleted. It 
demonstrated a severe defect of 10 fold decrease in causing cytotoxicity as shown by an 
unpublished data from Yahua Chen (Figure 14A).  This is consistent with a previous study 
showing that T3SS-3 is required for causing cytotoxicity through a caspase1 dependent 
manner (Sun et al., 2005). At 24 h post infection, ΔvirAG and ΔtssAB infected cells have 
comparable levels of LDH release, indicating no apparent defect in cytotoxicity (Figure 14B). 
As BsaN also controls certain T3SS-3 genes, a significantly lower cytotoxicity shown in 
ΔbsaN may be an indirect effect due in part to a decrease in T3SS-3 expression. Overall, these 
data imply that T6SS-1 only plays a minor role in killing the host cell at an early time point of 
















































Figure 14. Cytotoxicity assays in RAW264.7 cells infected with various B. pseudomallei 
strains. Monolayers of cells were infected with various B. pseudomallei strains at an MOI of 
10:1. The percentage cytotoxicity was determined by assaying for LDH release in the culture 
supernatants at A) 8 h and B) 24 h postinfection. The 8 h of infection with ΔbsaM was done 
separately as an individual experiment. The values are means ± standard deviations of 
triplicate.  * P <0.05 is statistically significant as compared to the wild-type strain.  
 
3.3.3 T6SS-1 mutants are unable to induce MNGC formation following infection in 
RAW264.7 cells.  
A unique feature of B. pseudomallei infection is the occasional appearance of MNGCs in 
human infected tissues, particularly macrophages (Wong et al., 1995). As mentioned 
previously, these giant cells resemble a protected environment whereby the bacteria can 
replicate, survive and spread intercellularly without being exposed to the antimicrobial factors 
in the extracellular milieu. MNGC formation and cell-to-cell spreading of bacteria was 
thought to depend on T3SS-3 function based on the phenotype of a ΔbipB mutant (Suparak et 
al., 2005), which lacks a translocation apparatus component. Recently, deletion of hcp1 has 
been reported to disrupt MNGC formation, suggesting that T6SS-1 function may also be 
required (Burtnick et al., 2011). 
To decipher the role of both secretion systems in inducing MNGC formation, we tested our 






















contrast to the wild-type strain which exhibited MNGC formation at 10 h post infection, 
∆bsaN, ∆bprC, ∆virAG, ∆tssAB and ∆clpV mutants were unable to do so (Figure15A and 
Table 7). This defect was also observed at 18 h post infection (Figure 15B). As T6SS-1 
cluster genes were not expressed in both ΔbsaN and ΔvirAG mutants, and the essential T6SS-
1 components were lost in the ΔbprC, ΔtssAB and ΔclpV mutants, the results indicated that 
T6SS-1 is essential for inducing MNGC formation in host cells. Complementation of clpV by 
overexpression under a lac promoter on a plasmid (pUCP28T) was able to restore the ability 
to form MNGC at both 10 h and 18 h post infection, signifying that ClpV is one of the T6SS-
1components essential for cell fusion. Consistent with the phenotype of a T3SS-3 mutant 
ΔbsaZ in a previous study (Burtnick et al., 2008), our ΔbsaM only formed MNGC at a later 
time point (18 h post infection) as this is due to delayed vacuolar escape into the cytosol 
(Burtnick et al., 2008). Hence, the defects in MNGC formation by ΔbsaM observed at early 
time point is due to its inability to access the host cytosol for spreading. To date, it is unclear 
whether the gene bimE, which is in the same operon as virAG, is part of the T6SS-1. To 
examine the role of bimE in T6SS-1 function, we also tested its ability to induce MNGC 
formation. The result revealed that the ΔbimE was able to induce MNGC formation at both 10 
and 18 h post infection comparable to the wild-type (Figure 15 and Table 7), thus suggesting 
that BimE is unlikely to be a critical part of T6SS-1. Our data demonstrated that MNGC 

















































ΔclpV  ΔbimE 
ΔbsaM ΔclpV + pUCP-clpV 
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Figure 15. Light micrographs of Giemsa stained RAW264.7 cells infected with various B. 
pseudomallei strains. Monolayers were left uninfected or infected with various B. 
pseudomallei strains at an MOI of 10:1. Cells were fixed and stained with Giemsa stain at A) 
10 h and B) 18 h post infection and were then visualized under light microscope (100X 
∆bprC 
ΔbsaM 





magnification) for MNGC formation. Arrows indicate MNGC formations. Each micrograph 
is representative of at least three independent experiments.  
 
 
B. pseudomallei strains  MNGC formation at 10 ha MNGC formation at 18 h  a  
KHW  Yes  Yes  
ΔvirAG  No  No  
ΔbprC  No  No  
ΔtssAB  No  No  
ΔbsaN  No  No  
ΔclpV  No  No  
ΔclpV + clpV  Yes  Yes  
ΔbimE  Yes  Yes  
ΔbsaM  No  Yes  
a
 
 MNGC formation were examined by performing Giemsa stain at 10 h and 18h post 
infection on RAW 264.7 cells with indicated strains of B. pseudomallei at an MOI of 
10:1.  
 
3.3.4 Actin polymerization is solely dependent on BimA and is not a T6SS-1 function. 
B. pseudomallei is able to stimulate host actin polymerization following vacuolar escape into 
the cytoplasm, resulting in the formation of actin tail at one end of the bacterial pole. By 
doing so, it is able to propel itself throughout the cytoplasm to facilitate cell to cell spread 
(Kespichayawattana et al., 2000). To assess the ability of T6SS-1 mutants in exhibiting actin 
polymerization, RAW264.7 cells were infected with wild-type (KHW), ΔvirAG, ΔbprC, 
ΔtssAB, ΔbsaN, ΔclpV and ΔbimE mutant strains, fixed and stained for actin tail formation at 
8 h post infection.  Table 8 shows a summary of the property of actin polymerization in each 
of the mutants examined. The results demonstrate that wild-type exhibited significant signs of 
actin tail formation at one end of each bacterium cell stained in green (Figure 16A). In 
contrast, both regulatory mutants ΔvirAG and ΔbsaN did not exhibit actin tail polymerization 
(Figure 16A). Interestingly, other T6SS-1 mutants such as ΔbprC, ΔtssAB, and ΔclpV retained 
the ability to form actin tails (Figure 16A, and Table 8), suggesting that actin based motility is 
likely independent of T6SS-1 function. Quantitative analysis revealed that these mutants were 
capable of forming actin tails at levels comparable to that of the wild-type (Figure 16B). In 
Table7. Summary of MNGC formation by various bacterial strains 
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addition, no apparent defects were seen in actin tail formation in the ΔbimE mutant as 
compared to the wild-type (Figure 16 and Table 8).  
It is well-established that BimA, an auto-transported protein located at one pole of the 
bacterial cell, is required for actin polymerization (Stevens et al., 2005). This leads one to 
speculate whether the 
(Burtnick et al., 
2010)
difference in the ability to form actin tail between the ΔvirAG and other 
T6SS-1 mutants could be due to the difference in their control of bimA expression. 
Quantitative gene expression showed that bimA was indeed down regulated in ΔvirAG but not 
in the other T6SS-1 mutants that exhibited actin polymerization (Figure 17). Hence, in 
contrast to what was seen in a B. mallei ΔtssE mutant as shown previously 
, our results suggest that the ability to polymerize actin is due to the expression of BimA, 
and T6SS-1is not responsible for it. However, to determine if BimA downregulation is solely 
responsible for the defect of virAG on actin-tail formation, complementation of bimA 



































































































































Figure 16. Confocal micrographs of actin tail polymerization by various B. pseudomallei 
strains. Monolayers of RAW264.7 cells were infected with A) Wild-type, ΔbsaN, ΔvirAG, 
ΔbprC, ΔtssAB, ΔclpV, Δhcp1 and ΔbimE strains for 8 h at an MOI of 10:1 and fixed prior to 
immunostaining. Bacteria were stained blue with rabbit anti- B. pseudomallei polyclonal sera 
and anti-rabbit IgG Alexa Fluor 405, host actin were stained green with Alexa Fluor 488 
phalloidin. The arrows indicate actin tail formation at one pole of the bacteria. The 
micrographs are representative of at least two independent experiments. B) Semi quantitative 
analysis of actin tail formation in various B. pseudomallei strains at 8 h post infection. At 
least 200 individual intracellular bacteria were counted in each field. Three fields were taken 
for each strain and that makes up to a total of 600 individual bacteria for analysis. Values are 








B. pseudomallei strains  Actin tail formation  
KHW  Yes  
ΔvirAG  No  
ΔbsaN  No  
ΔbprC  Yes  
ΔtssAB  Yes 
ΔclpV  Yes  










































Figure17. Expression levels of bimA in various T6SS-1 mutants. Relative mRNA level of 
bimA in A) ΔvirAG, B) ΔtssAB, C) Δhcp1, D) ΔclpV and E) ΔbimE mutants upon RAW264.7 
cells infection were measured by real-time PCR. Assays were performed in duplicate and 
error bars represent ± SD. Data are representative of two individual experiments. * P <0.05 is 






























































































As B. pseudomallei is an intracellular pathogen, its ability to survive and replicate within 
eukaryotic cells is critical for its persistence inside susceptible hosts. Although it is capable of 
infecting a variety of host cell types, macrophages or phagocytic cells are believed to be an 
important target for infection in vivo (Suparak et al., 2005). Following bacterial uptake, B. 
pseudomallei is known to escape from the endocytic vacuoles, induce caspase-1 dependent 
cell death, undergo cytosolic replication and spread intercellularly for dissemination of 
infection (Jones et al., 1996; Kespichayawattana et al., 2000; Sun et al., 2005; Burtnick et al., 
2008). Before the discovery of T6SS-1, T3SS-3 was implicated in all of these events. As we 
have shown previously that T6SS-1 expression is coordinately controlled with T3SS-3, some 
of these phenotypes could be attributed to T6SS-1. Hence in this study, we dissect the role of 
these two secretion systems in modulating the intracellular behavior of this pathogen.  
Besides T3SS-3, our results indicate that T6SS-1 is also indispensable for intracellular 
survival and growth. This is shown through the regulatory mutants, ΔvirAG and ΔbsaN, 
which exhibited significant growth defects of about a 100 fold decrease, whereas the ΔbprC 
and ΔtssAB mutants demonstrated a less severe defect as compared to the wild-type. 
Interestingly, the impairment in growth in these T6SS-1 mutants was only observed at a later 
stage such as 24 h post infection, but not at the earlier time point at 6 h post infection. It 
appears that T6SS-1 does not contribute significantly to bacterial survival in RAW264.7 cells.  
This is in agreement with Burtnick et al, who demonstrated that the growth rate of B. mallei 
ΔtssE mutant ( a T6SS-1 mutant) only decreased by about 10 fold at 24 h post infection 
(Burtnick et al., 2010). Unlike T3SS-3 which appears to be absolutely critical for intracellular 
replication as shown by the growth phenotype of ΔT3SS-3 mutant, T6SS-1 is only required 
for a more efficient and optimal growth inside macrophages. To rule out the argument that the 
effect seen in ΔT3SS-3 is due to a combination of both T3SS-3 and T6SS-1 clusters being 
affected, we have tested ΔbsaM, a T3SS-3 structural mutant with a single gene deletion and 
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demonstrated a comparable level of defect as the ΔT3SS-3 in intracellular replication 
(unpublished data by Chen Yahua). The relatively smaller contribution of T6SS-1 compared 
to T3SS-3 to intracellular growth was also shown by the ΔtssE mutant in B. mallei (Burtnick 
et al., 2010).  
Another study by Burtnick et al. demonstrated a delayed growth phenotype for the 
Δhcp1mutant in B. pseudomallei. In this mutant, the bacterial load in infected cells was lower 
at 12 h as compared to the wild-type but similar by 18 h post infection (Burtnick et al., 2011). 
As they have used a high MOI of 1 to 2, cytotoxicity was high ( about 50 % cytotoxicity) in 
the wild-type infected cells at 18 h post infection, thus causing the release of bacteria into the 
antibiotic-containing extracellular medium (Burtnick et al., 2011). This resulted is an 
underestimate of the intracellular bacterial load for the wild-type infected cells. This is also 
the case in a previous study by Shalom et al. who demonstrated that another T6SS-1 mutant 
ΔclpV (according to our nomenclature) in B. pseudomallei did not exhibit defective 
intracellular growth within RAW264.7 cells at both 4 h and 19 h post infection (Shalom et al., 
2007). Notably, they have infected cells with an MOI of  >10 :1, which caused a high 
cytotoxicity level of at least 30% even at the earlier time point (as shown in Figure 14). In our 
study, a lower MOI of 0.1 was used in which cell death was minimal for the wild-type 
infected cells even at 24 h post infection as determined by cytotoxicity assay (<5% 
cytotoxicity). Importantly, a significant growth defect is still observed at this late time point. 
Taken together, both T3SS-3 and T6SS-1 contribute to optimal intracellular growth and 
survival inside macrophages. It will be interesting to investigate the mechanism of how each 
secretion system contributes to replication inside host cells. 
Several studies on other pathogens such as E. tarda and S. enterica have also shown that 
T6SS influences their replication rate and survival inside host cells.  In E. tarda, both ΔevpB 
and ΔevpC (hcp1 homolog) mutants showed a lower replication rate in gourami phagocytoes 
when compared with the wild-type (Rao et al., 2004). Likewise in S. enterica, the SPI-6 T6SS 
contributes to intracellular proliferation in RAW264.7 macrophages as shown by the sciG and 
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sciS core T6SS gene mutants (Mulder et al., 2012; Parsons and Heffron, 2005). However, the 
contribution is minimal with a replication ratio of approximately 0.5 for both mutants as 
compared to the WT strain. In fact, a more significant defect was seen in a SPI-2 T3SS 
translocon mutant. This is somewhat akin to the T3SS and T6SS in B. pseudomallei.  
Given that T6SS-1 plays a role in intracellular growth and survival, it is tempting to speculate 
that T6SS-1 may also affect macrophages cell death. Our results show that the T6SS-1 
mutants have a lower cytotoxicity at an earlier phase of infection but not at 24 h post infection. 
This is not the result of reduced bacterial replication or survival in host cells as the growth 
phenotype shown in the T6SS-1 mutants were opposite, with growth defects seen only at the 
later stage at 24 h post infection but not 6 h. Conversely, Burtnick's cytotoxicity data showed 
that B. pseudomallei Δhcp mutant has a significant defect in inducing cell death in RAW264.7 
cells at 18 h post infection (Burtnick et al., 2011). Perhaps, a difference in 6 h of infection 
accounts for the difference in the results observed. To obtain a more precise knowledge about 
the kinetics, cytotoxicity should be measured across various time points. Nevertheless, T3SS-
3 still plays a more vital role in inducing cell death in a caspase1 dependent manner (Sun et 
al., 2005). Possibly, T3SS-3 that is functional in the T6SS-1 mutants is the main virulence 
factor that accounts for the cell death at 24 h post infection.  The importance of T6SS-1 in 
causing cell death is also demonstrated in other pathogens, thus showing a general function 
among the T6SS in different species (Suarez et al., 2008; Aubert et al., 2008). For instance, 
deletion of sciG reduces the cytotoxicity (about 30% lower than the wild-type) of S. typhi 
towards epithelial cells (Wang et al., 2011). Furthermore, mutations of vasH and vasK genes 
(T6SS mutants) in A. hydrophila reduced the cytotoxicity activity towards RAW264.7 and 
HeLa cells after 3-4 h of infection (Suarez et al., 2008). Of note, cell death observed could be 
an indirect effect of other factors. To fully understand the contribution of T6SS to cytotoxicity, 
it merits a closer and detailed investigation on the mechanism and pathway of how T6SS is 
involved in cell death.   
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The ability for B. pseudomallei to induce host cell fusions in vitro is proposed to facilitate 
intercellular spread (Suparak et al., 2005);  (Kespichayawattana et al., 2000). These MNGCs 
were also observed in infected tissues in melioidosis patients, suggesting its relevance in vivo 
(Wong et al., 1995). Furthermore, B. pseudomallei is able to hijack host actin to facilitate its 
intracellular movement inside host cytosol (Kespichayawattana et al., 2000).  This is 
mediated by BimA, an autotransported surface protein localized at one end of the bacterial 
pole, which binds actin and induce polymerization in a unidirectional manner (Stevens et al., 
2005). Indeed, it is tempting to speculate that MNGC formation is due in part to the actin-
based motility and both events contribute to spreading of bacteria to neighboring cells without 
being released into the extracellular milieu.  
Previously, a T3SS-3 mutant, ΔbsaZ, demonstrated delayed endosomal escape and thus leads 
to a delay in MNGC and actin tail formation in RAW264.7 cells at 18 h post infection 
(Burtnick et al., 2008). Consistently, our ΔbsaM mutant which also has a non-functional 
T3SS-3 exhibited the same delayed MNGC formation phenotype. This concludes that T3SS-3 
activity is only required for early endosomal escape but not in MNGC and actin tail formation. 
Indeed, bacterial entry into the host cytosol is a prerequisite for these processes to occur. Our 
results revealed that the T6SS-1 mutants ΔbsaN, ΔvirAG, ΔbprC, ΔtssAB and ΔclpV were 
unable to induce MNGC formation even at 18 h post infection. As the ability to undergo 
vacuolar escape was not affected in the B. mallei ΔtssE mutant (Burtnick et al., 2010), the 
defects seen in MNGC in these T6SS-1 mutants were unlikely to be due to entrapment in the 
phagocytic vacuoles. Interestingly, even though ΔbprC, ΔtssAB, ΔclpV and Δhcp1 were 
defective in forming MNGC, they remained fully capable in actin polymerization, again 
indicating that they have escaped into the cytosol. This is not the case for the two regulatory 
mutants, ΔbsaN and ΔvirAG, who were observed to be defective in actin tail formation. We 
discovered that this is due to bimA expression being under VirAG control, but not other 
T6SS-1 structural or assembly components. Hence, the results support the notion that actin 
based motility is not due to T6SS-1 but depends solely on BimA functionality.  This 
85 
 
contradicts the B. mallei ΔtssE mutant data, which demonstrated defects in actin 
polymerization (Burtnick et al., 2010). Even though there is no clear indication in the role of 
TssE in T6SS-1, one would expect it to be part of the T6SS apparatus as the mutant also 
exhibited impairment in MNGC formation and defects in intracellular growth (Burtnick et al., 
2010). One possibility could be that there are differences between B. pseudomallei and B. 
mallei T6SS-1, while the other possibility could be that for some reason, the B. mallei ΔtssE 
mutant exhibited defective bimA expression.    
Although both cell fusion and actin based motility facilitate intercellular spread of 
Burkholderia pathogens, our results lead us to propose that both events are independent of 
each other as tssAB, clpV and hcp1 are required for MNGC formation but not for actin based 
motility. This is also the case for the ΔclpV mutant in B. thailandensis, which shows defect in 
MNGC formation but not actin polymerization (French et al., 2011). Possibly, actin 
polymerization or intracellular motility facilitate bacterial dissemination by allowing the 
bacteria to come into contact with host cell membrane, and such contact is a prerequisite for 
membrane fusion through a process mediated by T6SS-1. Without actin motility but with 
intact T6SS-1, cell fusion is not possible as the bacterium is unable to come into contact with 
host membrane. Without T6SS1, actin tail mobility can take place but cell fusion cannot 
because the latter is a function of T6SS1. This differs fundamentally from intercellular spread 
by other intracellular pathogens such as Listeria monocytogenes and Shigella flexneri, which 
utilize only actin-based motility for exit from the existing cell, and through engulfment of 
bacterial protrusions into phagocytic vacuoles for entry into the adjacent cells (Tilney and 
Portnoy, 1989; Ray et al., 2009). At present, little is known about the mechanism, or the 
specific bacterial and host factors involved in MNGC formation. Perhaps, T6SS-1 secretes 
certain fusogenic effectors or membrane lysis factors that participate in this unique process. In 
fact, a more significant question to be answered is the in vivo significance of cell fusion or 
MNGC formation to pathogenesis. It is conceivable that stimulation of host cell fusion 
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represents a strategy for an efficient intercellular spread, evasion from host humoral immune 
responses and establishment of disease.  
Moreover, our results have aided in dissecting the role of various known or putative T6SS-1 
components. For certain mutants, it is not surprising if the deleted gene forms part of the 
T6SS secretion apparatus and confers a null T6SS phenotype. For instance, ΔtssAB exhibited 
similar phenotypes as ΔvirAG, suggesting that TssA and TssB dimers are critical for T6SS-1 
functions. They are homologs of VipA and VipB in V. cholerae, essential components 
encoding the outer sheath of the T6SS apparatus that provide the mechanical force to expel 
the inner Hcp tube out upon contraction (Bönemann et al., 2009). Conversely, the tssB 
homolog in B. mallei is dispensable for hcp1 secretion (Schell et al., 2007). Even though 
TssA/B dimer seems to be highly conserved among T6SSs from various pathogens, a more 
specific and closer investigation on the identity of TssA and TssB in the Burkholderia species 
would be necessary to reveal their roles. ClpV, being a member of the AAA+ protein family, 
binds and hydrolyze ATP to disassemble and recycle TssA/B dimers for efficient T6SS 
functions (Kapitein et al., 2013). Thus, ΔclpV would be expected to have either defective 
T6SS phenotype, or static, unproductive T6SS that can only be "fired" once (Kapitein et al., 
2013). In comparison with B. thailandensis ΔclpV mutant which only showed a delay in 
MNGC formation, MNGC is absolutely dependent on clpV in B. pseudomallei (French et al., 
2011). This is perplexing, which leaves one to wonder whether other specific factors in B. 
thailandensis T6SS could have compensated for the ability to exhibit cell fusion in the ΔclpV 
mutant. For instance, the function of ClpV could be compensated by other AAA+ hybrid 
proteins that hydrolyzed ATP for the disassembly of VipA/B in V. cholera (Kapitein et al., 
2013).  As for the function of bimE, given that its gene locus lies in the same operon and 
downstream of virG, it is tempting to postulate that bimE is part of the T6SS-1. Our results 
show that there is no apparent difference between the wild-type strain and ΔbimE mutant in 
terms of MNGC and actin tail formation; hence it is unlikely to be a T6SS-1 component. 
However, this contradicts with the B. mallei ΔbimE data which demonstrated impairment in 
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actin tail formation (Schell et al., 2007). In contrast to our clean deletion of bimE, the B. 
mallei ΔbimE is a transposon mutant that harbors an antibiotic resistant cassette. Hence, there 
could be a polar effect on the expression of downstream genes that leads to its inability to 
form actin tails in that study (Schell et al., 2007). It is also possible that BimE is an effector of 
T6SS-1 with yet an unknown function and exerting an undiscovered phenotype in mammalian 
cells. 
Thus far, the only unambiguous role that has been attributed to T6SS-1 in vitro is the 
induction of MNGC formation and an optimal intracellular growth. However, it is critical to 
determine whether the requirement of T6SS-1 in animal infection is due to the requirement of 
cell fusion for successful spread and establishment of disease. This means that we need to 
determine whether the slower intracellular growth and lack of MNGC formation seen in the 
mutants in vitro can adequately explain the complete abrogation of virulence in vivo. This is 
hindered by our inability to identify definitive effectors for such events. As far as we know, 
no T6SS-1 effector has been shown to be required for intracellular growth, MNGC formation, 
cell-to-cell spread, or virulence in animals. Therefore, what is crucial now to our 
understanding of the role of T6SS-1 in mammalian infection is the identification of such 
T6SS-1 effectors. However, this is currently hampered by the lack of an easy and 
unambiguous assay to detect secretion since the expression of T6SS-1 is very low in bacterial 





Figure 18. Model of the intracellular lifecycle of B. pseudomallei in macrophages, 
adapted from (French et al., 2011).  
 
In summary, there is no doubt that that both T3SS-3 and T6SS-1 are coordinately expressed 
and work hand in hand to confer virulence to the host. This is somewhat analogous to the two 
T3SSs in Salmonella, SPI-1 and SPI-2, which co-operatively function at different times 
during infection to confer virulence to the host. While SPI-1 is necessary for active invasion 
of both macrophages and epithelial cells through causing host actin rearrangement (Galan and 
Zhou, 2000), SPI-2 is required for intracellular replication in the specialized SCV 
compartment (Figueira and Holden, 2012). In B. pseudomallei, a model shown in Figure 19 
depicts the role of T3SS-3 and T6SS-1 in its intracellular lifecycle (French et al., 2011). Upon 
bacterial uptake by phagocytes through phagocytosis, the activity of T3SS-3 is essential for 
early endosomal escape into the host cytosol. Once inside host cytosol, T3SS-3 plays crucial 
role in mediating intracellular replication and inducing cytotoxicity while T6SS-1 is 
secondary for both of these events. In the cytosol, BimA is expressed through T6SS regulator 
for intracellular motility by inducing actin polymerization. Subsequently, T6SS-1 facilitates 
intercellular spread by inducing MNGC formation, possibly through host membranes fusions. 





























 Identification of the physiological 




In many Gram-negative pathogens that harbor T6SS clusters, the expression of their T6SS 
genes are precisely regulated by the presence of appropriate environmental cues. Generally, 
T6SSs are regulated in a highly species-specific manner in order to fit in with the particular 
role of the T6SS in that bacterium’s lifestyle. Indeed, regulation of T6SS occurs at multiple 
levels, from transcriptional to post translational regulation. In several species such as P. 
aeruginosa, T6SS remains inactive even upon production of the whole apparatus, and only 
secrete effectors under appropriate cues. The activation lies at the posttranslational regulatory 
level which involves a kinase (PpkA) or a phosphatase that regulates the phosphorylation 
state of a conserved T6SS structural component called Fha at the inner membrane (Mougous 
et al., 2007). Phosphorylated Fha triggers the recruitment of T6SS components for assembly 
and activation of the secretion system (Mougous et al., 2007; Hsu et al., 2009).  Although 
many studies focus on the regulatory proteins and mechanisms that modulate the expression 
of T6SS gene cluster, little is known about the direct signals being sensed by the regulators 
for T6SS transcription and activation thus far.  Generally, signal transduction systems 
constitute the basis of the sensing mechanism. Defining and characterizing the nature of the 
signals are crucial to understanding the physiological context in which these systems act.  
Several environmental conditions have been reported to influence the production of T6SS in 
various pathogens. Among them are mainly chemical and physical parameters such as acidity, 
copper or iron availability, concentration of phosphate and magnesium ions, temperature, 
biofilm formation, osmolality, cell-to-cell contact with other bacteria etc (Chakraborty et al., 
2011; Chakraborty et al., 2010). For instance, the T6SS cluster in Y. pestis is induced at low 
temperature at 26 °C and repressed at 37 ⁰C, which is plausibly essential for dissemination in 
the flea vector which has a lower ambient temperature than the mammalian host (Pieper et al., 
2009). Likewise for E. tarda, the evp (T6SS) cluster is induced at a lower temperature of 25 
⁰C when it infects freshwater and marine fishes which also have a low ambient temperature 
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(Chakraborty et al., 2010). In another fish pathogen Edwardsiella ictaluri, phagosomal 
environment such as low pH and phosphate limitation was shown to trigger T3SS and T6SS 
expression for virulence (Rogge and Thune, 2011).  In EAEC, iron concentration was shown 
to affect its T6SS expression. When the pathogen is disseminated to the gut, iron becomes 
depleted within the stable intestinal biofilm thereby leading to its T6SS activation (Brunet et 
al., 2011). Conceivably, this corresponds with its T6SS role in promoting adhesion and 
biofilm formation at the surface of colon epithelial cells in adaption to iron starvation 
(Aschtgen et al., 2008). In addition, a potato plant pathogen Pectobacterium atrosepticum 
induces T6SS expression in response to components in the tuber or stem host extracts 
(Mattinen et al., 2008). For other intracellular pathogens such as F. tularensis, S. enterica and 
Burkholderia species, their T6SSs are only induced inside host cells in the presence of host 
signals as mentioned previously, thus suggesting their involvement in interactions with the 
host (Shalom et al., 2007; Parsons and Heffron, 2005; de Bruin et al., 2007). However, the 
precise host signals that are sensed by the different T6SS regulators in these intracellular  
pathogens have yet to be reported. These examples illustrate that signals or factors required 
for T6SS production in various bacterial species are greatly determined by their specific 
functions and environmental context. 
 In the previous chapter, we have established that VirAG, is the main regulator required for 
T6SS-1 expression in B. pseudomallei. Expression of T6SS-1 genes is exclusively activated 
inside host cells. VirAG is likely to sense certain intracellular signals for the activation of 
T6SS-1 gene expression either directly or indirectly. In the event of infection, the bacteria are 
taken up by macrophages through phagocytosis and it will first reside in the phagosomal or 
phagolysosomal compartment before escaping into host cytosol. In fact, intracellular signals 
sensed by VirAG were reported to come from phagosomal compartments prior to bacterial 
escape into the cytosol (Burtnick et al., 2010).  During the course of maturation, 
phagolysosomes acquire a full arsenal of antimicrobial features, such as acidification, 
recruitment of NOX2 NADPH oxidase to generate reactive oxygen species (ROS), 
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antimicrobial peptides, activation of endo- and exopeptidases (Flannagan et al., 2009). 
Possibly, VirA bearing the histidine kinase domain senses some of these antimicrobial factors 
in the phagosomes or phagolysosomes either directly or indirectly, and transduces the signal 
to VirG for transcription activation. However, a study by French Todd et al 2011 suggested 
otherwise as they showed that direct delivery of bacteria into host cytosol is able to induce 
T6SS for MNGC formation (French et al., 2011).  
In this chapter, we attempt to elucidate the host signal critical for upregulating T6SS-1 
expression. We investigate the effect of some of the microbicidal factors mentioned above on 
T6SS-1 expression and explore the effects of other fundamental compounds such as amino 
acids that are ubiquitously found in host cells. To do so, we introduce various compounds 
directly to the bacterial culture to test their ability in upregulating T6SS-1 genes in vitro. In 
addition, we determine when T6SS-1 genes are expressed and activated during bacterial 
infection in host cells. Specifically, we determine the cellular compartment in which the 
physiological signal(s) for VirAG reside, whether the signal comes predominantly from the 
phagosomal vacuoles prior to escape into the cytoplasm or from the cytosol. We further 
determine the relevance of the in vitro identified signal in cellular infection models. These 
studies will provide critical insights into how B. pseudomallei senses its presence inside the 






















4.2 Materials and Methods 
4.2.1 Cell culture  
HepG2 human hepatocellular carcinoma cell-line were kindly provided by Dr Theresa Tan 
(NUS, Dept of Biochemistry) and maintained in DMEM (Gibco, CA) supplemented with 10% 
heat-inactivated FBS (Hyclone Laboratories, UT), 2 mM L-glutamine (Gibco, CA), 100 
units/ml penicillin (Gibco, CA), 0.1 mg/ ml streptomycin (Gibco, CA), 0.1 mM L-methionine 
Sigma, MO), and 1 X MEM nonessential amino acid solution (Sigma, MO) (complete 
DMEM + MEM) in a humidified 37°C and 5% CO2
4.2.2 Isolation of Peripheral Blood Mononuclear Cells  
 tissue-culture incubator. RAW264.7 cells 
were cultured and maintained in complete DMEM as described previously in Chapter 2.  
Peripheral Blood Mononuclear Cells (PBMCs) were isolated from healthy donors' blood by 
density gradient centrifugation using Histopaque 1077 (Sigma-Aldrich, MO). Cells were 
separated by centrifuging without deceleration at 400 g for 30 min at room temperature. 
Following cell separation, PBMCs were recovered and washed twice with 1X PBS at 400 g 
for 5 min before they were resuspended in antibiotic-free RPMI supplemented with 10 % 
heat-inactivated FBS (Gibco, CA). 
4.2.3 Bacterial strains and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table 9. Mutants created are 
a derivative of the fully virulent B. pseudomallei clinical strain KHW (Liu et al., 2002). All 
bacterial strains were maintained and cultured as mentioned in Chapter 2. Similarly, 
quantification of the bacterial numbers by measuring optical density (OD600) using a 
spectrophotometer was described in detail in Chapter 2. Antibiotics added to LB medium 
were as follows (in µg/ml): For E. coli, kanamycin (Km), 25; trimethoprim (Tm), 25 and for 




Table 9. List of bacterial strains and plasmids used in this study 
Strain or plasmid Relevant characteristic(s) Source or reference a 
   
B. pseudomallei   
KHW B. pseudomallei wild-type strain Gm (Liu et al., 2002)r  
ΔvirA KHW ΔvirA, codon 2-606 of BPSS1495 was 
deleted 
This study 
ΔvirAG ΔvirAG::FRT, codon 1-233 of BPSS1494 and 
56-614 codon of BPSS1495 were deleted 
(Sun et al., 2010) 
ΔbsaM ΔbsaM, codon 39-411 of BPSS1547 was 
deleted 
This study in chapter 3 
ΔvirAG::tet ΔvirAG, codon 1-233 of BPSS1494 and 56-
614 codon of BPSS1495 were deleted and 
replaced with FRT-flanked tet casette, Tet
This study 
R 
B. thailandensis   
E264 Wild-type B. thailandensis E264 reference 
strain 
(Smith et al., 1995) 
E. coli   
DH5α Cloning host (Sambrook et al., 1989) 
S17 S17-1 Donor strain for conjugation  (Simon et al., 1983) 
SM10 λpir Donor strain for conjugation (Simon et al., 1983) 
BL-21 (DE3) Expression host Novagen 
   
Plasmid   
pK18mobsacB Conjugative, suicide vector, Kmr (Schäfer et al., 1994)   
pFRTT1 pGEM contains FRT sites and tetRA 
sequence, Apr, Tc
(Sun et al., 2010)
r 
 
pKO-virA pK18mobsacB containing upstream and 
downstream sequences of virA, Km
This study 
r 
pKO-virAG::tet pK18mobsacB containing upstream and 
downstream sequences of virAG, with tet 
casette inserted in between, Kmr, Tet
This study 
r 
pUCP28T Broad-range plasmid, Tm (West et al., 1994)r  
pUCP-virA pUCP containing virA endogenous promoter 
and orf from KHW, Tm
This study 
r. 
pUCP-virAG pUCP containing virA endogenous promoter 
linked to virAG orf from KHW, Tm
This study 
r 




pIRES-EGFP Plasmid containing EGFP gene, Amp Clontech r 
pET-28a E. coli expression vector, Kmr Novagen   
a Abbreviations: Gmr, gentamicin resistant; Tmr, trimethoprim resistant; Kmr, 
kanamycin;  Ampr
 
 , ampicillin resistant 
 
4.2.4 Construction of ΔvirA and ΔvirAG::tet mutants 
ΔvirA and ΔvirAG::tet mutants were generated from the KHW wild-type strain by allelic 
exchange as described in chapter 3. The gene loci virA (BPSS1495) and virAG (BPSS1494-
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1495), with reference to the genome sequence of K96243 strain, were targeted for deletion. 
Briefly, approximately 1 kb fragments upstream and downstream of targeted genes were 
amplified from KHW genomic DNA and cloned into pK18mobsacB vector (Schäfer et al., 
1994) simultaneously using In-Fusion PCR cloning kit (Clontech, CA). For ΔvirAG::tet, FRT-
flanked tet cassette from pFRTT1 (Sun et al., 2005) was inserted between virAG gene 
fragments at BamH1 site to generate pKO-virAG::tet. PCR primers for plasmid constructions 
are listed below. The resulting plasmid pKO-virA and pKO-virAG::tet were subsequently 
conjugated into B. pseudomallei KHW strain through E.coli S17.  Clones with successful 
single cross-over by homologous recombination were first selected on TSA plate with 250 
µg/ml kanamycin and 50 µg/ml gentamycin. Positive clones were then subjected to several 
passages of growth in LB + 15% sucrose to counter-select against the sacB in the suicide 
plasmid pk18mobsacB. Successful double cross-over clones were screened via colony PCR 
for the deletion of virA from kanamycin-sensitive colonies, and virAG from tetracyclin 
resistant colonies.  




virA up                  F: 5'GCAGGCATGCAAGCTTGAGCGTGAGCTGGAGGTT3' 
virA up                  R: 5'CATAGGTCTCAGAGGTCGGCGA3' 
virA down             F: 5'CCTCTGAGACCTATGGCGCAGTACAGGAGAGGAC3' 
virA down             R: 5'GGCCAGTGCCAAGCTT
virAG tet up          F: 
CCGACGAGCAAATCCTTG3' 
5’ TTGAATTC
virAG tet up          R: 
GGTTCTCCTCTTCGTTGTCG 3’ 
5’ TTGGATCC
virAG tet down     F: 
AGCAGATGATTCGCGTAGA 3’ 
5’ TTGGATCC
virAG tet down     R: 
TACTTCGACGCGAAAGAGGT 3’ 
5’ TTTTAAGCTTACCACCTCAACCACCTCAAC 3’ 
a 
 
Restriction site used are underlined  
4.2.5 Construction of virA and virAG complementation and hcp1 reporter plasmids  
Bacterial genomic DNA from B. pseudomallei KHW strain was extracted using the GenElute 
Bacterial Genomic kit (Sigma, MO) and served as the template for amplification of all B. 
pseudomallei genes. The pUCP28T broad host range vector was used for cloning of full-
96 
 
length virA (BPSS1495) and virAG (BPSS1494-1495) coding sequence with their upstream 
endogenous promoter for expression in B. pseudomallei (West et al., 1994). For pUCP-Phcp-
egfp which is a reporter plasmid for hcp1 gene expression, the endogenous hcp1 promoter and 
egfp gene were amplified from KHW genomic DNA and pIRES-EGFP (Clontech, CA) 
respectively before cloning into the pUCP28T plasmid. All genes and promoters were cloned 
in opposite direction of the existing lacZ operon in the pUCP28T plasmid. The primers used 
to amplify the full-length genes or promoters through PCR are as follow:  
 
List of primers for cloning
 
a 
Primer name Sequence (5’ to 3’) 
pUCP PvirA      F: CCAAGCTTGCATGCCTGCAGGAGCGTGAGCTGGAGGTT  
pUCP virA        R: CCATGATTACGAATTC
pUCP PvirAG   F: 
CGACAGGTAATTGCAAAGCA 
CCAAGCTTGCATGCCTGCAG
pUCP virAG     R: 
GAGCGTGAGCTGGAGGTT 
CCATGATTACGAATTC
Phcp                  F: 
CCGACGAGCAAATCCTTG 
GCAGGCATGCAAGCTT
Phcp                  R: 
AAGCTCGAAAAGCGCTAGG 
GCGTAGTTCCTCCTTGATGTGsGATTTTCCCGTCAT 
Egfp                  F: AAGGAGGAACTACGCGATGGTGAGCAAGGGCGAGGA 
Egfp                  R: GGCCAGTGCCAAGCTTACTTGTACAGCTCGTCCA 
a 
 
Restriction sites used are underlined. 
PCR amplifications were carried out with the MyCyclerTM thermo cycler machine (Biorad, 
CA) using the following conditions: 95°C for 5 min, 30 cycles each of 10 s at 95 °C, 30 s at 
gradient annealing temperature from 56 to 61 °C, extension time of 1 min per kb at 72 °C, and 
a final extension of 5 min at 72 °C. PCR products were purified using the Wizard SV PCR 
Clean-Up system (Promega, MI), and cloned into pUCP28T vector using In-Fusion PCR 
cloning kit (Clontech, CA) before transforming into E. coli DH5α competent cells. The 
resulting plasmids were isolated using Wizard Plus SV Minpreps DNA Purification System 
(Promega, MI) according to the manufacturer's protocol and transformed into SM10 λpir 
conjugating strains. Plasmids were transferred conjugally from E. coli SM10 to B. 
pseudomallei on membrane filters with E. coli as donors (≈108) and B. pseudomallei as 
recipients (≈108) from overnight cultures. Conjugations were performed on non-selective LB 
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agar for 3 h at 37°C before transferring filters onto selective Gmr and Tmr
4.2.6 Cell infection  
 TSA agar. 
Successful clones that are resistant to both antibiotics are B. pseudomallei conjugated with the 
plasmids. 
RAW264.7 cells were seeded overnight at 0.5 X 106 
 
cells/ml in 12 well-plates in complete 
DMEM. The next day, cells were changed to RPMI media supplemented with 10% FBS prior 
to infection. To block acidification of the phagosome and reduce the general amount of 
intracellular ROS, cells were pre-treated with indicated concentrations of bafilomycin A1 
(Sigma, MO) and N-acetyl cysteine (NAC) (Sigma, MO) respectively, for 1 h prior to 
infection. Pre-treated cells were infected with mid-log phase wild-type (KHW) bacteria at 
MOI of 100:1. Kanamycin (250 µg/ml) was added at 2 h post infection to kill off extracellular 
bacteria. At 5 h post infection or at the indicated time point, infected cells were washed once 
with 1X PBS and lysed with 1 ml of TRizol reagent (Life technologies, CA) for RNA 
isolation. All conditions were done in duplicate.  
4.2.7 Screening of compounds and growth conditions for the induction of T6SS 
expression in bacterial culture 
Mid-log phase wild-type bacterial culture grown in LB was used in the following experiments. 
Unless stated otherwise, all compounds are from Sigma, MO. After 2 h of subculture from an 
overnight bacterial culture, bacteria were quantified by measuring OD600 using a 
spectrophotometer as mentioned above.  Approximately 200 X 106  bacteria cfu were 
inoculated into normal RPMI serum free culture medium (500 µl) in a 12 well plate. 
Compounds such as H2O2, LL-37 antimicrobial peptide, hydrogen sulphide (H2
(Lee et al., 2011)
S) donors: 
GYY4137, sodium hydrosulphide (NaHS), and negative control ZYJ1122  
(provided by Dr Deng Lih Wen, NUS) and various amino acids: glycine, cysteine, glutamine, 
methionine, histidine, isoleucine, leucine, phenylanine, proline, threonine, valine and 
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asparagine, glutamic acids, aspartic acid, tryptophan and tyrosine, were added at indicated 
concentrations directly into the bacterial culture during inoculation. In the case of cysteine, 
cystine, glutathione (GSH), NAC and dithiothreitol ( DTT), sulphur amino acid-free RPMI 
medium (Sigma, MO) was used as the culture medium and these compounds were added into 
the bacterial culture at 3 h post incubation and treated for another 2 h prior to harvest. To 
examine the acidic condition, bacterial cells were cultured in normal RPMI medium with pH 
7.4 or acidic medium with pH 5.8. To test the effect of various amino acids, bacteria were 
cultured in 1X PBS with groups of amino acids as indicated in the results section. After a total 
of 5 h incubation at 37 °C and 5% CO2 
4.2.8 RNA isolation and quantitative real-time PCR  
, bacterial cells were spun down and cell pellets were 
lysed with 1 ml of TRizol reagent (Life Technologies, CA) for RNA isolation. All conditions 
were done in duplicate.  
RNA were isolated and quantitated as described in previous chapters. Briefly, RNA was 
purified using Illustra RNAspin Mini Kit together with On-column DNase treatment 
according to manufacturer’s protocol (GE Healthcare Life Science, NJ). cDNA was 
synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, MA) 
according to manufacturer’s protocol. Transcripts of various genes were quantified using 
iQTM
List of real-time primers for this study 
 SYBR Green Supermix for iQ5 (Biorad, CA) in a BioRad iQ5 Thermo Cycler machine 
(Biorad, CA).  The following primers were used for real-time PCR detection: 
Gene Sequence 
16S 5' GGCTAGTCTAACCGCAAGGA 3' 
5' TCCGATACGGCTACCTTGTT 3' 
virA 5’ GTCGATATGGGGATACCAGG 
5’ TCGGTGTGGATGAACGAC 
virG 5' CCCCATAGCGTCTCCACCTC 3' 
5' GATCCGAAGCATCCCGAACTG 3' 
tssA 5' GTCGACAAGGACGACTTCAA 3'  
5' GAGCGTGAGCTGGAGGTT 3' 
hcp1 5' CACATCCTCGCCTTCAA 3' 
5' AGATGATGGAAGAGTTCGAGA 3' 
vgrG 5' CTCACGTCCGGCAACAAGTTC 3' 
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5' TTGCCGCCCATCGACACC 3' 
bsaN 5' AATAAATCGGCGCTGGTTATCGGC 3' 
5' AGCAATTTCGCCGCCTCGAATAAC 3' 
rpoB 5’ GTTCCATCGTTCACCAAGTG 3’ 
5’ TTGCAGAAATGTGCTGAATG 3’ 
 
All real-time PCR reactions were done in duplicate. Relative mRNA level of a particular gene 
in conditions treated with compounds or in test medium was normalized to that of untreated 
control using the 2-ΔΔ (Livak and Schmittgen, 
2001)
Ct method with 16S rRNA as the reference gene 
.  
4.2.9 Western blot analysis for Hcp1 protein expression 
Expression of recombinant Hcp1 for antibody production: 
For expression of recombinant B. pseudomallei Hcp1 with a 6XHis-Tag, the hcp1 ORF 
(BPSS1498) was amplified from genomic DNA and cloned in frame with the N-terminal 6X 
HisTag in the pET28a expression vector (Novagen, Germany) using Nde1 and Xho1 
restriction sites. Primers used for cloning are as follow: 
ReHcp1 F: 5’ CATATGCTGGCCGGAATATATC      3’                                                         
ReHcp1 R: 5’ CTCGAG
 
TCAGCCATTCGTCCAGTT 3’ 
The resulting clone was transformed into BL21 (DE3) E. coli strain for protein expression and 
purification. Briefly, cultures were induced with 0.5 mM IPTG for 4 h at 37 °C and cells were 
centrifuged at 4000 rpm for 15 min and lysed using B-PER Reagent (Thermo, MA). 
Recombinant Hcp1 was purified using B-PER 6xHis Fusion Protein Purification Kit (Thermo, 
MA) according to manufacturer’s protocol. Monoclonal antibody against Hcp1 was generated 
and provided by Lim Yan Ting (Paul MacAry’s lab, NUS).  
 
Western blot analysis to detect Hcp1 expression: 
Both wild-type KHW and ΔvirAG::tet strains were sub-cultured in 5 ml of RPMI serum free 
medium (Gibco,CA) at 5 X dilution from the respective overnight culture. To one of the 
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KHW culture, 0.2 mM of cysteine was added directly into the culture.  After 8 h of culture, 
bacterial cells were pelleted by centrifugation at 4000 rpm for 5 min. Whole cell lysates were 
prepared by lysis with 1 ml of B-PER lysis buffer supplemented with 200 µg/ml of lysozyme 
(Sigma, MO), 25 µg/ml of deoxyribonuclease
4.2.10 Cysteine depletion in HepG2 cells  
 (DNase) (Sigma, MO) and 1X protease 
inhibitor cocktail (Thermo, MA). As Hcp1 monoclonal antibody can only detect Hcp1 in its 
native form, non-denaturing condition was used for resolving the protein lysate.  Buffer 
exchange was performed on the cell lysate with 10 ml of 1X PBS and concentrated with a 10 
kDa Vivaspin concentrator (Merck Millipore, Germany) to 200 μL. Forty microgram of each 
concentrated eluate was resolved on 10% native-PAGE and transferred onto polyvinylidene 
fluoride (PVDF) membranes (Biorad, CA) using wet transfer method. The membranes were 
blocked with 5% non-fat milk in Tris-Buffered Saline with 0.1 % Tween 20 (Sigma, MO) 
(TBST) at room temperature for 1 h. Blots were then incubated overnight with mouse anti-
Hcp1 monoclonal antibody at 2000 X dilution or rabbit anti-BopE polyclonal antibody at 
3000 X dilution in blocking reagent at 4 °C, and incubated with anti-mouse IgG (for Hcp1) or 
anti-rabbit IgG (for BopE) horseradish peroxidase (HRP) conjugated antibodies (Abcam, UK) 
at 2500 X dilution in blocking reagent for 30 min. Membranes were washed three times at 5 
min each with TBST in between each incubation step. Blots were visualized using Pierce 
ECL Plus Western Blotting Substrate (Thermo, MA) and developed using X-ray film 
(Thermo, MA).  
To deplete intracellular cysteine in HepG2 hepatocellular carcinoma cells , sulphur amino 
acid-free DMEM supplemented with 10% FBS, 2 mM L-glutamine and 1 X MEM solution 
was used as the experimental medium, as adapted from (Lee et al., 2008). HepG2 cells were 
seeded at 0.5 X 106 cells/well in 12 well plate in cysteine sufficient medium (+ Cys: 0.2 mM 
cysteine + 0.1 mM methionine) or cysteine deficient medium (-Cys: 0.1 mM methionine only) 
and cultured for 24 h. After 24 h of incubation, all cultured media were changed to -Cys 
medium prior to infection with a log-phase KHW culture at an MOI of 100:1. Cell integrity 
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was comparable between the two conditions after 24 h as cell death was assayed using Trypan 
Blue exclusion method. At 2 h post infection, extracellular bacteria were killed by the 
addition of kanamycin (250 µg/ml). After 5 h of infection, cells were washed once with 1X 
PBS, lysed with TRizol reagent (Life Technologies, CA) and RNA isolation was performed 
as described above.  
4.2.11 Assay of intracellular glutathione (GSH) levels in HepG2 cells and PBMCs 
HepG2 cells were cultured under cysteine sufficient or cysteine deficient conditions for 24 h 
as described above. Subsequently, all cultured media were changed to -Cys medium and 
incubated for another 5 h. HepG2 cells were detached from the culture plate by treatment with 
trypsin (100 μl/106 cells) for 5 min in the  37 ⁰C incubator, and 2 X 105 cells were used for the 
assay for each condition. For PBMCs, 5 X 106 
4.2.12 Immunofluorescence staining and confocal microscopy 
 cells were left untreated or treated with 250 
µM or 500 µM of diethylmaleate (DEM) for 6 h before they were harvested for GSH assay. 
Cells were washed once with 1X PBS before lysing with 80 μl of ice cold lysis Buffer: 0.1 M 
potassium phosphate buffer with 5 mM EDTA disodium salt (Biorad, CA), 0.1% Triton X-
100 (Sigma, MO), pH 7.5, and 20 μl of 5 % sulfosalicylic acid (Sigma, MO). Supernatants 
collected after centrifugation at 12, 000 rpm for 5 min, at 4 ⁰C were assayed for total 
intracellular GSH using the GSH Colorimetric Detection Kit (Arbor Assays, MI), as per 
manufacturer’s instructions. All conditions were performed in duplicates.  
RAW264.7 cells (3.5 X105 cells/well) were seeded and grown overnight on 13 mm cover 
slips in 24 well plates at 37 °C under 5 % CO2. Cells were infected with overnight culture of 
various B. pseudomallei strains at an MOI of 20:1. After 2 h of infection, kanamycin (250 
µg/ml) was added to kill off extracellular bacteria. At 6 h post infection, infected cells were 
washed once with 1X PBS and fixed overnight at 4 ⁰C with 1 % PFA. Prior to 
immunostaining, fixed cells were washed twice with 1X PBS, twice with wash buffer: 0.1 % 
Bovine Serum Albumin (BSA) (VWR, PA) in 1X PBS and blocked with blocking buffer: 10 % 
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FBS, 0.3 % Triton X-100 in 1X PBS for 45 min at room temperature. All staining steps were 
performed at room temperature for 45 min and all antibodies were diluted in dilution buffer: 
1X PBS containing 0.3 % Triton X-100, 1 % FBS, 1 % BSA and 0.01% sodium azide (Sigma, 
MO). Cells were first stained with B. pseudomallei LPS-specific rabbit polyclonal antibodies 
at 1:100 dilution (Ganjana Lertmemongkolchai, Khon Kaen University, Thailand) and goat-
anti LAMP-1 antibody at 1:20 dilution (R&D Systems, MN) simultaneously. This is followed 
by incubation with donkey anti-goat IgG conjugated with Alexa Fluor 633 (Life Technologies, 
CA) at 1:100 dilution, and incubation with goat anti-rabbit IgG conjugated with Pacific Blue 
(PB) (Life Technologies, CA) at 100:1 dilution. Monolayer cells were washed thrice with 
wash buffer in between each incubation step. After the last wash, cover slips were mounted 
onto clean glass slides using ProLong® Gold Antifade reagent. Images were acquired using 
Carl Zeiss LSM 710 MicroImaging System with a 63X objective lens (Carl Zeiss AG, 
Germany). The experiment was done in biological duplicate and three representative fields 
were taken for each sample. For each field, z-stack (3D) images were taken to determine the 
intracellular bacteria that lie within the cells. At least 200 bacteria were counted in each of the 
three fields (a total of 600 bacteria were counted for each sample). Association of intracellular 
bacteria with LAMP-1 positive vacuoles was quatified by scoring the co-localization of blue 
(PB) and red (Alexa Fluor 633). Various statistics were calculated in each sample as follows: 
% of co-localization       =        Number of bacteria co-localized with LAMP-1     X 100 
                                                      Total number of intracellular bacteria 
 
% of green bacteria          =       Number of green bacteria (inside cells)         X 100 
(hcp1 expressing bacteria)        Total number of intracellular bacteria  
 
                                          =       Number of green bacteria co-localized with LAMP-1   X 100 





4.2.13  Detection of hcp1 expression by flow cytometry 
PBMCs (1 X 106 cells/well) were seeded in a 12-well plate and treated with 250 µM or 500 
µM DEM for 4 h to deplete intracellular GSH. After depletion, cells were infected with 
overnight culture of KHW + Phcp-egfp and ΔvirAG + Phcp-egfp at an MOI of 100:1. Infected 
cells were centrifuged at 250 g for 5 min to allow maximum bacterial contact with the cells 
before incubating at 37 °C and 5 % CO2
 
. After 2 h of infection, cells were washed once with 
1X PBS and fixed in 4% PFA for 10 min at room temperature. Fixed cells were centrifuged at 
400 g for 5 min and resuspended in 1 X PBS supplemented with 0.5% BSA (VWR,PA) and 2 
mM EDTA (Biorad, CA). The expression of hcp1 was detected at 488 nM wavelength for 
excitation and FITC channel for detection using Cyan flow cytometer (CyAn ADP Analyzer, 

















4.3.1 Acidic pH in the phagosome plays a minor role in triggering T6SS-1 gene 
expression  
During phagosomal maturation, acidification of the phagosome occurs rapidly from pH 7.5 to 
below pH 5 (Yates et al., 2005). To examine whether the drop in pH plays a role in activating 
T6SS-1 expression, we used bafilomycin A1 to block the acidification process in the 
phagosomal compartment. Bafilomycin is an inhibitor of V-ATPase which prevents proton 
translocation into the phagosomal lumen (Dröse and Altendorf, 1997). Prior to infection with 
wild-type bacteria, cells were either untreated (control) or pretreated with various 
concentrations of bafilomycin A1 for 1 h. At 5 h post infection, bacterial RNA was isolated 
and mRNA transcript levels were measured by real-time PCR. When acidification was 
blocked in infected cells, T6SS-1 gene expression (tssA, hcp1, vgrG) significantly decreases 
with increasing concentrations of bafilomycin A1 treated (> 5 fold decrease) as compared to 
the untreated control (Figure 19A). To verify whether pH plays a role in activating T6SS-1 
expression, wild-type bacteria were grown in normal culture medium with pH 7.4 or acidic 
medium with pH 5.8. When bacteria were cultured in pH 5.8, T6SS-1 expression 
demonstrated a slight increase of about 2 fold compared to the expression when cultured in 
pH7.2 (Figure 19B).  Overall, the results suggest that pH plays a role in triggering T6SS-1 
expression. Possibly, the slight increase of T6SS-1 gene expression could be indirect as pH is 
known to increase T3SS-3, as shown by bopE expression (Figure 19B), and T3SS-3 





Figure 19. Effect of blocking acidification in host cells and lowering pH in culture 
medium on T6SS-1 gene expression. A) RAW264.7 cells were treated with bafilomycin A1 
(BaA1) at 20, 100, 200 and 500 nM prior to infection with wild-type strain (KHW) at of MOI 
100:1 for 5 h. Transcript levels of representative T6SS-1 genes of B. pseudomallei during 
infection of BaA1 treated RAW264.7 cells were measured and normalized to bacteria from 
infection of untreated cells. B) Wild-type B. pseudomallei were grown in normal (pH7.2) or 
acidic (pH5.8) RPMI culture medium for 5 h and the transcript levels of representative T6SS-
1 genes were measured. T6SS-1 and T3SS-3 (bopE) gene expressions in acidic medium were 
normalized to that in normal medium. All assays were performed in duplicate and values are 
the means ± SD. Data are representative of three individual experiments.   
 
4.3.2 Reactive Oxygen Species (ROS) and antimicrobial peptide LL-37 do not play a role 
in triggering T6SS-1 expression. 
Professional phagocytes destroy pathogens in part through generating ROS directly or 
indirectly by the NADPH oxidase in the phagosomes (Shepherd, 1986). On the other hand, 
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mechanisms. To examine whether ROS plays a role in triggering T6SS-1 expression, 
RAW264.7 cells were pre-treated with NAC at varying concentrations for 1 h prior to 
infection with wild-type B. pseudomallei. NAC is an antioxidant that can act both as a direct 
ROS scavenger and as a precursor of reduced GSH, hence reducing the general amount of 
ROS in the cells (Sadowska et al., 2007). Similarly, bacterial RNA was isolated at 5 h post 
infection and assayed for the transcription of tssA, hcp1 and vgrG. To examine the direct 
effect of H2O2, bacteria were cultured in medium with a titration of H2O2 concentrations. We 
have previously determined that bacterial viability was not affected in the presence H2O2 with 
a concentration as high as 500 μM. Our results show that both NAC treatment (Figure 20A) in 
host cells and H2O2  
(Rosenberger et al., 2004)
treatment (Figure 20B) on bacteria alone did not have significant effects 
on T6SS-1 gene expression as compared to the untreated control. Furthermore, antimicrobial 
peptides such as LL-37, which serve as a host defence mechanism against pathogens, are 
likely to be encountered by intracellular pathogens in macrophages . 
To test whether B. pseudomallei responds to antimicrobial peptides for T6SS-1 expression, 
LL-37 was introduced directly into the bacterial culture. Similarly, no significant effect is 
observed upon the addition of antimicrobial peptide LL-37 to the bacterial culture medium 
(Figure 21). These results indicated that both ROS and LL-37 antimicrobial peptide are not 
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Figure 20. Effect of ROS depletion in host cells and H2O2 in culture medium on T6SS-1 
gene expression. A) RAW264.7 cells were treated with N-acetylcysteine (NAC) at 50, 500, 
and 100 µM prior to infection with wild-type strain at MOI 100:1. Transcript levels of 
representative T6SS-1 genes during infection of NAC treated cells were measured and 
normalized to bacteria from infection of untreated cells. B) Wild-type B. pseudomallei was 
grown in culture medium without or with H2O2 
 
at 500, 100 and 20 µM for 5 h. Transcript 
levels of representative T6SS-1 genes in treated samples were normalized to that of untreated 
samples. All assays were performed in duplicate and values are the means ± SD.  
 
Figure 21. Effect of LL-37 antimicrobial peptide on T6SS-1 gene expression in bacteria 
cultured in RPMI medium. Wild-type B. pseudomallei was grown in RPMI culture medium 
without or with LL-37 at 1 and 5 µg/ml for 5 h and the transcript level of representative 
T6SS-1 genes in treated samples were normalized to that in untreated samples. The house 
keeping gene dnaK was measured and served as a control. The assay was performed in 
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4.3.3 Presence of cysteine in culture medium significantly upregulates T6SS-1 gene 
expression through VirA sensor  
Besides factors mentioned above, we also explored whether components in the RPMI culture 
medium affect the expression of T6SS-1 genes in the bacteria. We investigated the effect of 
16 amino acids that are found in the RPMI culture medium on T6SS-1 expression. To screen 
for their effects, groups of four amino acids were added exogenously into the bacterial culture 
medium. The list of 16 amino acids tested is shown in Figure 22. At 5 h post incubation, 
bacterial cells were lysed for RNA isolation and assayed for hcp1 upregulation. In order to 
minimize complication, PBS was used as the basal medium in this case. From the results, 
only the group of amino acids comprising of glycine, cysteine, glutamine and histidine 
demonstrated a significant increase in hcp1 gene expression (Figure 22A). A further 
investigation into each of these four amino acids revealed that only cysteine significantly 
upregulated hcp1 expression to about 100 fold as compared to the untreated sample (Figure 
23A). Similar results were observed in B. thailandensis as shown in Figure 23B, with a lower 
upregulation level of about 10 fold increase in hcp1 expression upon cysteine induction as 
compared to untreated control. Expression of virG remained constant among all conditions, 
suggesting that cysteine may act on the VirAG regulator to turn on its transcription activity on 
the T6SS1 gene cluster.  
To determine whether an increase in hcp1 gene expression by cysteine is translatable to 
increase in protein concentration, we examined Hcp1 protein expression upon cysteine 
induction. Due to the limitation of the antibody, Hcp1 was detected in its native form and the 
size corresponds to an Hcp1 hexamer (~ 100 kDa). Hcp1 expression was undetectable at the 
basal level when the wild-type bacteria were grown in culture medium. Consistent with the 
gene expression result, Hcp1 protein production in its native form is significantly upregulated 
in the presence of cysteine (200 µM) (Figure 34 C). ΔvirAG::tet mutant, with an inserted tet 
cassette at the virAG loci driving the expression of hcp1 gene cluster constitutively was 
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Figure 22. Effect of amino acids on hcp1 gene expression in bacteria cultured in PBS 
minimal medium. Wild-type B. pseudomallei were incubated in PBS minimal medium for 5 
h with the respective amino acids added. Bacterial culture were treated with groups of 4 
amino acids with each at 200 µM, A) glycine, cysteine, glutamine and histidine, B) isoleucine, 
leucine, methionine and phenylanine, C) proline, threonine, valine and asparagine, D) 
glutamic acids, aspartic acid, tryptophan and tyrosine. Transcript levels of virG and hcp1 in 
treated samples were normalized to that in untreated control for all experiments. Gene 
expression of the regulator virG served as a control for unspecific T6SS-1 upregulation. All 















































































Figure 23. Effect of cysteine on hcp1 gene and protein expression in bacterial culture. 
Wild-type A) B. pseudomallei and B) B. thailandensis were cultured in sulfur amino acid free 
RPMI medium for 5 h, without or with cysteine (200 µM) for the last 2 h of incubation. 
Transcript levels of virG and hcp1 in cysteine treated samples were measured and normalized 
to untreated control. Assay was performed in duplicate and values are the means ±SD. C) 
Wild-type (KHW) strain was cultured in RPMI serum free medium without or with cysteine 
(200 µM) for 8 h. An hcp1 overexpressing strain, ΔvirAG::tet, was added as a positive control 
for Hcp1 expression. Total proteins were resolved on 10% native gel and analyzed by 
Western blot with antibodies against Hcp1 and BopE. BopE was used as a loading control. 
The blot is a representative of three individual experiments.  
 
Importantly, we demonstrated that cysteine induced hcp1 expression requires the VirA sensor 
as the ΔvirA mutant failed to exhibit hcp1 upregulation upon cysteine induction (Figure 24). 
Complementation of VirA by expression of a plasmid-borne copy of virAG (in pUCP28T) in 
ΔvirA restored expression of hcp1 upon cysteine induction (as indicated with an arrow). 
However, cysteine induction on hcp1 expression was not observed in ΔvirA + pUCP-virA 
complemented strain. Since coding sequences of virA and virG were observed to overlap, it is 
likely that both virA and virG have to be transcribed and translated together in order to 
produce a functional VirAG two-component sensory system. This explained the inability to 
observe hcp1 upregulation by complementing with virA alone. Taken together, these findings 








Figure 24. Effect of cysteine on hcp1 gene expression in the ΔvirA mutant and in 
complemented strains. Both wild-type (KHW) and ΔvirA + pUCP28T and two 
complemented strains, ΔvirA + pUCP-virA and ΔvirA + pUCP-virAG bacterial strains were 
incubated in sulfur amino acid free RPMI medium for 5 h without or with cysteine (200 µM) 
for the last 2 h of incubation. Transcript levels of virA, hcp1 and rpoB gene for all other 
conditions were normalized to that in untreated wild-type samples. The assay was performed 
in duplicates and values are means ± SD.  
 
4.3.4 Thiol reducing compounds upregulate T6SS-1 expression  
Since cysteine gives a positive signal for T6SS-1 expression, we hypothesized that the 
presence of free thiol group in this compound is essential for VirA activation. This is also 
consistent with the fact that methionine, which is a sulfur-containing amino acid but without a 
free thiol group, has no effect on hcp1 expression (Figure 22B). To test this, we examined and 
compared the effect of the reduced form cysteine and the oxidized form cystine on hcp1 
upregulation. In contrast to cysteine which showed a 100 fold increase in hcp1 expression, 
cystine does not has an effect (Figure 25). To further support our notion, we also examined 
other thiol compounds with free thiol groups such as GSH, DTT and NAC. Interestingly, 
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increase of about 450 fold increase as compared to the untreated control (Figure 26). 
Similarly, both virA and the house keeping gene rpoB expressions remained constant in all 
conditions. To investigate whether there is a dose response relationship between thiol 
compound concentrations and hcp1 activation, we performed the assay with a titration of both 
cysteine and GSH concentration. While both compounds showed an increasing hcp1 
expression with increasing concentration, GSH exhibited a stronger induction with the highest 
degree of upregulation with 600 fold increase (Figure 27B) as compared to 200 fold increase 
by cysteine (Figure 27A). This would denote that a lower GSH concentration (at 20 µM) 
compared to cysteine is capable to activate hcp1 expression. Taken together, we have shown 
that free thiol groups in the thiol reducing compounds mediate hcp1 gene upregulation. Likely, 
redox reaction is involved in the activation of VirA sensor.  
H2
(Li et al., 2011)
S is biological active gasotransmitter which functions as a signaling molecule for cellular 
functions, such as vasodilation, cardioprotection, neurotransmission and anti-inflammatory 
action . Nonetheless, H2
(Li et al., 2011)
S is a powerful reducing agent as it is an antioxidant 
agent for endogenous oxidant species such as peroxynitrite, superoxide, and hydrogen 
peroxide . In this regard, we examine whether H2S exerts similar effect as 
other thiol compounds on T6SS-1 expression. A fast release H2S donor, NaHS, and a slow-
releasing H2S donor GYY4137 are used in current H2S research to provide H2S exogenously 
to mimic biological effects of endogenous H2 (Lee et al., 2011)S . Hence in our experiment, 
bacterial cultures were treated with either NaHS or GYY4137, and a structural analogue of 
GYY4137 which lacks sulfur, ZYJ1122, was included as a negative control. However, no 
significant difference was observed in hcp1 gene expression between treated and untreated 
conditions (Figure 28). As shown in Lee Z.W et al study, it is unlikely that both compounds 
failed to release H2S into the medium as NaHS was reported to release about 400 µM of H2S 
within an hour while GYY4137 released H2
(Lee et al., 2011)
S at a sustainable amount of 20 µM for several 
days . Perhaps, VirA may not be able to sense a reducing compound in its 




Figure 25. Effect of cysteine (reduced) and cystine (oxidized) on hcp1 gene expression in 
bacterial culture. Wild-type bacterial culture were incubated in sulfur amino acid free RPMI 
medium for 5 h, treated with cysteine (200 µM) or cystine (200 µM) for the last 2 h of 
incubation. Transcript levels of virG and hcp1 gene in treated samples were normalized to the 
untreated control. Assay was performed in duplicate and values are means ± SD.  
 
 
Figure 26. Effect of various thiol compounds of hcp1 expression in bacterial culture. 
Wild-type bacterial culture were incubated in sulfur amino acid free RPMI medium for 5 h 
treated with cysteine (200 µM), GSH (200 µM), NAC (200 µM) or DTT (200 µM) for the last 
2 h of incubation. Transcript levels of virG and hcp1 gene in treated samples were normalized 














































Figure 27. Dose dependent response of cysteine and GSH on hcp1 gene expression. Wild-
type bacteria were incubated in sulfur amino acid free RPMI medium for 5 h and treated with 
A) increasing concentration of cysteine (2, 10, 20, 50, 100, 200 and 2000 µM) or B) 
increasing concentration of GSH (2, 20, 50, 200 and 2000 µM) for the last 2 h of incubation. 
Transcript levels of virA, hcp1 and rpoB genes in treated samples were normalized to the 
untreated control. All assays were performed in duplicate and values are means ± SD. Data 
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Figure 28. Effect of H2S on T6SS-1 gene expression in bacteria cultured in RPMI 
medium. Wild-type B. pseudomallei was grown in sulfur amino acid free RPMI medium 
without or with various H2
 
S donors at 400 µM for 5 h and the transcript level of hcp1and 
virG in treated samples were normalized to that in untreated samples. dnaK was measured and 
served as a housekeeping control. The assay was performed in duplicate and values are the 
means ± SD.  
4.3.5 T6SS-1 expression is induced when the bacteria escape into the cytosol 
Thus far, we have shown that thiol compounds activate T6SS-1 expression exogenously 
through the addition of these signals directly into bacterial culture. Nevertheless, it is critical 
to determine the relevance of this in the physiological context. We first investigated the 
cellular compartment where the signals for VirAG emanate. Previously, T3SS-3 was shown 
to exhibit delayed vacuole escape at 16 h post infection (Burtnick et al., 2008). Hence, we 
took advantage of this phenotype in our T3SS-3 mutant, ΔbsaM, in our assay to determine 
whether signals for VirAG derived from the endosomal or phagosomal compartment. To do 
so, we measured the kinetics of hcp1 gene expression in RAW264.7 macrophages infected 
with wild-type and ΔbsaM. While hcp1 expression increased exponentially in wild-type 
bacteria over time, the expression of hcp1 in ΔbsaM remained relatively low for up to 8 h post 
infection (Figure 29). Yet, there was no inherent defect in T6SS-1 gene expression in the 
ΔbsaM mutant, as hcp1 expression was upregulated to a comparable level as the wild-type 





























that the inability of ΔbsaM to express hcp1 at the earlier time point of up to 8 h post infection 
is likely due to inaccessibility of the signal derived from the cytosol.  
In order to further substantiate our findings, confocal microscopy was used to visualize the 
localization of the bacteria when hcp1 was expressed. Since we have shown that hcp1 
promoter was induced by at least a hundred fold after 5 h of host infection, it should be able 
to drive the downstream reporter gene very well inside host cells.  As such, we fused EGFP 
downstream of the hcp1 promoter in the pUCP28T plasmid for visualization purpose. The 
transcriptional fusion Phcp-egfp plasmid was then conjugated into both wild-type and ΔbsaM 
strains.  When hcp1 promoter is activated, it will drive the expression of EGFP and thus 
turning the bacterium green. In conjunction, infected macrophages were stained with anti-
LAMP-1 (red) (a late lysosomal marker) and anti-LPS antibodies (blue) to visualize 
phagolysosomal compartments and whole bacterium respectively. As predicted, majority of 
the wild-type bacteria (>60% of intracellular bacteria) have escaped from the LAMP-1 
associated vacuoles into the cytosol at 6 h post infection (Figure 31A and C), while > 90% of 
the ΔbsaM remained trapped within the vacuoles, as evidenced in the co-localization of 
bacteria in blue with LAMP-1(red) (Figure 31B and C). Analysis of RAW264.7 cells infected 
with the wild-type strain containing the reporter plasmid at the same time point revealed that 
about 20% of the intracellular bacteria were green, which represents hcp1 expression (Figure 
31A and 31D). Interestingly, most of these wild-type green bacteria did not co-localize with 
LAMP-1 markers (about 15% of the total wild-type bacteria did not co-localize as compared 
to 2% that co-localized), suggesting that expression of hcp1 did not occur within LAMP-1 
associated vacuoles (Figure 31E). In contrast, hardly any green bacteria were observed in the 
ΔbsaM strain (about 0.5% of the total intracellular bacteria) (Figure 31B and 31D), as most of 
these mutant bacteria were confined to the vacuole at this time point. Collectively, these 
findings indicate that the signal required for T6SS-1 expression is provided in the cytosol 




Figure 29. Time course expression of hcp1 in RAW264.7 macrophages infected with 
wild-type and ΔbsaM bacteria. Monolayers of RAW264.7 cells were infected with wild-
type or ΔbsaM mutant at an MOI of 100:1 for 1, 3, 6 and 8 h. Transcript levels of hcp1 gene 
at various time point were normalized to that at 1 h post infection. Assays were performed in 




Figure 30. Effect of cysteine on hcp1 gene expression in ΔbsaM mutant bacterial culture. 
Both wild-type and ΔbsaM bacterial strains were incubated in RPMI cysteine free medium for 
5 h without or with cysteine (200 µM) for the last 2 h of incubation. Transcript levels of hcp1 
gene for all other conditions were normalized to untreated wild-type samples. Assays were 
































































Figure 31. Representative confocal micrographs showing the association of total 
intracellular bacteria and hcp1 expressing bacteria with LAMP-1-associated vacuoles in 
RAW264.7 macrophages. Monolayers cells were infected with overnight culture of A) 
KHW and B) ΔbsaM, both containing Phcp1-EGFP reporter plasmid (pUCP28T), at an MOI 
of 10:1. At 6 h post infection, cells were fixed, immunostained, and visualized by fluoresence 
microscopy. Extracellular bacteria were killed with kanamycin (250 µg/ml) and extensive 
washing before and during staining. Total intracellular bacteria were stained blue with rabbit 
ΔvirA
G::te
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anti- B. pseudomallei polyclonal sera and anti-rabbit IgG Alexa Fluor 405. Intracellular 
bacteria that activated hcp1 promoter and expressed EGFP were in green, LAMP-1 were 
stained red with goat anti-LAMP-1 and anti-goat IgG Alexa Fluor 633. DIC microscopy 
images were shown to reveal cell boundaries. Arrows indicate co-localization of bacteria with 
LAMP-1 markers. Micrographs are representative of two independent experiments. Scale bars 
represent 20 µM.    
 





C) Quantitative analysis of the intracellular wild-type and ΔbsaM mutant that co-localized 
with LAMP-1-associated vacuole in RAW264. 7 cells. D) Quantitative analysis of the 
intracellular wild-type and ΔbsaM mutant that expressed hcp1 (green). E) Pie chart 
representing the percentage of hcp1 expressing bacteria that co-localized and did not co-
localize with the LAMP-1 marker in total number of intracellular wild-type bacteria, in one 
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Proximity of at least 600 individual intracellular bacteria from each samples were analyzed 
for co-localization with LAMP-1 marker and for expression of hcp1 by confocal microscopy. 
The experiment was done in duplicate with at least 1200 bacteria of each strain were 
examined in total. The numbers of intracellular bacteria that co-localized with LAMP-1 
marker or that expressed hcp1 are presented as a percentage of the total number of 
intracellular bacteria examined (± SD).  
 
4.3.6 Expression of T6SS-1 by intracellular bacteria depends on the availability of host 
cysteine/GSH  
We have yet to demonstrate the relevance of T6SS-1 upregulation by thiol compounds when 
the bacteria are inside the host during infection. In mammalian cells, the two natural 
occurring thiols in relative abundance are cysteine and GSH. Cellular GSH is present 
abundantly in the cytosol and is maintained in a highly reduced state. Hence, it is a major 
source of non-protein intracellular reducing equivalents for many biosynthetic processes and 
exerts protective functions from oxidative damage (Morris et al., 2013). Cysteine is the 
precursor and limiting substrate for the formation of GSH and is present in much lower 
concentrations than GSH (Lee et al., 2008). Together, they account for the highly reducing 
environment in the cytosol. We hypothesized that cellular GSH and cysteine from the cytosol 
serve as the intracellular signal that triggers VirAG activation. To test this, we used HepG2 
hepatocarcinoma cell-line for generating a cysteine deficient infection model.  HepG2 cells 
were chosen as it has very limited capacity to convert methionine to cysteine, due to the lack 
of expression of a high-Km isoform of methionine adenosyltransferase (MAT1) (Lee et al., 
2008). Hence, it is unable to maintain intracellular cysteine and GSH levels without the 
provision of cysteine in the culture medium (Lee et al., 2008). As such, we take advantage of 
this property in HepG2 to determine whether infection of a cell deficient in cysteine and GSH 
results in the inability of the bacteria to upregulate T6SS-1 genes. HepG2 cells were cultured 
in the presence or absence of cysteine in the culture medium for 24 h prior to infection with 
wild-type B. pseudomallei. As shown in Figure 32B, intracellular GSH amount was about 10 
fold lower after 24 h of culture in the absence of cysteine. Expectedly, expression of hcp1 was 
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upregulated in the normal HepG2 cells to about 40 fold as compared to bacterial culture alone, 
while in cysteine deficient cells; hcp1 expression was significantly lower than in normal 
condition (Figure 32A). Even though the expression of T6SS-1 regulators, bsaN, virA and 
virG were higher inside host cells, there was no significant difference observed in the 
expression of these regulators between normal and cysteine deficient HepG2 cells. This 
denotes that the effect of cysteine on hcp1 expression acts through the VirAG sensor and not 
on upstream regulators. Taken together, the results demonstrate that a decrease in intracellular 
cysteine and GSH correlates with a lower hcp1 expression. This supports our notion that thiol 




Figure 32. Effect of cysteine deficiency in HepG2 cells on T6SS-1 gene expression. 




















































DMEM (cysteine-deficient medium) for 24 h. A) Cells were then infected with mid-log phase 
wild-type bacteria at an MOI of 100:1 for 5 h in cysteine-deficient medium. Bacteria grown in 
the cysteine-deficient medium alone were included as the baseline control. Transcript levels 
of various T6SS regulator genes, hcp1 and rpoB during cell infection is relative to that in the 
culture medium. B) Intracellular GSH concentration was assayed after 24 h of culture in 
either cysteine-sufficient or cysteine-deficient medium. Values presented are only relative 
which do not reflect true intracellular GSH concentration. All assays were performed in 
duplicate and values are means ± SD. Data are representative of three individual experiments.   
 
4.5.7 Cellular GSH reduction in PBMCs by DEM decreased hcp1 expression  
Besides cell-lines, it is significant to ascertain the physiological relevance of  hcp1 
upregulation by thiol compounds in primary monocytes. To do so, PBMCs from healthy 
donors were examined for hcp1 expression. Since PBMCs are suspension cells, our previous 
method of quantifying T6SS-1 gene expression using real time PCR is inappropriate as it is 
unable to exclude extracellular bacteria in the assay. To assess hcp1 expression in primary 
cells, we infected PBMCs with the wild-type strain conjugated with the Phcp-egfp reporter 
plasmid that was described previously. Flow cytometry was performed to detect EGFP 
fluorescence output (excitation at 488 nm wavelength) as a read out of hcp1 expression in the 
infected cells. ΔvirAG conjugated with the reporter plasmid was also included as a negative 
control for hcp1 expression. To test whether depletion of GSH (which is the most abundant 
thiol compound in the cells) results in T6SS-1 expression, we treated  PBMCs with DEM 
prior to infection . DEM is a GSH conjugating reagent that is able to deplete existing 
intracellular GSH. Since induction of T6SS-1 expression in B. pseudomallei had been shown 
previously in phagocytic cells (Shalom et al., 2007), only primary monocytes from the PBMC 
populations were gated for hcp1 expression analysis as shown in Figure 33A. The overall 
expression of hcp1 in the wild-type strain has a Mean Fluorescence Intensity (MFI) of 18.9 as 
compared to 12 in the ΔvirAG negative control (Figure 33B). Upon depletion of intracellular 
GSH in PBMCs by DEM treatment, expression of hcp1 decreased significantly from an MFI 
of 18.9 MFI to 15 for conditions with 250 µM DEM and 12 for 500 µM DEM treatments 
(Figure 33C). This decrease correlates to a decrease in intracellular GSH from about 40 µM in 
the untreated control to about 15 µM and 25 µM of free GSH in DEM treated conditions 
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(Figure 33D). Overall, the results demonstrated a decrease in free GSH in the cells reduced 
hcp1 expression and supports our hypothesis that free GSH is the major cellular signal that 
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Figure 33. Effect of DEM treatment on hcp1 reporter gene expression in the monocytes 
from PBMCs. PBMCs were incubated for 4 h and infected with overnight culture of wild-
type KHW + Phcp-egfp or ΔvirAG + Phcp-egfp at an MOI of 100:1 for 2 h. A) A 
representative forward scatter and side scatter plot of infected PBMCs. The polygon 
represents the monocytes being gated for hcp1 expression analysis (A488 MFI). B) Histogram 
of hcp1 expression (A488 MFI ) in KHW + Phcp-egfp and ΔvirAG + Phcp-egfp infected 
monocytes. C) PBMCs were left untreated or pretreated with 250 µM and 500 µM DEM for 4 
h prior to infection, with DEM in the culture for a total of 6 h throughout the experiment. 
Histogram of hcp1 expression in infected monocytes under indicated conditions. D) 
Intracellular reduced GSH concentrations were assayed in PBMCs after 6 h of culture in 














































Given that Type VI secretion system is a multi-functional virulence mechanism utilized by a 
wide diversity of Gram-negative bacteria towards eukaryotic and prokaryotic cells, it is not 
surprising that the expression of their T6SS gene clusters are under tight control by various 
regulatory systems in response to appropriate signals. Nevertheless, some species such as V. 
cholerae V52 strain, Serratia marcescens and B. thailandensis possess constitutively active 
T6SS (Schwarz et al., 2010; Pukatzki et al., 2006; Murdoch et al., 2011). Notably, these 
constitutively active T6SSs generally kill prokaryotic target cells which provide them with a 
competitive advantage for survival during inter-bacterial interactions in the environment 
(Schwarz et al., 2010; Pukatzki et al., 2006; Murdoch et al., 2011). It is postulated that in the 
events where bacteria co-evolved with eukaryotes and become pathogens, a stricter T6SS 
regulatory mechanism for response to specific signals could have evolved to additionally 
target eukaryotic cells in order to provide themselves with additional competitive advantage 
in their hosts (Miyata et al., 2013).  Recently, many studies have uncovered the regulatory 
mechanisms of T6SSs in various pathogens and much knowledge have been gained regarding 
the environmental signals that influence its expression. However, the direct host signal sensed 
by intracellular pathogens for T6SS regulations remains largely unknown. In B. pseudomallei, 
we have previously found that T6SS-1 is predominantly regulated by a two-component 
system, VirAG, in the host cells. Here, we made a highly novel discovery on the signals 
activating T6SS-1 in B. pseudomallei. We demonstrated that thiol compounds such as 
cysteine, GSH, DTT and NAC in their reduced state were able to upregulate hcp1 expression 
significantly when added into bacterial culture grown under standard laboratory conditions.   
Clearly, an effective means for the induction of virulence genes by pathogens is to sense the 
presence of host-specific molecules or host-specific environments. In a plant pathogenic 
bacterium such as A. tumefaciens, acidity potentially activates T6SS expression and secretion 
via a ChvG/Chvl two-component system (Wu et al., 2012). Such activation of T6SS by an 
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acidic signal which is normally present in plant wound sites represents an example of how 
T6SS is precisely upregulated when it is needed in Agrobacterium-plant interaction in the 
presence of appropriate signals (Wu et al., 2012). Conversely, pH only plays a minor role in 
T6SS-1 upregulation for B. pseudomallei. In fact, acidic pH has been documented to 
upregulate T3SS-3 virulence factor in B. thailandensis (Jitprasutwit et al., 2010). Likely, 
acidity inside phaogosome induces T3SS-3 expression in Burkholderia strains to exhibit early 
endosomal escape into the cytosol. We had established in the previous chapter that VirAG is 
under the control of BsaN, a T3SS-3 regulator. Hence, an inhibitory effect on T6SS 
expression by bafilomycin treatment observed in our result could be an indirect effect through 
a decrease in T3SS-3 expression. However, there is no increase in T6SS-1 gene expression 
when the bacteria were incubated in acidic pH culture medium, suggesting acidity is unlikely 
a T6SS-1 inducible signal. 
A well-studied example of virulence-associated two-component system is the PhoPQ system 
of Salmonella, which responds to changes in Mg2+, Ca2+ or Mn2+
(Prost and Miller, 2008)
 concentrations, acidic pH, 
and antimicrobial peptides . It was reported that antimicrobial 
peptides directly activate PhoQ, the histidine kinase, through interactions with its periplasmic 
sensor domain. This demonstrated an adaptation mechanism by which bacteria sense their 
presence in the host tissues through sensing of host-specific immune molecules to initiate the 
expression of virulence determinants for pathogenesis, such as replication and survival in 
macrophages. On the contrary, this is not the case for Burkholderia as LL-37 peptides failed 
to cause an effect on T6SS-1 expression. However, further examination on other 
antimicrobial peptides such as C18G is required in order to be ruled out as a T6SS-inducible 
signal.   
In this study, we discover that the exogenous addition of low molecular weight thiol 
compounds is able to upregulate T6SS-1 gene expression by about 100 fold. Importantly, we 
found that free thiol groups (-SH) present in these compounds account for the upregulation as 
there was no increase observed upon cystine (an oxidized form of cysteine) addition. Possibly, 
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free thiols are required to reduce disulfide bonds formed in VirA sensor or proteins that are 
involved in the signaling pathway. However, we also found that other thiol free reducing 
agents such as Tris(2-carboxyethyl) phosphine hydrochloride (TCEP) was unable to 
upregulate hcp1 expression. TCEP is a strong reducing agent which reduces disulfide to free 
thiol readily (Godoy et al., 2003). Structurally, TCEP has a charged phosphorous and such 
polarity is unable to diffuse through lipid bilayer membranes. This could possibly hinder its 
accessibility to the VirA sensor at the inner membrane and thus account for its inability to 
activate VirA. Nevertheless, there is still a possibility that VirA is uniquely activated by thiol 
reducing compounds.  
Furthermore, we have determined the cellular compartment in which the signals are being 
sensed. Two important observations from this study suggest that the signals required for 
T6SS-1 activation occur in the cytosol, as hcp1 was expressed after the bacteria have escaped 
from the phagosomal compartment into the host cytosol. Firstly, upregulation of hcp1 
expression up till 8 h post infection was only seen in the wild-type and not in a T3SS-3 
mutant which has deficiency in phagosomal escape. Secondly, expression of GFP by B. 
pseudomallei strains with Phcp-EGFP reporter plasmid was observed only in the wild-type 
strain, and mainly in bacteria without association with LAMP-1 positive vacuoles. We have 
shown that exogenous addition of cysteine to ΔbsaM mutant was able to upregulate hcp1 
expression to a level comparable to that of the wild-type strain, signifying that the absence of 
hcp1 expression in ΔbsaM mutant is not due to its inability to drive T6SS-1 expression. Both 
findings indicate strongly that T6SS-1 is induced by intracellular signals present in the host 
cell cytosol.   
On the contrary, findings by Burtnick et al suggested that the intracellular signal required for 
T6SS-1 expression in B. mallei was provided prior to escape from LAMP-1 vacuoles into the 
cytosol. This was shown through a reporter strain, ΔbsaZ ΔtssE::gfp, which expressed GFP 
while it remained trapped within the vacuole at 3 h postinfection (Burtnick et al., 2010). 
Conversely, our data are consistent with another study which demonstrated that MNGCs were 
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induced (an indication of a functional T6SS-1 being expressed) when B. thailandensis were 
delivered directly into host cytosol through photothermal nanoblade and thus bypassing the 
vacuolar or phagosomal compartments (French et al., 2011). This would argue that signals 
sensed by VirAG were coming from the cytosol.  
Among the signals that were identified, the two natural occurring thiol compounds found in 
human cells are GSH and cysteine. In mammalian cells, cellular GSH are found abundantly in 
the host cytosol in the reduced form, in concentration ranging from 0.5 to 10 mM (Meister, 
1988), making it a highly reducing environment for biological functions. Besides being an 
antioxidant that serve as a protection for cells from oxidative damage, GSH participates in 
many important physiological processes such as controlling cellular homeostasis, transport of 
amino acids, protein synthesis and also enhance functional activity of immune cells such as 
NK cells and T cells (Morris et al., 2013; Griffith and Meister, 1979; Santangelo, 2003). 
Cysteine is the precursor and limiting substrate to the formation of GSH and is present in 
much lower concentrations than GSH, of about 400 µM in hepatocytes (Lee et al., 2008). We 
demonstrated a dose dependent response between cysteine and GSH concentration and hcp1 
activation. The concentrations under test (a range from 2 µM to 2 mM) encompassed the 
physiological concentrations, hence simulating the expression of T6SS-1 by cellular thiols 
when bacteria are inside mammalian cells. In a cellular model of infection, we showed that 
cellular deficiency in cysteine and GSH in HepG2 hepatocarcinoma cell-line results in the 
inability of the bacteria to activate T6SS-1 genes. Furthermore, a decrease in intracellular free 
GSH by DEM treatment was able to reduce hcp1 expression in primary monocytes. This 
further substantiates our hypothesis in a human infection context. It is conceivable that B. 
pseudomallei has adapted to its intracellular life cycle in mammalian hosts by hijacking GSH 
for its own purposes, which is to use them as signals for turning on T6SS-1 virulence factor to 
facilitate its survival and spread inside the intracellular niche.  
Recently, a study by Burtnick et al has revealed other possible signals that influence T6SS-1 
expression. They found that defined minimal media condition highly activates T6SS-1 gene 
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expression of B. mallei and B. pseudomallei as compared to culture in rich media such as LB 
broth in vitro (Burtnick et al., 2013). Notably, the expression of VirG regulator was also 
increased in minimal media, thus indicating that the induction could be an indirect effect from 
an upstream regulator rather than acting directly through VirAG sensor. It is likely that there 
are additional levels of regulation upstream of VirAG which control expression of both T3SS-
3 and T6SS-1 genes in response to these signals. In addition, they showed the presence of Fe 
and Zn divalent metals repressed T6SS-1 expression and Hcp1 production (Burtnick et al., 
2013). It is plausible that such iron dependent regulation is through the Fur protein, a ferric 
uptake regulator. Besides regulating iron acquisition, Fur protein is a key modulator in 
sensing iron concentrations to activate and suppress the expression of virulence genes in 
bacteria (Carpenter et al., 2009). In fact, Fur has been shown to negatively regulate T6SS 
expression at the transcriptional level in the presence of iron in E. tarda and EAEC. In EAEC, 
the expression of T6SS sci-1 gene cluster is suppressed directly by Fur (Brunet et al., 2011). 
For E. tarda, it was shown that Fur confers iron-dependent repression of production and 
export of EvpC (an Hcp homolog) by binding directly to a Fur box sequence upstream of 
evpP, the first gene in the cluster (Chakraborty et al., 2011). Besides, aadditional complexity 
was reported in which T6SS-1 is indirectly suppressed by Fur through suppressing 
transcription of the upstream regulators, phoB and esrC, through an unidentified regulatory 
pathway (Chakraborty et al., 2011). Iron is one of the nutrients that are essential for bacterial 
growth. However, eukaryotic host sequesters iron as a mean of protection against invading 
pathogens. On the other hand, pathogens have evolved to sense iron depletion as a signal, 
signifying that they are within eukaryotic host to express virulence genes. This is thus another 
illustration of an effective mechanism for inducing expression of virulence genes by sensing 
the host-specific environment.  
Unlike bacteria such as V. cholera V52 and S. marcescens which possess constitutively active 
T6SSs to target other prokaryotes (Pukatzki et al., 2006; Murdoch et al., 2011), expression of 
virulence associated T6SS-1 in B. pseudomallei is precisely regulated and tightly controlled at 
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the transcriptional level so that it is produced under appropriate environmental cues to confer 
pathogenicity in mammalian host cells. Specifically, we found that B. pseudomallei senses its 
presence inside the host through thiol compounds such as GSH that are abundantly found in 
host cytosol for T6SS-1 upregulation. Subsequently, we aim to elucidate the mechanism of 
how these thiol compounds activate VirA. Conceivably, VirA is sensing these thiols in the 
periplasm of the bacteria as these thiols could diffuse into the bacterial periplasm from the 
external environment.  Perhaps, it could be sensed indirectly through an additional adapter 









































For microbes to adapt to the varying environments they thrive in, they have developed 
versatile and sophisticated adaptive response systems that sense and respond to the 
environmental cues by modulating cellular processes. Integral to these responses is the 
regulation of gene transcriptions pertinent to the adaptation processes. The prevalent 
mechanism widely used by prokaryotes for stimulus-responsive adaptation is the two-
component signal transduction system (TCS) (Krell et al., 2010), which translates 
environmental signals into regulation of gene expression. TCSs have long been implicated in 
important cellular processes such as cell cycle progression, stress response, biofilm formation, 
osmoregulation, quorum sensing, motility and metabolism (Gotoh et al., 2010). All of these 
are vital for bacteria to survive and adapt both inside and outside of their host. In many 
instances, TCSs contribute to bacterial pathogenesis in Gram-negative pathogens by 
regulating expression of virulence factors.  
The common feature of a two component system consists of a membrane-bound histidine 
kinase (HK) sensor which senses extracellular signals, and its cognate response regulator (RR) 
which interacts with the promoter region of target genes to modulate DNA transcriptions 
(Krell et al., 2010). A prototypical histidine kinase is a membrane associated sensor that exist 
in dimer, with usually one or two transmembrane (TM) -spanning regions which typically 
links a periplasmic sensory input domain to the cytoplasmic autokinase domain. In the 
cytoplasmic domain, it typically consists of two conserved domains, namely the catalytic 
ATP binding (CA) domain and the dimerization histidine phosphotransfer (DHp) domain 
containing the conserved His residue (Dutta et al., 1999).  However, variations in the 
organization of conserved domains or the presence of multiple TM segments in the sensor 
kinase are frequent (Krell et al., 2010), which reflect adaptations of the basic system to meet 
the specific localizations, functions and regulatory needs of many different signaling systems 
(West and Stock, 2001).  
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Most of the response regulators are two-domain proteins, which consist of a receiver domain 
containing an aspartic phosphorylation site fused to another domain with a DNA-binding site. 
In the event of signal transduction, histidine kinase autophosphorylates on a specific histidine 
residue in the DHp domain, subsequently leading to the phosphorylation of the aspartic 
residue in the receiver domain of its cognate response regulator (Chang and Stewart, 1998). 
The phosphorylation of Asp either leads to binding to its target DNA and thus altering the 
transcriptional properties or it promotes transcriptional activation by regulating its 
interactions with other transcriptional regulators (Parkinson, 1993; Hakenbeck and Stock, 
1996). Such typical TCS is well represented by EnvZ/OmpR of E. coli, with EnvZ being the 
osmosensor HK and OmpR being the RR. It is recently shown that changes in osmolarity may 
be sensed in the dimerization domain of EnvZ rather than at the typical transmembrane 
sensory domain (Wang et al., 2012).  As illustrated in Figure 34, a change in osmolarity 
perceived by EnvZ leads to autophosphorylation at the conserved histidine site.The phosphate 
is then transferred to the receiver module of OmpR, thereby affecting interactions of the 
OmpR DNA-binding domain with the promoter of two porin genes, ompF and ompC, and 
hence regulating their expressions (Pratt and Silhavy, 1995). The regulation of OmpF and 
OmpC porins in the outer bacterial membrane by the EnvZ/OmpR system controls the 
diffusion of molecules across the outer membrane under high osmotic conditions (Pratt and 




Figure 34. Schematic diagram on a basic two-component system (left) and the signal 
propagation in the osmolarity response system EnvZ/OmpR TCS in E. coli (right) adapted 
(Chang and Stewart, 1998).  
 
Importantly, many TCSs play a role in the pathogenicity of bacteria as attenuated virulence 
were described in some of these TCS mutants (Beier and Gross, 2006). For instance, the 
BvgA/BvgS system is the master regulator of virulence in Bordetella pertusis, the etiological 
agent of whooping cough (Cotter and Jones, 2003). The sensor kinase BvgS utilizes a 
multistep His-Asp-His phosphorelay for signal transduction between its different domains 
before phosphotransfer to BvgA, its cognate response regulator. BvgS senses host signals 
such as body temperature and limitation of MgSO4 (Cotter and Jones, 
2003)
 and nicotinic acids 
. Upon activation, BvgA expresses all known virulence associated genes in B. pertussis, 
including factors implicated in adherence, electron transport, secretion of toxins and even 
T3SS factors (Cotter and DiRita, 2000). In contrast, other TCS virulence regulators exhibit an 
additional level of complexity as various other systems are integrated into the virulence-
regulatory networks. This is best illustrated in well-characterized the PhoP/Q system which is 
conserved in many Gram-negative pathogens such as Salmonella that has been described 
extensively in chapter 1.  
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In B. pseudomallei, the VirA sensor kinase of T6SS-1 is predicted by bioinformatics software 
(TMHMM server 2.0, P2CS) to have nine to ten transmembrane domains embedded in the 
bacterial inner membrane with its N terminal exposed to the cytoplasmic space. Likewise, the 
transmitter domain of VirA contains a histidine kinase and a HATPase domain. However, 
unlike the other sensory or input domains such as the most commonly found PAS (Per-Amt-
Sim) domain found situated in the periplasmic or cytoplasmic region of histidine sensor 
kinases, the integral membrane sensory domain of VirA shows some homology to the 
MASE1 domain that has been reported to exist in histidine kinases of cyanobacteria, α-
proteobacteria, and some enterobacteriaceae (Nikolskaya et al., 2003). The nature of the 
signals and the mechanisms for signal perception and transduction for MASE1 sensing are 
largely unknown until recently, when the function of a MASE1 domain in the YfgF protein 
found in Salmonella has been assigned as a redox-responsive regulator of bacteria that sense 
aerobic conditions to inhibit response towards aspartate (Lacey et al., 2013). Structurally, the 
MASE1 domain is reported to have eight transmembrane regions whereas VirA is predicted 
to have nine or ten. In fact, it is rare for a histidine kinase to have more than three 
transmembrane regions. Such uniqueness in the structure of the input domain of VirA may 
reflect specific and dedicated functions.  
In chapter 4, we have discovered that the exogenous addition of low molecular weight thiols 
are able to upregulate T6SS-1 gene expression by a 100 fold, stimulating the expression of 
T6SS-1 when bacteria are inside mammalian cells. We also found that free thiol groups (-SH), 
but not the oxidized form, are essential for the upregulation. Since we had established earlier 
that the T6SS-1 cluster is controlled mainly by VirAG when inside the host environment, we 
hypothesized that VirA is sensing these thiols in the periplasm of the bacteria, as these thiols 
could diffuse into the bacterial periplasm from the external environment. We believe that 
these signals cause a modification at the sensory domain which leads to a conformational 
change and is propagated to the catalytic kinase and HATPase domain. As a result, the 
conserved His residue is aligned facing the ATP-binding pocket for autophosphorylation 
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(Khorchid and Ikura, 2006). In the context of VirA, it is possible that the thiols could be 
acting as reducing agents to reduce disulfide bonds formed in the VirA signal input domain. 
As opposed to the cytosol, the periplasm is highly oxidizing due to the presence of the 
periplasmic thiol-disulfide oxidoreductase DsbA and the cytoplasmic inner membrane protein 
DsbB (Sevier and Kaiser, 2002). Thus, cysteine or GSH could potentially reduce the default 
disulfide linkages between two cysteines present in VirA exposed to the periplasmic region, 
thereby affecting a conformational change that is propagated to the transmitter domain of 
VirA. Another possibility is that cysteine or GSH is covalently attached to VirA via S-
cysteinylation or S-glutathionylation. This involves the disulfide bond formation between the 
free thiol and the cysteine residues in VirA.  
In this study, we elucidate the mechanism of how cysteine or GSH are modulating VirA, by 
determining whether and which cysteine residues on VirA are important in reacting with the 
thiols. To do so, we first determine whether the transmembrane domain of VirA is essential 
for the sensing of thiol signal. Furthermore, we investigate whether the cysteine residues in 












5.2 Materials and Methods 
5.2.1 Bacterial strains and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table 10. All bacterial 
strains were maintained and cultured as mentioned in Chapter 2. Similarly, quantification of 
the bacterial numbers by measuring optical density (OD600
Table10 . List of bacterial strains and plasmids used in this study 
) using a spectrophotometer was 
described in detailed in Chapter 2. Antibiotics added to LB medium were as follows (in 
µg/ml): For E. coli, kanamycin (Km), 25; tetracyclin (Tet), 20 and for B. pseudomallei, 
gentamicin (Gm), 50; Km, 250; Tet, 50. All antibiotics are from Sigma-Aldrich, MO. 
Strain or plasmid Relevant characteristic(s) Source or reference a 
B. pseudomallei   
KHW B. pseudomallei wild-type strain Gm (Liu et al., 2002)r  
ΔvirA KHW ΔvirA, codon 2-606 of BPSS1495 was 
deleted 
This study 
ΔvirA::tet KHW ΔvirA, 1-404 codon of BPSS1495 was 




ΔvirA TM KHW ΔvirA, transmembrane region from 
codon 2-317 of BPSS1495 was deleted.  
This study 
C62A Site directed mutation (SDM) of VirA at 
codon 62 from Cys to Ala 
This study 
C62S SDM of VirA at codon 62 from Cys to Ser This study 
C87A SDM of VirA at codon 87 from Cys to Ala This study 
C214A SDM of VirA at codon 214 from Cys to Ala This study 
C235A SDM of VirA at codon 235 from Cys to Ala This study 
C314S SDM of VirA at codon 314 from Cys to Ser This study 
C358A SDM of VirA at codon 358 from Cys to Ala This study 
C434A SDM of VirA at codon 434 from Cys to Ala This study 
C585A SDM of VirA at codon 585 from Cys to Ala This study 
ΔdsbA KHW ΔdsbA, codon  2-210 of BPSL0381 
was deleted 
This study 
   
E. coli   




Cloning host for SDM Agilent technologies 
S17 S17-1 Donor strain for conjugation  (Simon et al., 1983) 
   
Plasmid   
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pK18mobsacB Conjugative, suicide vector, Kmr (Schäfer et al., 1994)   
pFRTT1 pGEM contains FRT sites and tetRA 
sequence, Ampr, Tet
Sun et al 2010 
r 
pKO-virA::tet pK18mobsacB containing upstream and 
downstream sequences of virA with tet 
casette inserted in between, Kmr, Tet
This study 
r 
pKO-dsbA pK18mobsacB containing upstream and 
downstream sequences of dsbA, Km
This study 
r 
pKO-virA TM pK18mobsacB containing upstream and 




pk18-virAwt pK18mobsacB containing upstream and 
downstream sequences of virA and wild-type 
virA sequence intended for SDM, Km
This study 
r 




5.2.2 Construction of ΔdsbA and ΔvirA::tet mutant 
Both ΔdsbA and ΔvirA::tet mutants were generated from the KHW wild-type strain by allelic 
exchange as described previously. ΔvirA::tet mutant was created as the parental strain for the 
subsequent construction of virA site-directed mutants. The gene loci virA (BPSS1495) and 
dsbA (BPSL0381), with reference to the genome sequence of K96243 strain, were targeted for 
deletion. Briefly, approximately 1 kb fragments upstream and downstream of each gene were 
amplified from KHW genomic DNA and cloned into pK18mobsacB vector simultaneously 
using In-Fusion PCR cloning kit (Clontech, CA). PCR primers for plasmid constructions are 
listed below. For the construction of ΔvirA::tet, the FRT-flanked tet cassette from pFRTT1 
(Sun et al., 2010) was inserted between the virA upstream and downstream gene fragments at 
BamH1 sites to generate the pKO-virA::tet plasmid. The resulting plasmid pKO-virA::tet and 
pKO-dsbA were subsequently conjugated into B. pseudomallei KHW strain through E.coli 
S17. Clones with successful single cross-over by homologous recombination were first 
selected on TSA plate with 250 µg/ml kanamycin and 50 µg/ml gentamycin. Positive clones 
were then subjected to several passages of growth in LB + 15% sucrose to counter-select 
against the sacB in the suicide plasmid pk18mobsacB. Successful double cross-over clones 
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were screened via colony PCR for the deletion of the targeted genes from kanamycin 
sensitive colonies for ΔdsbA and tetracyclin resistant colonies for ΔvirA::tet.  




virAtet up       F: ACATGATTACGAATTCGATCGGGTATGCGTCTTCGTCG      
virAtet up       R: TCACATGACAACGAACGGATCCG  
virAtet down  F: TTCGTTGTCATG
virAtet down  R: 
TGACGCGGGTGAGCGTCGAC  
GGCCAGTGCCAAGCTT
dsbA up          F: 
TGTTCAGCGTCCATCCGTCG  
CCATGATTACGAATTC
dsbA up          R: 
TGGCGCTCTACATCACCC  
dsbA down     F: 
TACCCGGGGATCCTCCATGTTCGGACGTTCAATCG 
GAGGATCCCCGGGTAGAAGCTGTAATCCCCATCGC





 Restriction sites used are underlined 
5.2.3 In situ site directed mutagenesis and construction of ΔvirA TM 
Alanine (GCG) or serine (TCG) substitution of Cys62 (TGC), Cys87, Cys214, Cys235, 
Cys358, Cys434 and Cys585 in VirA were generated by site-directed mutagenesis (SDM) on 
plasmids using QuikChange II XL Site-Directed Mutagenesis kit (Agilent technologies, CA). 
The plasmid pk18-virAwt which encompassed the same upstream and downstream fragments 
in pKO-virA::tet and with the virA wild-type sequence targeted for mutations in between the 
fragments, was used as the DNA template for SDM. Briefly, primers listed in Table 11 with 
intended mutations for SDM were designed using the web-based QuikChange Primer Design 
Program (http://www.stratagene.com/qcprimerdesign) and PCR was carried out using pk18-
virAwt as the DNA template. PCR products were incubated with Dpn1 for 1 h at 37 °C to 
digest the original methylated DNA template, before transformation into XL10 Gold 
ultracompetent cells. Successful clones carrying desired mutations were verified by 
sequencing (1st Base, Singapore). For ΔvirA TM, both upstream and downstream sequences 
of the virA transmembrane region were amplified from wild-type genomic DNA and cloned 
into pK18mobsacB vector simultaneously using In-Fusion PCR cloning kit (Clontech, CA). 
For mutagenesis of Cys314 to Ser (C314S),  primers encompassing the mutations and with 
their respective paired primers were used to amplify from wild-type genomic DNA to 
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generate two fragments that were cloned directly into pK18mobsacB vector by In-fusion PCR 
cloning kit. The resulting plasmids were then introduced into B. pseudomallei ΔvirA::tet 
strains by conjugation from E. coli S17-1. In situ SDM mutants were constructed similarly to 
knock out mutants as described above. Successful double-cross over clones were screened for 
Tet sensitivity with the tet marker being flipped out and intended mutations inserted into the 
chromosome. Sequencing was carried out from colony PCR products to confirm the site-
directed mutations.  
 




Primer name Sequence 5’-3’ 
C62A C62A    F 





C62S C62S     F 







C87A    F 







C214A  F 







C235A  F 







C314S  1 F 
C314S  1R 
C314S  2F 








C358A C358A  F 







C434A  F 







C585A  F 







virATM up F 
virATM up R 
virATM down F 











5.2.4 Bacterial culture with cysteine induction and quantification of gene expression 
Mid-log phase of all bacterial strains cultured in LB medium were used for the following 
experiment. Approximately 200 X 106  cfu were inoculated into 500 µl of sulphur amino acid-
free RPMI medium (Sigma, MO) in a 12 well plate. Cysteine (200 µM) (Sigma, MO) was 
added into the bacterial culture at 3 h post incubation and treated for another 2 h prior to 
harvest. After a total of 5 h incubation at 37 °C and 5% CO2, bacterial cells were centrifuged 
at 4000 rpm for 3 min and cell pellets were lysed with 1 ml of TRizol reagent (Life 
Technologies, CA) for RNA isolation. All conditions were done in duplicates. RNA was 
purified using Illustra RNAspin Mini Kit together with On-column DNase treatment 
according to manufacturer’s protocol (GE Healthcare Life Science, NJ). cDNA was 
synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, MA) 
according to manufacturer’s protocol. Transcripts of various genes were quantified using 
iQTM
List of real-time primers for this study 
 SYBR Green Supermix for iQ5 (Biorad, CA) in a BioRad iQ5 Thermo Cycler machine 
(Biorad, CA).  The following primers were used for real-time PCR detection: 
Gene Sequence 
16S 5' GGCTAGTCTAACCGCAAGGA 3' 
5' TCCGATACGGCTACCTTGTT 3' 
virA 5’ GTCGATATGGGGATACCAGG 
5’ TCGGTGTGGATGAACGAC 
hcp1 5' CACATCCTCGCCTTCAA 3' 
5' AGATGATGGAAGAGTTCGAGA 3' 
rpoB 5’ GTTCCATCGTTCACCAAGTG 3’ 
5’ TTGCAGAAATGTGCTGAATG 3’ 
 
5.2.5 Western blot analysis for Hcp1 protein expression 
Both wild-type KHW and C62A strains were sub-cultured in 5 ml of RPMI serum free 
medium (Gibco,CA) at 5 X dilution from the respective overnight culture. The bacteria were 
cultured in the presence or absence of cysteine (0.2 mM) for 8 h at 37 °C in the shaking 
incubator. After 8 h of culture, bacterial cells were pelleted by centrifugation at 4000 rpm for 
5 min. Whole cell lysate were prepared and detection of Hcp1 expression in each sample were 
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performed as described previously in Chapter 4. Detection of BopE for all samples was 
included as a loading control.  
5.2.6 VirA structural analysis 
The protein sequence of VirA BPSS1495 retrieved from NCBI (ref seq: YP_111502) was 
analyzed for conserved domains using NCBI Conserved Domains database. From the search, 
domains such as MASE1, HisKA and HATPase were identified. Transmembrane regions 
were predicted using the following web-based databases that focus exclusively on TCSs: 
P2CS (http://www.p2cs.org), TMHMM Server v2.0 
(http://www.cbs.dtu.dk/services/TMHMM/), PHDhtm (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=/NPSA/npsa_htm.html) and HMMTOP 
(http://www.enzim.hu/hmmtop/). In all databases, transmembrane helices and the topology of 
VirA protein were predicted and they were compared for consensus regions. All eight 












5.3.1 Structural analysis of VirA via bioinformatics prediction 
To investigate the possibility of VirA being the direct target of thiol compounds in mediating 
T6SS-1 upregulation, we first examined and analyzed the structure of VirA in detail via 
bioinformatics. VirA protein sequence retrieved from NCBI database with reference number 
YP_111502 was blasted for conserved domains. Three conserved domains were identified as 
shown in Figure 35: MASE1 being the integral membrane sensory domain, HisKinase  
bearing the conserved His site which is activated via trans-autophosphorylation by the 
catalytic domain, and HATPase which is the catalytic ATP binding domain. The 
transmembrane helices and topology were further predicted using several web resources such 
as P2CS, TMHMM Server v2.0, PHDhtm and HMMTOP. While HMMTOP and P2CS 
predicted 10 TM helixes, TMHMM and PHDhtm predicted 9. While all programs predicted 
the same conserved  7 TM regions from position 33 to 245 of the amino acid sequence, 
discrepancy in the number of TM region occurs at position 249 to 290 region. A difference in 
the number of helical transmembrane regions predicted affects the topology of non-TM 
regions being in the cytoplasmic or periplasmic region. All programs predicted a cytoplasmic 
N terminal, and it is conceivable for the transmitter domains to be situated at the cytoplasmic 
region. Hence, a model with an even number of TM helix is preferred and Figure 24 depicts 
the most probable VirA structure.   
To examine the hypothesis that cysteine residues in VirA participate in sensing of thiol 
compounds, we first identified all eight cysteine residues in VirA. According to the most 
probable topology predicted (Figure 35), cysteine at position 62 of the amino acid sequence 
(C62) is situated at the periplasmic region, C87 and C214 at the cytoplasmic, C235 and C314 
are part of the transmembrane helices. The rest of the cysteine residues, C358, C434 and 




     
Figure 35. Schematic diagram for predicted VirA sensor protein structure situated at 
the bacterial inner membrane. Three conserved domains: MASE1 transmembrane region 
(blue), HisKinase (green) and HATPase (red) were identified. For the MASE1 region, nine to 
ten transmembrane helices were predicted differently by various bioinformatics programs. 
Eight cysteine residues in VirA were indicated in red ovals and denote as C with the number 
representing the position of the cysteine amino acid in the protein. Out of the eight, 5 
cysteines (C62, C87, C214, C235, and C314) are in the transmembrane domain while 3 
cysteines (C358, C434, C585) are in the cytoplasmic transmitter domain. IM: inner membrane 
of bacteria; N: N-terminus of the protein; C: Cytoplasmic domain  
 
5.3.2 VirA C62A and C62S variants constitutively turn on hcp1 expression. 
To explore the role of all eight cysteine residues in VirA in the mechanism of sensing of thiol 
compounds, we tested the effects of cysteine-to alanine substitution on each of the eight 
cysteine residues denoted above. Since there is no hcp1 upregulation upon cysteine induction 
in the ΔvirA TM mutant, which has an in frame deletion of the whole TM (Figure 36G), it 
suggests that TM region is essential for sensing and transmission of signals. However, 
confirmation can only be made if the cytoplasmic region is expressed at nearly wild-type 
levels and if the protein is well-folded and in its functional state.  Interestingly, the VirA 
C62A variant exhibited an increased in hcp1 gene (> 10 fold increase) as compared to the 
untreated wild-type control even without the presence of cysteine (Figure 36B). To mimic the 
size and steric hindrance of sulphur in the cysteine molecule, a C62S substitution (cysteine to 
serine) was generated as a more conservative mutation since the hydroxyl group in serine 
resembles the thiol group. Similarly, C62S gave a constitutive expression phenotype even 
without cysteine. However, cysteine induction in both C62A and C62S further potentiated 
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hcp1 expression to a level comparable to that in the wild-type strain. Besides transcription, we 
also examined Hcp1 protein expression in the C62A variant. In agreement with the phenotype 
seen in gene expression profile, the basal expression of Hcp1 protein is higher in the C62A 
variant than the wild-type strain, and a further increase was observed upon cysteine induction 
(Figure 37). BopE, which is a T3SS-3 effector, was included to serve as the loading control. 
In Figure 37D , two other VirA variants, C87A and C314S demonstrated a significantly lower 
upregulation of about 10-15 fold increase upon cysteine induction as compared to the 
cysteine-induced wild-type condition (100 fold increase).  For other variants, C214A, C235A, 
C358A, C434A and C585A, no differences were observed in the ability to activate VirA for 
hcp1 upregulation compared to wild-type bacteria (Figure 36B, C, E and F). The data for all 
VirA variants are summarized in Table12. Taken together, the data indicate that C62 plays a 
part in maintaining the conformation of VirA likely through the reducibility of its thiol group 
to turn the sensor on. The absence of a thiol group causes a conformational change to an “on” 
























































































































Figure 36: Effect of cysteine mutation in VirA on hcp1 upregulation by cysteine at 
position A) C62 to alanine or serine (C62A and C62S), B) C214A, C) C235A D) C87A and 
C314S,  E) C358 and C434, F) C585 and G) ΔvirA TM with the transmembrane region 
deleted. All bacterial strains grown to mid-log phase were incubated in RPMI cysteine free 
medium for 5 h with or without cysteine (200 μM) for the last 2 h of incubation. Transcript 
levels of virA, hcp1 and rpoB gene for all other conditions were normalized to that in 
untreated wild-type samples. Assays were performed in duplicates and values are means ± SD.  
 
 
Table 12: Summary of the effect of VirA mutations on hcp1 upregulation upon cysteine 
induction.  
VirA variants  Effect on hcp1 upregulation  
C62A  Constitutive hcp1 expression in the absence of thiol compounds  
C62S  Constitutive hcp1 expression in the absence of thiol compounds 
C87A  Reduced hcp1 upregulation upon cysteine induction as compared 













































C214A  Same as wild-type 
C235A  Same as wild-type 
C314S  Reduced hcp1 upregulation upon cysteine induction as compared 
to wild-type 
C358A  Same as wild-type 
C434A  Same as wild-type 
C585A  Same as wild-type 





Figure 37. Hcp1 protein expression in wild-type (KHW) and VirA C62A variant. Both 
strains were cultured in RPMI serum free medium without or with cysteine (200 µM) for 8 h. 
Total protein lysate were resolved on 10% native gel and analyzed by Western blot with 
antibodies against Hcp1 and BopE. BopE was used as an internal control.  
 
5.3.3 ΔdsbA mutant exhibited attenuated upregulation of hcp1 gene expression by thiol 
compound 
To test the hypothesis that thiol compounds activate VirA sensor through reduction of default 
disulfide bonds formed at the periplasmic region of VirA, we created a dsbA deletion mutant. 
It is well-established that DsbA/DsbB in bacteria are periplasmic proteins which catalyze 
disulfide bond formations in proteins in the inner membrane (Kadokura and Beckwith, 2010). 
Based on this, deleting either dsbA or dsbB in B. pseudomallei would hypothetically reduce 
the disulfide bond formation in VirA, causing a conformational change that could turn on 
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T6SS-1 expression constitutively as in the C62A/C62S mutant. From the result shown in 
Figure 38, the ΔdsbA mutant did not show a constitutive activation in the absence of cysteine. 
On top of that, hcp1 expression was still upregulated significantly in the ΔdsbA mutant upon 
the addition of cysteine (about 35 fold increase). This shows that VirA is still reducible even 
without DsbA, hence indicating DsbA is not required to oxidise a disulfide bond that may be 
required to switch VirA into an “off” state.  
 
 
Figure 38. Effect of cysteine on hcp1 expression in ΔdsbA mutant. Both wild-type and 
ΔdsbA bacterial strains were incubated in RPMI cysteine free medium for 5 h without or with 
cysteine (200 μM) for the last 2 h of incubation. Transcript levels of hcp1 gene for all other 
conditions were normalized to untreated wild-type samples. Assay was performed in 






























The reactive property of the thiol groups in cysteine is exploited by protein regulators for 
redox sensing in their environment (Cremers and Jakob, 2013). In the context of sensory 
protein kinases, the reversible oxidation and reduction state of cysteines and the 
conformational changes associated with the disulfide bonds formed from cysteine oxidation 
allow the regulator to be modulated, probably via protein conformational changes which lead 
to a topology that align the catalytic kinase and HATPase domain to undergo 
autophosphorylation at the conserved His residue (Khorchid and Ikura, 2006). In chapter 4, 
we have provided evidence that VirA senses thiol compounds for T6SS-1 gene upregulation. 
In this chapter, we elucidate the molecular mechanism of how thiols are modulating VirA. It 
is possible that certain cysteine residues in VirA form intra- or intermolecular disulfide bonds 
which serve as the redox-active sensing domain. Potentially, the presence of thiol compounds 
reduce or cleave the disulfide bond(s) formed in the VirA sensing domain to cause a possible 
conformational change that lock VirA in an active state. Here, we investigated the possibility 
that cysteine residues in VirA participate in the sensing of thiol compounds.  
In bacteria, the cytoplasm is maintained in a reducing environment by the presence of GSH 
for vital chemical reactions to take place, while the periplasm of bacterial cells is in a much 
more oxidized state (Smirnova and Oktyabrsky, 2005). In fact, many proteins situated in the 
periplasmic region are linked by disulfide bonds since GSH is low or non-existent in this 
location (Smirnova and Oktyabrsky, 2005). As such, it is conceivable that VirA could have 
encompassed cysteines that potentially form disulfide bonds in the periplasm for cleavage by 
reducing signals. VirA contains eight cysteines, five of which are at the transmenbrane region 
while three are at the cytoplasmic region. Interestingly, Cys62 which is predicted to be at the 
periplasmic region plays a role in maintaining the conformation of VirA, as substitution to 
alanine or serine is able to turn it to a constitutively "on" state.  Possibly, a substitution of C62 
to non-thiol based residues is unable to form disulfide bond, thus resulting in a conformation 
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that drives the activation of its cognate response regulator, VirG, without the presence of 
stimuli. Since histidine kinases usually operate as dimers for signal transduction (Chang and 
Stewart, 1998), it is very likely that two VirA are interlinked via disulfide bond at C62 in the 
default inactivated state. Presence of reducing agents will then cleave the bonds to release 
individual VirA sensors, resulting in an “activated" conformational state. However, the 
substituted variants were still inducible by cysteines to further upregulate hcp1 expression, 
suggesting that it is only part of the redox-sensing domain for thiol compounds. There could 
be other redox active sites that are unidentified. Another observation made is that both C87 
and C314 which were predicted to be at the cytoplasmic and transmembrane helix region 
respectively had a reduced level of VirA activation. Perhaps both mutations have decreased 
the protein expression and statbility of VirA. Alternatively, a substitution of these two 
cysteines to other group could have spatially altered its interaction with other amino acids and 
slightly affected the conformation for proper phosphorelay in the presence of thiol signals.  
In the periplasm, it is well-established that DsbA/B system catalyzes the formation of 
disulfide bonds in proteins (Bardwell et al., 1991). This is shown in the DsbA/B system in E. 
coli was shown to negatively regulate PhoQ/P transcription activity as a dsbA gene knockout 
cause an increase in the expression of PhoQ/P-regulated genes (Lippa and Goulian, 2012), 
Furthermore, addition of reducing agent such as DTT to the wild-type strain has a similar 
phenotype as the dsbA deletion mutant in upregulating PhoP/Q regulated genes (Lippa and 
Goulian, 2012). As such, it is tempting to hypothesize that DsbA/B potentially catalyzes the 
disulfide bond formation in VirA and hence negatively regulates its activity. We therefore 
tested the effect of deleting dsbA on VirA-dependent hcp1 expression. As opposed to our 
hypothesis, there was no constitutive hcp1 expression at basal level in the ΔdsbA mutant and 
there was still upregulation of hcp1 in the presence of cysteine. However, the upregulation 
was lower as compared to the wild-type activated level. It could be that deletion of dsbA may 
affect the stability and protein expression of VirA. It will be also worthwhile to find out 
whether dsbA mutant is pleiotrophic phenotypes, which may have an indirect effect in optimal 
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hcp upregulation. Nevertheless, it suggests that the DsbA/B system is dispensable for thiol 
sensing by VirA, and thus does not affect the downstream T6SS-1 gene expression. Through 
homology search via bioinformatics, there is no other potential protein in B. pseudomallei that 
is similar to DsbA/B. Possibly, there could be other disulfide bond forming pathways 
involved. This is again shown in E. coli that an overexpression of a periplasmic protein, PspE, 
restores disulfide bond formation in many proteins (substrates of DsbA) in a dsbA mutant 
(Chng et al., 2012).     
Another example illustrating redox sensing regulation is the Arc (anoxic redox control) TCS 
in E. coli, that allows facultative anaerobic bacteria to respond to low oxygen condition by 
expressing appropriate gene expression for adaptation (Iuchi et al., 1990). Likewise, under 
reducing or anaerobic growth conditions, ArcB kinase is activated to transcribe genes 
encoding proteins involved in anaerobic respiration. On the other hand, quinone electron 
carriers oxidize two redox-active cysteine residues (C180 and C241) in ArcB to form a 
disulfide bond, hence inhibiting the kinase activity under aerobic growth conditions (Malpica 
et al., 2004). In contrast to PhoQ/P system, DsbA is not involved in oxidizing ArcB as the 
signaling domain lies in the cytosolic region. Such redox signaling by ArcB through thiol 
oxidation and reduction represents a way TCS is modulated in response to various respiratory 
growth conditions.   
It is conceivable that the signal sensed by VirA is modulated indirectly through other co-
sensing accessory proteins, which could be the primary proteins sensing the signal and 
relaying the information to the sensory domain of VirA. Many TCSs depend on more than the 
two core protein components for proper signal transduction, which could be located in the 
outer or inner membrane, the periplasm or cytosol. This is well illustrated in PhoQ/PhoP in E. 
coli and Salmonella. In addition to the previously mentioned environmental signals, it is also 
modulated by another small inner membrane protein MgrB, which functions downstream of 
DsbA and negatively regulates PhoQ transcription activity directly (Lippa and Goulian, 2009). 
MgrB maintains an oxidizing environment in the periplasm through disulfide bond formation 
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between its cysteine residues, hence inhibiting PhoQ activity. This indicates that the redox 
state in the periplasmic space plays a vital role in the regulation of PhoP/Q circuit and MgrB 
is the accessory protein that is involved in the modulation.  
In many cases, redox-sensitive sensors respond to reactive oxygen species (ROS), reactive 
nitrogen species (RNS) or chlorine species, and they are usually in the first line of oxidative 
stress defense, or even modulating the pathogenicity in vivo (Cremers and Jakob, 2013). 
These proteins usually undergo reversible oxidant-mediated disulfide bond formation to 
regulate their activity in response to oxidants. For instance, SsrB response regulator in 
Salmonella that encompassed the redox active Cys203, is a target of RNS generated from the 
host (Husain et al., 2010). During gastrointestinal infection of Salmonella, RNS are produced 
by the acidification of NO2-
(Husain et al., 2010; 
 in the gastric lumen and enzymatic synthesis of NO in epithelial 
cells as a form of host immune defense response Bourret et al., 2008). 
Oxidation of the thiol group in Cys203 by RNS inhibited binding of SsrB to DNA, thus 
suppressing the expression of SPI-2. Suppression of SPI-2 can be advantageous as it is 
concomitant with the expression of SPI-1 virulence factor, which promote cell adhesion, 
invasion and motility during the gastrointestinal phase of the infection (Husain et al., 2010).  
We do not rule out the possibility that cysteine or GSH molecules are covalently attached to 
VirA via S-cysteinylation or S-glutathionylation, in which disulfide bonds are formed 
between the signal and the cysteine residues in VirA. This is the case for the 1-Cys type OhrR 
peroxide sensor in Bacillus subtilis, which undergoes S-thiolation or S-cysteinylations 
between Cys15 and low molecular weight thiol compounds (Lee et al., 2007). Oxidized OhrR 
is then dissociated from target gene operons, hence allowing the activation of antioxidant 
genes transcription compounds (Lee et al., 2007).  
Currently, we are identifying the chemical modifications induced by thiol compounds on 
VirA. Several attempts have been made on expressing recombinant VirA protein for 
polyclonal antibody production. However, we still fail to detect endogenous VirA protein in 
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bacterial lysate.  This could be hindered by the fact that endogenous expression of the sensor 
is too low to be detected by Western blot or the polyclonal antibody produced was not 
specific enough and of low affinity. As an alternative, we are constructing an in situ HA 
affinity tag VirA strain which allows us to detect VirA using HA antibody. This could also 
increase the sensitivity of detection by performing affinity purification prior to subsequent 
detection.  Meanwhile, we are also performing sequential extractions of proteins from the 
bacterial lysate using different detergents and denaturants of varying solubilizing power. VirA 
location will then be identified in each protein fraction through mass spectrometry. 
Subsequently, to examine whether VirA activation is by thiol reduction or S-thiolation, the 
oxidation states of VirA can be determined through chemical alkylation. Briefly, 
cysteine/GSH will be added to bacterial culture before bacterial lysis. The lysate will then be 
subjected to alkylation by reacting with maleimide compounds that react with free thiol 
groups that are exposed. In the event where thiol reduction is involved, disulfide bonds in 
VirA are reduced and maleimide compounds will be bound to the free thiol groups in the 
redox active cysteines in VirA. Conversely, cysteine residues will not react with maleimide in 
the case of S-thiolation. The chemical modification on the redox active cysteines can be 
detected via mass spectrometry after the maleimide reaction from bacterial culture grown 
with or without cysteine induction.  
We believe that the detailed understanding of the regulation of T6SS-1 by thiol compounds 
would reveal a novel mode of communication between the host and pathogen, where the 
pathogen senses its presence inside the host via thiol redox chemistry to express virulence 
factor for pathogenesis. This model is also likely applicable to other pathogens and infection 
systems. Furthermore, such knowledge will present opportunities for novel therapeutic 
options in the long term. Since existence of two-component regulators in eukaryotic systems 
is only limited to lower eukaryotes such as fungi, amoeba, yeast and plants (Loomis W F et 
al., 1997), it makes targeting the TCSs of pathogens attractive for drug development with 
potentially minimal side effects to the host. In fact, development of TCS inhibitors will be an 
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ideal new class of antimicrobial drugs that reduce virulence without killing the pathogenic 
bacteria directly. In contrast to existing antibiotics treatment, such TCSs inhibitors would not 
























Given the fact that T6SS is widely distributed in Gram-negative pathogens and its importance 
in bacterial pathogenesis, it has become a hot topic of research in recent years.  Clearly, 
T6SS-1 is a virulence determinant in B. pseudomallei as shown from our previous study in a 
mice infection model (Chen et al., 2011), and in a hamster infection model (Burtnick et al., 
2011). In this study, we have focused on elucidating the regulatory cascade for T6SS-1 
expression inside the mammalian host.  We have also identified the host signals responsible 
for T6SS-1 expression, and attempted to elucidate the mechanism of how VirA senses the 
signal. Furthermore, the function of T6SS-1 was investigated in various regulatory and 
component mutants to decipher their contribution in T6SS-1 function. 
From chapter 2, we showed that T6SS-1 expression in B. pseudomallei was highly 
upregulated in mammalian host. Unlike T3SS-3 where host cell contact is sufficient for its 
expression, bacterial internalization is required for T6SS-1 expression. In terms of the 
regulatory cascade, the main T3SS-3 transcription factor BsaN controls the expression of 
T3SS-3 effectors (bopE, bopA, bopC), BprC and VirAG regulators. Both VirAG and BprC 
are then required to drive T6SS-1 expression. Collectively, expression of T3SS-3 precedes 
that of T6SS-1, and such coordination ensures that these virulence determinants are expressed 
at the appropriate times during infection to cooperatively confer bacterial pathogenesis. In 
chapter 3, we have demonstrated the interplay of T3SS-3 and T6SS-1 functions in B. 
pseudomallei's intracellular lifestyle. During the infection of phagocytic cells, T3SS-3 is first 
upregulated upon bacterium-macrophage contact. Once inside the phagosomal compartment, 
T3SS-3 is required for early endosomal escape and entry into the host cytoplasm. Inside host 
cytosol, T3SS-3 plays a crucial role in intracellular replication and inducing cytotoxicity 
while T6SS-1 is secondary for both of these events (as evidenced in Chapter 3). BimA which 
is expressed through VirAG, is required for intracellular motility by inducing host actin 
polymerization. Both BimA and T6SS-1 are essential for successful cell to cell spread, with 
actin polymerization allowing bacteria to move towards host cell membrane vicinity and 
T6SS-1 for facilitating MNGC formation, possibly through host cell membranes fusions. 
160 
 
From these results, it seems that T3SS-3 plays a more aggressive role in pathogenesis by 
promoting replication and causing cytotoxicity, while T6SS-1 is essential for the pathogen to 
disseminate to the neighbouring cells and persist within the host.   
We have demonstrated that T6SS-1 regulation differs greatly when in vitro and upon host cell 
infection. In culture medium alone, BprC, but not VirAG, controls all T6SS-1 expression. 
Inside cells, VirAG becomes the major regulator which regulates the expression of all T6SS-1 
components including the hcp1 operon and the downstream genes, while BprC is only 
required for regulating the tssAB operon. This indicates that apart from being regulated by 
BsaN, VirAG is activated in the presence of certain host signals. For the first time, we 
discovered that thiol compounds such as cysteine and glutathione are able to induce T6SS-1 
expression. In the physiological context, cysteine depletion in HepG2 cells and glutathione 
reduction in PBMC are able to negate T6SS upregulation. This is consistent with the data 
showing that expression of hcp1 occurred mainly in the cytosol, since reduced GSH are 
abundantly present in this cellular compartment. In chapter 5, we went on to test the 
hypothesis that the sensing is through thiol reduction on VirA sensor. We identified that a 
substitution of cysteine residue at 62 to alanine or serine was able to drive hcp1 expression 
constitutively even without cysteine induction. Currently, we are 
Even though much progression has been made in the understanding of T6SS-1 regulation, 
many questions still remain unanswered. Crucial to our understanding of T6SS-1 roles in 
mammalian infection is the identification of T6SS-1 effectors and their functions. Currently, 
the effectors of T6SS-1 are unknown and many essential components remain poorly 
characterized. Since the basal expression of T6SS-1 is low in vitro, this hinders our ability to 
detect secretion in an easy and unambiguous way. In view that Hcp1 expression is inducible 
elucidating the chemical 
modification of VirA by thiol compounds. To do so, mass spectrometry will be employed to 
detect the cellular localization of VirA in bacteria lysate. Following that, cell lysate from 
bacterial culture induced with thiol compounds could be analyzed again by mass-
spectrometry to detect modifications on VirA as mentioned in detail in Chapter 5. 
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by thiol compounds, secretion assays can now be employed to test various T6SS mutants for 
their contribution to T6SS1 secretion.  Nonetheless, the development of a secretion assay in 
the context of a mammalian cell infection would be optimal as the secretion would be 
physiological. According to an unpublished study by Lim Yanting (Lim Yan Ting’s PhD 
thesis, Paul MacAry's lab, NUS), Hcp1 can be detected on the host cell surface upon infection, 
signifying that Hcp1 is secreted by the bacteria and transported to the cell exterior through an 
unknown mechanism. This would suggest that detection of Hcp1 on host surface by 
immunofluoresence staining could be used as a readout for T6SS-1 secretion inside cells. If 
such a system is established, one could categorize gene products either as part of the secretion 
complex or as substrates. Once the substrates are identified, their roles can be systematically 
interrogated in exhibiting phenotypic functions of T6SS-1, such as intracellular replication 
and MNGC formation. Furthermore, the role of these genes in known virulence assays and 
mortality studies can be tested in mice or hamster models of infection. This will greatly aid in 
understanding the mechanism of T6SS involvement in virulence. 
Although MNGC formation is undoubtedly a T6SS-1 function, we are still far from 
understanding the precise mechanism of T6SS-1 in virulence. It is important to question 
whether the virulence caused by T6SS-1 is solely due to its ability to form MNGC or cell 
fusions. Till now, there is still no direct evidence showing the relevance of MNGC in 
virulence and pathogenesis in vivo although they were observed in infected tissues of 
melioidosis patients. In fact, the specific effectors and host targets involved in its formation 
are still unknown. It is conceivable that MNGC provides a niche for the bacteria to multiply 
and persist inside the host cells without exposing themselves to extracellular antibiotics or 
antibodies and humoral component of the immune system. This resembles the formation of 
granulomas in tuberculosis where it allows growth and persistence of mycobacteria (Davis 
and Ramakrishnan, 2009). It is also possible that there are additional cellular targets by T6SS-
1 in eukaryotic hosts that remain to be identified. To examine it, microarray can be employed 
to screen for a broad range of host effects attributed to T6SS-1. This can be done by 
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comparing the cellular transcriptional profiles between host cells infected with the wild-type 
and a T6SS-1 mutant. Potential host genes with significant changes in expression will merit 
further studies in relation to T6SS-1 function.  
With respect to T6SS-1 regulation, our study has only focused at the gene transcription level. 
We do not yet know whether T6SS-1 activity can be regulated post- translationally in 
response to different environmental cues. Specifically, we question whether the regulation of 
activity is controlled at the protein level, such as T6SS assembly and contraction of the sheath 
for secretion.  This is the case for P. aeruginosa, where activation of T6SS activities lies at 
the post-translational regulatory level. It involves a kinase (PpkA) that regulates the 
phosphorylation state of a T6SS structural component called Fha at the inner membrane 
(Mougous et al., 2007). Upon sensing of an unknown signal, PpkA phosphorylates Fha which 
triggers the recruitment of ClpV ATPase to the secretion apparatus for assembly and secretion 
activity (Mougous et al., 2007; Hsu et al., 2009). Even though such post-translational 
regulation of T6SS has only been characterized in P. aeruginosa thus far, it may also 
applicable to other pathogens.   
In addition, T6SS-1 regulation in B. pseudomallei can be complex and may involve multiple 
signals besides thiol compounds. Furthermore, cluster is regulated both positively and 
negatively in different conditions. A recent study by Burtnick et al. has demonstrated that 
T6SS-1 expression in B. pseudomallei and B. mallei is negatively regulated by iron and zinc 
when the bacteria were grown in vitro (Burtnick et al., 2013).  It could be modulated through 
the Fur regulatory protein which senses iron concentration. Fur was shown to negatively 
regulate the expression of sci1 T6SS in E. coli, the HSI2-T6SS in P aeruginosa, and the evp 
T6SS cluster in E. tarda  (Brunet et al., 2011; Sana et al., 2012; Chakraborty et al., 2011). In 
B. pseudomallei, two Fur homologs have been identified in the genome (Loprasert et al., 
2000). However, the potential role of the Fur in T6SS-1 regulation has yet to be explored. 
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Overall, much progress has been achieved in the understanding of T6SS-1 in B. pseudomallei 
from the current study. Herein, characterizing the regulatory network of T6SS-1, defining 
how its functions are integrated with T3SS-3 and identifying the signals for its expression 
have given a fuller molecular description of pathogenesis. More importantly, this can form the 
basis for future research in targeting the T6SS-1 cluster, or the regulator (VirAG) for the 
discovery of novel therapeutic interventions to thwart bacterial virulence.  It might be a 
promising target for the development of inhibitor drugs since blocking the expressions and 
functions of T6SS-1 would effectively reduce the virulence without the risk of inducing 
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II  List of poster and oral presentations 
Oral 
1.  3rd Biochemistry Student Symposium  
Coordinate regulation of Type III and Type VI secretion systems in 
Burkholderia  pseudomallei controls bacterial virulence 
Jocelyn Wong and Yunn Hwen Gan 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 
NUS Graduate School for Integrative Sciences & Engineering, National University of 
Singapore. 
Many Gram-negative bacteria employ diverse secretion systems to target host cells. In 
Burkholderia pseudomallei, Type III (T3SS3) and Type VI secretion (T6SS5) systems are 
essential for bacterial pathogenesis.  Previously, we have shown that both systems are crucial 
for virulence in the mouse infection model. However, it is unclear how the systems are 
coordinately regulated and how they contribute to pathogenesis. We have found that T3SS3 
genes are expressed upon bacterial contact with host cell surface whereas T6SS5 gene 
expression requires sensing signals from inside the host cell, likely within endosomal 
compartments.  In the host cell, the bsaN regulator from the T3SS3 cluster controls the gene 
expression of both virAG and bprC, which in turn regulate T6SS5 gene expression. 
Functionally, we found that T3SS3 is required for bacterial intracellular replication and 
phagocytic/endosomal escape into the cytoplasm. T6SS5 contributes to bacterial actin-based 
mobility and bacterial induced multinucleated cell formation. The present study allows us to 
construct a model on how B pseudomallei utilize highly specialized secretion systems 
coordinately in a time and space dependent manner to execute a series of maneuvers to evade 
host defenses and survive inside host cells. 
 













2. 6th World Melioidosis Congress, Queensland, Australia 2010 
TYPE VI SECRETION SYSTEM EXPRESSION IS CONTROLLED BY 
REGULATORS IN TYPE III SECRETION SYSTEM IN BURKHOLDERIA 
PSEUDOMALLEI  
Wong J., Chen Y., Sun G.W., and Gan Y.H. 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 
NUS Graduate School for Integrative Sciences & Engineering, National University of 
Singapore. 
Burkholderia pseudomallei is the causative agent of melioidosis. This pathogen has three 
Type Three Secretion Systems (T3SSs) and the T3SS3 has been shown to be important for 
bacterial virulence in mammalian hosts. B. pseudomallei also has six Type Six Secretion 
Systems (T6SS) and we have shown that T6SS5 is essential for virulence in the mouse 
infection model. However, how T6SS5 expression is regulated by the bacteria is unclear. 
Here, we show that T6SS5 gene expression upon host cell infection is blocked by 
cytochalasin D, an inhibitor of phagocytosis. This indicates that T6SS5 expression requires 
sensing signals from the host cell. In the host cell, the bsaN regulator from the T3SS3 cluster 
controls the gene expression of both virAG and bprC, which are regulators of T6SS5 gene 
expression. Together, they regulate the rest of T6SS5 gene expression. Via the use of 
microscopy, the T6SS-null mutant was shown to exhibit defects in multinucleated cell 
formation in RAW 264.7 murine macrophages, which is a characteristic of intercellular 
spread. Consistently, this T6SS mutant phenotype was also observed in the virAG, bprC and 
bsaN mutants. Based on these findings, it appears that the gene expression and functional 
phenotype of T6SS are under T3SS control. This shows that B. pseudomallei has evolved a 
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Regulation of the Type VI secretion system in Burkholderia  
pseudomallei 
 
Jocelyn Wong1, Yahua Chen and Yunn Hwen Gan
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 




Type VI Secretion Systems are critical virulence determinants in several Gram-negative 
pathogens.  In Burkholderia pseudomallei, the T6SS-1 cluster is essential for virulence in 
mammalian host. However, how T6SS-1 expression is regulated by the bacteria is unclear. 
Here, we show that T6SS-1 gene expression upon host cell infection is blocked by 
cytochalasin D, an inhibitor of phagocytosis. This indicates that T6SS-1 expression requires 
sensing signals from the host cell. In the host cell, the bsaN regulator from the T3SS-3 cluster 
controls the gene expression of both virAG and bprC, which subsequently regulate the rest of 
T6SS-1 gene expression. Whereas most of the T6SS-1 genes expression is dependent on 
VirAG, only the tssAB operon requires both virAG and bprC regulators. We also provide 
evidence that virAG, bprC and tssAB are critical for T6SS-1 function in macrophages such as 
cell to cell spreading through multinucleate giant cell (MNGC) formation and actin-tail 
motility. Furthermore, we aim to identify the intracellular signals sensed by the two 
component regulator VirAG critical for activating T6SS-1 gene expression. We 
Awarded: Runner up for poster presentation 
demonstrate 
that whereas acidic pH plays a small role, proteases such as cathepsin significantly activates 
T6SS-1 expression through VirAG. We also found that certain amino acids in the culture 
medium are required for the upregulation of T6SS-1 genes. We will next elucidate the 
mechanism of how cathepsin and amino acid contribute toT6SS-1 gene upregulation as these 
host signals have never been identified for bacterial sensors before. Determining the 
physiological signals that trigger bacterial virulence would contribute greatly to our 










4. 112th American Society of Microbiology (ASM) General Meeting, San 
Francisco,  
 
    2012  
Poster 
 
Regulation of the Type VI secretion System in Burkholderia  
pseudomallei 
 
Jocelyn Wong, Yahua Chen and Yunn-Hwen Gan
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 
NUS Graduate School for Integrative Sciences & Engineering, National University of 
Singapore. 
* 
Type VI Secretion Systems are critical virulence determinants in several Gram-negative 
pathogens.  In Burkholderia pseudomallei, the causative agent of melioidosis, T6SS-1 cluster 
is essential for bacterial virulence in mammalian hosts. However, how T6SS-1 expression is 
activated and regulated by the bacteria is unclear. We have found that T6SS-1 gene 
expression is upregulated only upon host cell infection. Inside macrophages, whereas most of 
the T6SS-1 genes expression is dependent on VirAG, a two-component sensor-regulator 
system, only the tssAB operon requires both VirAG and BprC regulators. We also provide 
evidence that virAG, bprC and tssAB are critical for T6SS-1 functions such as spreading to 
other cells through multinucleated giant cell (MNGC) formation and actin-tail motility. As 
T6SS-1 is significantly upregulated inside host cells, VirAG is likely responsible for sensing 
certain intracellular signals, possibly from the phagosomal compartment. We investigated the 
effects of acidic pH, reactive oxygen species (ROS) and phagosomal proteases on T6SS-1 
upregulation. Interestingly, 
 
cathepsin but not pH and ROS, significantly activates T6SS-1 
expression through VirAG. Upon cathepsin inhibitor treatment in macrophages, T6SS-1 gene 
expression decreased and MNGC formation was inhibited. We are determining the 
mechanism of how cathepsin contributes to the expression of T6SS-1. Determining the 
physiological signals that trigger bacterial virulence would contribute greatly to our 
understanding on the pathogenesis of B. pseudomallei in mammalian hosts and points to 
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Type VI Secretion System in Burkholderia pseudomallei is 
turned on by thiol compounds in host cell cytosol 
Jocelyn Wong, Yahua Chen and Yunn-Hwen Gan
Department of Biochemistry, NUS Graduate School for Integrative Science and Engineering, 
National University of Singapore, 5, Kent Ridge Crescent, Singapore 119222 
* 
Several secretion systems have evolved in Gram-negative bacteria to release virulence factors 
into the environment or directly into the target host cells. The type VI Secretion System 
(T6SS) was recently identified as one of the critical virulence determinants in many 
pathogens. In Burkholderia pseudomallei, the causative agent of melioidosis, the T6SS-1 
cluster is essential for virulence in the mammalian host and is required for the bacteria to 
polymerize actin to form actin tails in order to facilitate intracellular spreading and mediate 
host cell fusion. However, the molecular basis for the regulation and the environmental 
signals that trigger its expression is unknown. We have shown that T6SS-1 gene expression is 
upregulated only upon host cell infection and is regulated mainly by a two component system, 
VirAG.  VirA, being a histidine kinase sensor, together with VirG, its cognate transcription 
DNA binding partner, regulate T6SS-1 in response to certain intracellular signals. Our goal is 
to identify the endogenous signals that activate VirA. Using immunofluorescence staining, we 
found that the expression of Hcp1, a major component of T6SS-1 and under the regulation of 
VirAG, does not occur in the phagosomal compartment as reported in some bacteria which 
also possess T6SS. Signals from the cytosol are likely responsible for its upregulation. We 
discovered that presence of thiol group in reducing agents such as cysteine and GSH both 
present abundantly in host cytosol, significantly upregulate hcp1 expression through VirA. To 
demonstrate its relevance in the physiological context, we explore the effect of cysteine 
deprivation on T6SS-1 expression by using HepG2 cells to produce a cysteine deficiency 
model. Consistently, depleting cysteine leads to impairment on hcp1 upregulation.  Work is in 
progress to elucidate the chemical basis and molecular mechanism by which the thiol 
compounds modify VirA, the bacterial sensor. These results provide a critical insight into 
how B. pseudomallei adapt its virulence to mammalian host environment through sensing of 
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Thiol compounds in the host cell cytosol induces Type VI 
Secretion system in Burkholderia pseudomallei 
Jocelyn Wong, 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 
NUS Graduate School for Integrative Sciences & Engineering, National University of 
Singapore. 
Yahua Chen and Yunn Hwen Gan  
 
Type VI Secretion Systems are critical virulence determinants in several Gram-negative 
pathogens. In Burkholderia pseudomallei, the causative agent of melioidosis, T6SS-1 is 
essential for bacterial virulence in the mammalian host. We have shown that T6SS-1 gene 
expression is upregulated only upon host cell infection. However, the molecular basis for the 
regulation and the environmental signals that trigger its expression is unknown. Inside cells, 
T6SS is regulated mainly by a two component system, VirAG. VirA is a kinase sensor, 
together with VirG, its cognate transcription regulator, regulates T6SS-1 in response to 
certain intracellular signals. Our goal is to identify the endogenous signals that activate VirA. 
Using immunofluorescence staining, we found that the expression of Hcp1, a major 
component of T6SS-1 under VirAG control, occurs when the bacteria had escaped from the 
phagosomal compartment into the cytosol. We discovered that the presence of thiol group in 
reducing agents significantly upregulate hcp1 expression through VirA. Work is in progress 
to elucidate the chemical basis and molecular mechanism by which the thiol compounds 
modify VirA. These results provide a critical insight into how B. pseudomallei adapt its 
virulence to mammalian host environment through sensing of the host signals to further its 
















7. 7th World Melioidosis Congress, Thailand, Bangkok 
Thiol compounds induce Type VI Secretion system in Burkholderia 
pseudomallei 
Jocelyn Wong, 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, 
NUS Graduate School for Integrative Sciences & Engineering 
Yahua Chen and Yunn Hwen Gan  
In Burkholderia pseudomallei, the cluster 1 of Type VI secretion system (T6SS-1) has been 
shown to be a virulence determinant in mammalian hosts. T6SS-1 has been implicated in the 
intracellular life cycle of this pathogen, such as optimal intracellular survival and replication 
and induction of multi-nucleated giant cell (MNGC) formation that facilitates cell to cell 
spread.  In terms of regulation, we have shown that T6SS-1 gene expression is under the 
control of two component system VirAG, and upregulated only upon host cell infection. 
However, the environmental signals that trigger its expression remain unknown. Our 
objective is to identify the physiological signals that activate VirA during infection in 
mammalian cells. Using immunofluorescence staining and the promoter of hcp1 linked to 
EGFP reporter, we are able to identify the cellular compartment when the expression of hcp1, 
a major component of T6SS-1 under VirAG control, occurs. We also discovered that low 
molecular weight thiol compounds significantly upregulate hcp1 expression through VirA. 
We hypothesize that thiol compounds could reduce the disulfide bonds formed between the 
cysteine residues on VirA. Through site directed mutagenesis, we identified that mutation of a 
cysteine residue on VirA leads to an “on” state which turns on hcp1 expression constitutively.  
Work is in progress to demonstrate the physiological relevance of thiol compounds in 
inducing T6SS-1 expression and to elucidate the chemical modification of VirA by thiol 
compounds. These results will provide a critical insight into how B. pseudomallei adapts to 
the mammalian host environment through sensing of host cytosolic signals to further its own 

























II  List of poster and oral presentations 
Oral 
1.  3rd Biochemistry Student Symposium  
Coordinate regulation of Type III and Type VI secretion systems in 
Burkholderia  pseudomallei controls bacterial virulence 
Jocelyn Wong and Yunn Hwen Gan 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, NUS 
Graduate School for Integrative Sciences & Engineering, National University of Singapore. 
Many Gram-negative bacteria employ diverse secretion systems to target host cells. In Burkholderia 
pseudomallei, Type III (T3SS3) and Type VI secretion (T6SS5) systems are essential for bacterial 
pathogenesis.  Previously, we have shown that both systems are crucial for virulence in the mouse 
infection model. However, it is unclear how the systems are coordinately regulated and how they 
contribute to pathogenesis. We have found that T3SS3 genes are expressed upon bacterial contact 
with host cell surface whereas T6SS5 gene expression requires sensing signals from inside the host 
cell, likely within endosomal compartments.  In the host cell, the bsaN regulator from the T3SS3 
cluster controls the gene expression of both virAG and bprC, which in turn regulate T6SS5 gene 
expression. Functionally, we found that T3SS3 is required for bacterial intracellular replication and 
phagocytic/endosomal escape into the cytoplasm. T6SS5 contributes to bacterial actin-based mobility 
and bacterial induced multinucleated cell formation. The present study allows us to construct a model 
on how B pseudomallei utilize highly specialized secretion systems coordinately in a time and space 
dependent manner to execute a series of maneuvers to evade host defenses and survive inside host 
cells. 
 












2. 6th World Melioidosis Congress, Queensland, Australia 2010 
TYPE VI SECRETION SYSTEM EXPRESSION IS CONTROLLED BY 
REGULATORS IN TYPE III SECRETION SYSTEM IN BURKHOLDERIA 
PSEUDOMALLEI  
Wong J., Chen Y., Sun G.W., and Gan Y.H. 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, NUS 
Graduate School for Integrative Sciences & Engineering, National University of Singapore. 
Burkholderia pseudomallei is the causative agent of melioidosis. This pathogen has three Type Three 
Secretion Systems (T3SSs) and the T3SS3 has been shown to be important for bacterial virulence in 
mammalian hosts. B. pseudomallei also has six Type Six Secretion Systems (T6SS) and we have 
shown that T6SS5 is essential for virulence in the mouse infection model. However, how T6SS5 
expression is regulated by the bacteria is unclear. Here, we show that T6SS5 gene expression upon 
host cell infection is blocked by cytochalasin D, an inhibitor of phagocytosis. This indicates that 
T6SS5 expression requires sensing signals from the host cell. In the host cell, the bsaN regulator from 
the T3SS3 cluster controls the gene expression of both virAG and bprC, which are regulators of 
T6SS5 gene expression. Together, they regulate the rest of T6SS5 gene expression. Via the use of 
microscopy, the T6SS-null mutant was shown to exhibit defects in multinucleated cell formation in 
RAW 264.7 murine macrophages, which is a characteristic of intercellular spread. Consistently, this 
T6SS mutant phenotype was also observed in the virAG, bprC and bsaN mutants. Based on these 
findings, it appears that the gene expression and functional phenotype of T6SS are under T3SS 
control. This shows that B. pseudomallei has evolved a mechanism to coordinate the expression of 
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Poster 
 
Regulation of the Type VI secretion system in Burkholderia  
pseudomallei 
 
Jocelyn Wong1, Yahua Chen and Yunn Hwen Gan
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, NUS 
Graduate School for Integrative Sciences & Engineering, National University of Singapore. 
1 
Abstract 
Type VI Secretion Systems are critical virulence determinants in several Gram-negative 
pathogens.  In Burkholderia pseudomallei, the T6SS-1 cluster is essential for virulence in mammalian 
host. However, how T6SS-1 expression is regulated by the bacteria is unclear. Here, we show that 
T6SS-1 gene expression upon host cell infection is blocked by cytochalasin D, an inhibitor of 
phagocytosis. This indicates that T6SS-1 expression requires sensing signals from the host cell. In the 
host cell, the bsaN regulator from the T3SS-3 cluster controls the gene expression of both virAG and 
bprC, which subsequently regulate the rest of T6SS-1 gene expression. Whereas most of the T6SS-1 
genes expression is dependent on VirAG, only the tssAB operon requires both virAG and bprC 
regulators. We also provide evidence that virAG, bprC and tssAB are critical for T6SS-1 function in 
macrophages such as cell to cell spreading through multinucleate giant cell (MNGC) formation and 
actin-tail motility. Furthermore, we aim to identify the intracellular signals sensed by the two 
component regulator VirAG critical for activating T6SS-1 gene expression. We 
Awarded: Runner up for poster presentation 
demonstrate that 
whereas acidic pH plays a small role, proteases such as cathepsin significantly activates T6SS-1 
expression through VirAG. We also found that certain amino acids in the culture medium are required 
for the upregulation of T6SS-1 genes. We will next elucidate the mechanism of how cathepsin and 
amino acid contribute toT6SS-1 gene upregulation as these host signals have never been identified for 
bacterial sensors before. Determining the physiological signals that trigger bacterial virulence would 
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Jocelyn Wong, Yahua Chen and Yunn-Hwen Gan
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, NUS 
Graduate School for Integrative Sciences & Engineering, National University of Singapore. 
* 
Type VI Secretion Systems are critical virulence determinants in several Gram-negative 
pathogens.  In Burkholderia pseudomallei, the causative agent of melioidosis, T6SS-1 cluster 
is essential for bacterial virulence in mammalian hosts. However, how T6SS-1 expression is activated 
and regulated by the bacteria is unclear. We have found that T6SS-1 gene expression is upregulated 
only upon host cell infection. Inside macrophages, whereas most of the T6SS-1 genes expression is 
dependent on VirAG, a two-component sensor-regulator system, only the tssAB operon requires both 
VirAG and BprC regulators. We also provide evidence that virAG, bprC and tssAB are critical for 
T6SS-1 functions such as spreading to other cells through multinucleated giant cell (MNGC) 
formation and actin-tail motility. As T6SS-1 is significantly upregulated inside host cells, VirAG is 
likely responsible for sensing certain intracellular signals, possibly from the phagosomal compartment. 
We investigated the effects of acidic pH, reactive oxygen species (ROS) and phagosomal proteases on 
T6SS-1 upregulation. Interestingly, 
 
cathepsin but not pH and ROS, significantly activates T6SS-1 
expression through VirAG. Upon cathepsin inhibitor treatment in macrophages, T6SS-1 gene 
expression decreased and MNGC formation was inhibited. We are determining the mechanism of how 
cathepsin contributes to the expression of T6SS-1. Determining the physiological signals that trigger 
bacterial virulence would contribute greatly to our understanding on the pathogenesis of B. 
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Type VI Secretion System in Burkholderia pseudomallei is turned 
on by thiol compounds in host cell cytosol 
Jocelyn Wong, Yahua Chen and Yunn-Hwen Gan
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University of Singapore, 5, Kent Ridge Crescent, Singapore 119222 
* 
Several secretion systems have evolved in Gram-negative bacteria to release virulence factors into the 
environment or directly into the target host cells. The type VI Secretion System (T6SS) was recently 
identified as one of the critical virulence determinants in many pathogens. In Burkholderia 
pseudomallei, the causative agent of melioidosis, the T6SS-1 cluster is essential for virulence in the 
mammalian host and is required for the bacteria to polymerize actin to form actin tails in order to 
facilitate intracellular spreading and mediate host cell fusion. However, the molecular basis for the 
regulation and the environmental signals that trigger its expression is unknown. We have shown that 
T6SS-1 gene expression is upregulated only upon host cell infection and is regulated mainly by a two 
component system, VirAG.  VirA, being a histidine kinase sensor, together with VirG, its cognate 
transcription DNA binding partner, regulate T6SS-1 in response to certain intracellular signals. Our 
goal is to identify the endogenous signals that activate VirA. Using immunofluorescence staining, we 
found that the expression of Hcp1, a major component of T6SS-1 and under the regulation of VirAG, 
does not occur in the phagosomal compartment as reported in some bacteria which also possess T6SS. 
Signals from the cytosol are likely responsible for its upregulation. We discovered that presence of 
thiol group in reducing agents such as cysteine and GSH both present abundantly in host cytosol, 
significantly upregulate hcp1 expression through VirA. To demonstrate its relevance in the 
physiological context, we explore the effect of cysteine deprivation on T6SS-1 expression by using 
HepG2 cells to produce a cysteine deficiency model. Consistently, depleting cysteine leads to 
impairment on hcp1 upregulation.  Work is in progress to elucidate the chemical basis and molecular 
mechanism by which the thiol compounds modify VirA, the bacterial sensor. These results provide a 
critical insight into how B. pseudomallei adapt its virulence to mammalian host environment through 
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Type VI Secretion Systems are critical virulence determinants in several Gram-negative pathogens. In 
Burkholderia pseudomallei, the causative agent of melioidosis, T6SS-1 is essential for bacterial 
virulence in the mammalian host. We have shown that T6SS-1 gene expression is upregulated only 
upon host cell infection. However, the molecular basis for the regulation and the environmental 
signals that trigger its expression is unknown. Inside cells, T6SS is regulated mainly by a two 
component system, VirAG. VirA is a kinase sensor, together with VirG, its cognate transcription 
regulator, regulates T6SS-1 in response to certain intracellular signals. Our goal is to identify the 
endogenous signals that activate VirA. Using immunofluorescence staining, we found that the 
expression of Hcp1, a major component of T6SS-1 under VirAG control, occurs when the bacteria 
had escaped from the phagosomal compartment into the cytosol. We discovered that the presence of 
thiol group in reducing agents significantly upregulate hcp1 expression through VirA. Work is in 
progress to elucidate the chemical basis and molecular mechanism by which the thiol compounds 
modify VirA. These results provide a critical insight into how B. pseudomallei adapt its virulence to 
mammalian host environment through sensing of the host signals to further its own survival and 
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Thiol compounds induce Type VI Secretion system in Burkholderia 
pseudomallei 
Jocelyn Wong, 
Department of Biochemistry, Yong Loo Lin School of Medicine, Immunology Programme, NUS 
Graduate School for Integrative Sciences & Engineering 
Yahua Chen and Yunn Hwen Gan  
In Burkholderia pseudomallei, the cluster 1 of Type VI secretion system (T6SS-1) has been shown to 
be a virulence determinant in mammalian hosts. T6SS-1 has been implicated in the intracellular life 
cycle of this pathogen, such as optimal intracellular survival and replication and induction of multi-
nucleated giant cell (MNGC) formation that facilitates cell to cell spread.  In terms of regulation, we 
have shown that T6SS-1 gene expression is under the control of two component system VirAG, and 
upregulated only upon host cell infection. However, the environmental signals that trigger its 
expression remain unknown. Our objective is to identify the physiological signals that activate VirA 
during infection in mammalian cells. Using immunofluorescence staining and the promoter of hcp1 
linked to EGFP reporter, we are able to identify the cellular compartment when the expression of 
hcp1, a major component of T6SS-1 under VirAG control, occurs. We also discovered that low 
molecular weight thiol compounds significantly upregulate hcp1 expression through VirA. We 
hypothesize that thiol compounds could reduce the disulfide bonds formed between the cysteine 
residues on VirA. Through site directed mutagenesis, we identified that mutation of a cysteine residue 
on VirA leads to an “on” state which turns on hcp1 expression constitutively.  Work is in progress to 
demonstrate the physiological relevance of thiol compounds in inducing T6SS-1 expression and to 
elucidate the chemical modification of VirA by thiol compounds. These results will provide a critical 
insight into how B. pseudomallei adapts to the mammalian host environment through sensing of host 
cytosolic signals to further its own survival and spread.   
 
 
